20.03.2015 Views

Annual Report 2008 English [PDF, 2.69 MB] - Tessenderlo Group

Annual Report 2008 English [PDF, 2.69 MB] - Tessenderlo Group

Annual Report 2008 English [PDF, 2.69 MB] - Tessenderlo Group

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

annual report <strong>2008</strong><br />

MAKING IT SUCCEED


MAKING IT WORK<br />

MAKING IT TOGETHER<br />

MAKING IT INSPIRING<br />

MAKING IT CONVINCING<br />

MAKING IT LASTING<br />

MAKING IT FIT


annual report <strong>2008</strong><br />

The group<br />

in a few figures<br />

The group in a few figures<br />

over 10 years (*)<br />

(millions EUR)<br />

Revenue<br />

Rebitda<br />

Rebit<br />

Non-recurring items<br />

Ebit<br />

Profit (+) / loss (-)<br />

Net cash flow<br />

Profit (+) / loss (-)/Revenue<br />

Rebit/Revenue<br />

Net cash flow/Revenue<br />

Capital Employed (CE)<br />

Working Capital<br />

Roce<br />

Capital expenditure (PP&E)<br />

Equity attributable to equity shareholders of the group<br />

Return on equity (ROE)<br />

Net financial liabilities<br />

Net financial liabilities/Equity (Gearing)<br />

Net financial liabilities/Rebitda<br />

Interest coverage<br />

Dividend paid<br />

Pay out ratio<br />

Headcount<br />

(*) A financial glossary is available on pg 182


<strong>Tessenderlo</strong> <strong>Group</strong><br />

IFRS<br />

<strong>2008</strong> 2007 2006 2005 2004 2003 2002 2001 2000 1999<br />

2,765.0 2,405.9 2,238.3 2,149.6 2,062.9 1,972.0 1,934.0 1,890.0 1,818.0 1,571.0<br />

344.7 261.6 188.4 191.8 220.8 204.0 259.0 230.0 251.0 213.0<br />

239.1 152.3 72.3 67.4 106.2 82.0 115.0 109.0 135.0 102.0<br />

- 26.9 35.1 - 76.9 - 8.2 - 25.0<br />

212.2 187.4 - 4.6 59.2 81.2<br />

140.4 128.7 - 24.3 35.1 53.6 43.0 71.0 65.0 90.0 70.0<br />

280.1 248.1 142.8 161.0 195.6 162.0 207.0 168.0 211.0 180.0<br />

5.1 5.3 -1.1 1.6 2.6 2.2 3.7 3.4 5.0 4.4<br />

8.6 6.3 3.2 3.1 5.1 4.2 5.9 5.8 7.4 6.5<br />

10.1 10.3 6.4 7.5 9.5 8.2 10.7 8.9 11.6 11.5<br />

1,282.7 1,118.9 1,181.3 1,258.0 1,166.0 1,136.0 1,141.0 1,259.0 1,114.0 1,013.0<br />

552.5 367.0 392.7 447.0 413.2 425.0 436.0 521.0 452.0 390.0<br />

18.6 13.6 6.1 5.4 9.1 7.2 10.1 8.7 12.1 10.1<br />

94.2 98.6 119.3 172.5 171.1 119.0 110.0 133.0 137.0 133.0<br />

900.0 800.2 709.5 774.3 755.5 756.0 758.0 836.0 796.0 729.0<br />

16.5 17.0 - 3.3 4.6 7.2 5.7 9.5 9.2 13.3 10.5<br />

294.6 243.8 411.0 428.9 351.4 339.0 303.0 341.0 242.0 209.0<br />

32.7 30.4 57.8 55.4 46.5 44.8 40.0 41.0 30.0 28.0<br />

0.9 0.9 2.2 2.2 1.6 1.7 1.2 1.5 1.0 1.0<br />

14.3 10.9 0.5 3.9 5.2 5.0 8.0 5.0 7.0 9.0<br />

36.9 35.0 33.3 32.7 32.7 30.7 30.6 30.5 30.3 26.8<br />

26.3 27.2 n/a 94.4 58.0 71.5 43.1 46.9 33.7 38.3<br />

8,237 8,121 8,124 8,123 8,181 8,223 7,934 7,849 7,087 6,847


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Summary<br />

1 The group in a few figures<br />

Key figures p. 2<br />

Financial calendar p. 7<br />

2 Message from the chairman p. 10<br />

3 General presentation<br />

Company profile p. 14<br />

Strategy p. 16<br />

International presence p. 18<br />

Markets and Applications p. 22<br />

4 Activity <strong>Report</strong><br />

Highlights of <strong>2008</strong> p. 26<br />

Chemicals p. 28<br />

Inorganics p. 30<br />

PVC/Chlor-alkali p. 35<br />

Plastics Converting p. 40<br />

Profiles p. 42<br />

Plastic pipe systems p. 46<br />

Compounds p. 50<br />

Specialities p. 54<br />

Fine chemicals p. 56<br />

Gelatin p. 60<br />

Natural derivatives p. 64<br />

1<br />

5 Commitments<br />

Human Resources p. 70<br />

Environment, Quality, Safety and Risk Management p. 74<br />

Corporate Governance p. 81<br />

6 Information for shareholders p. 92<br />

7 Financial report<br />

<strong>Annual</strong> accounts <strong>2008</strong><br />

- Consolidated Financial <strong>Report</strong> p. 100<br />

- Statutory Financial <strong>Report</strong> p. 168<br />

8 General information<br />

Production units p. 172<br />

Addresses of the plants and sales offices p. 175<br />

Index p. 181<br />

Financial Glossary p. 182


annual report <strong>2008</strong><br />

<strong>Tessenderlo</strong> <strong>Group</strong> in a few charts<br />

Revenue (millions EUR)<br />

<br />

<br />

<br />

<br />

<br />

<br />

IFRS<br />

2,765<br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

Rebitda (millions EUR)<br />

2<br />

<br />

345<br />

<br />

<br />

IFRS<br />

<br />

<br />

<br />

<br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

Profit (+) / loss (-) (millions EUR)<br />

<br />

140.5<br />

<br />

<br />

<br />

IFRS<br />

<br />

<br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong>


<strong>Tessenderlo</strong> <strong>Group</strong><br />

ROCE (%) Net financial liabilities/Equity (%)<br />

<br />

18.6<br />

<br />

IFRS<br />

<br />

<br />

IFRS<br />

<br />

<br />

<br />

33<br />

<br />

<br />

<br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

Working capital / Revenue (%) Return on equity (%)<br />

3<br />

<br />

<br />

<br />

IFRS<br />

20.0<br />

<br />

<br />

16.5<br />

<br />

<br />

IFRS<br />

<br />

<br />

<br />

<br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

Equity attributable to equity<br />

shareholders of the group<br />

(millions EUR)<br />

Capital expenditure (PP&E)<br />

(millions EUR)<br />

<br />

IFRS<br />

900<br />

<br />

IFRS<br />

<br />

<br />

<br />

<br />

<br />

94<br />

<br />

<br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong>


annual report <strong>2008</strong><br />

Synthetic consolidated balance sheet<br />

IFRS<br />

(millions EUR) <strong>2008</strong> % 2007 %<br />

Property, plant and equipment 652.0 677.8<br />

Goodwill 38.3 37.2<br />

Intangible assets 39.9 36.9<br />

Other non-current assets 79.9 71.9<br />

Non-current assets 810.1 45 823.8 49<br />

Inventories 473.7 339.9<br />

Trade and other receivables 474.9 425.9<br />

Cash and cash equivalents 53.5 93.6<br />

Current assets 1,002.1 55 859.4 51<br />

Non-current assets held for sale 0.7 0.0<br />

Assets 1,812.9 100 1,683.2 100<br />

4<br />

Issued capital and share premium 181.3 179.0<br />

Reserves 313.4 238.6<br />

Retained earnings 405.3 382.6<br />

Minority interests 2.0 2.0<br />

Equity 902.0 50 802.2 48<br />

Provisions and deferred taxes 171.9 146.7<br />

Financial liabilities<br />

- Non-current 96.7 122.6<br />

- Current 251.4 214.8<br />

Other liabilities 390.9 396.9<br />

Liabilities 910.9 50 881.0 52<br />

Equity and Liabilities 1,812.9 100 1,683.2 100<br />

Synthetic consolidated P&L account<br />

IFRS<br />

(millions EUR) <strong>2008</strong> 2007<br />

Revenue 2,765.0 2,405.9<br />

Cost of sales -2,165.9 -1,873.6<br />

Gross profit 599.1 532.3<br />

Distribution expenses -144.6 -165.2<br />

Sales and marketing expenses -62.7 -77.4<br />

Administrative expenses -126.1 -125.2<br />

Other operating income/expenses -26.6 -12.2<br />

REBIT 239.1 152.3<br />

Non-recurring items -26.9 35.1<br />

EBIT 212.2 187.4<br />

Finance costs -21.6 -17.6<br />

Share of result of investements accounted for using the equity method 11.5 6.0<br />

Profit (+) / loss (-) before tax 202.1 175.8<br />

Income tax expense -61.7 -47.1<br />

Profit (+) / loss (-) for the period 140.4 128.7<br />

Attributable to :<br />

Equity holders of the group 140.5 128.9<br />

Minority interests -0.1 -0.2


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Distribution of the revenue <strong>2008</strong><br />

Per business group<br />

Per destination<br />

Specialities<br />

21 %<br />

Chemicals<br />

51 %<br />

Rest of the world<br />

12 %<br />

USA<br />

11 %<br />

Europe<br />

77 %<br />

Plastics Converting<br />

28 %<br />

5<br />

Per country of production<br />

Per consumption market<br />

The Netherlands<br />

6 %<br />

Italy<br />

4 % Other<br />

5 %<br />

Belgium<br />

45 %<br />

Health & Hygiene<br />

14 %<br />

Household<br />

5 %<br />

Building Industry<br />

& Public Works<br />

32 %<br />

USA<br />

10 %<br />

Great Britain<br />

10 %<br />

France<br />

20 %<br />

Industry<br />

20 %<br />

Fertilisers &<br />

Animal Nutrition<br />

29 %


annual report <strong>2008</strong><br />

Key figures per business group<br />

Rebit<br />

Specialities<br />

13.6 %<br />

Plastics Converting<br />

8.8 %<br />

Chemicals<br />

77.6 %<br />

Capital expenditures (PP&E)<br />

Headcount<br />

6<br />

Specialities<br />

33 %<br />

Chemicals<br />

33 %<br />

Specialities<br />

33 %<br />

Chemicals<br />

24 %<br />

Plastics Converting<br />

34 %<br />

Plastics Converting<br />

43 %<br />

Key figures per share<br />

EUR <strong>2008</strong> 2007<br />

Basic earnings per share<br />

(Basic EPS)<br />

5.08 4.69<br />

Net cash flow per share 10.11 8.98<br />

Shareholders’ equity per<br />

share<br />

32.55 29.04<br />

Net dividend per normal<br />

share<br />

1.00 0.95<br />

Net dividend per normal<br />

share with VVPR strips<br />

1.13 1.08<br />

Number of shares 27,713,288 27,626,444<br />

<br />

<br />

<br />

<br />

<br />

<br />

Evolution of the net dividend<br />

per share (EUR)<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

IFRS<br />

2004<br />

2005<br />

2006<br />

2007<br />

1.00<br />

<strong>2008</strong>


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Financial calendar<br />

Results<br />

<strong>Tessenderlo</strong> <strong>Group</strong> publishes quarterly releases of its consolidated results through the news<br />

media. The dates of the releases will be as follows:<br />

• 31 December <strong>2008</strong> results March 12 th , 2009<br />

• 1 st quarter 2009 results April 23 th , 2009<br />

• 1 st half-year 2009 results August 27 th , 2009<br />

• 3 rd quarter 2009 results November 5 th , 2009<br />

General Meeting<br />

• Approval of the financial statements <strong>2008</strong> June 2 nd , 2009<br />

• Approval of the financial statements 2009 June 1 st , 2010<br />

Dividend<br />

• Payment dividend <strong>2008</strong> June 9 th , 2009<br />

(coupon n° 72)<br />

7<br />

News releases: see our website www.tessenderlogroup.com under ‘News & Media’ - ‘News’.<br />

Contacts<br />

Shareholders’ service<br />

Jo VERSPECHT<br />

Tel.: +32 2 639 18 31 - e-mail: jo.verspecht@tessenderlo.com<br />

Investor relations<br />

Christian VREBOSCH (CFO)<br />

Tel.: +32 2 639 18 87 - e-mail: christian.vrebosch@tessenderlo.com<br />

Media relations<br />

Geert DUSAR<br />

Tel: +32 2 639 17 75 - e-mail: geert.dusar@tessenderlo.com


MAKING<br />

IT<br />

TOGETHER


To find out what our customers exactly need, we visit them.<br />

Together we find the answers to their specific questions.<br />

Not every type of feed phosphate is suitable for every<br />

breed. To determine exactly which products the farmers need,<br />

our sales representatives provide guidance for cattle feed<br />

manufacturers and cattle farmers.<br />

9


annual report <strong>2008</strong><br />

Message from the<br />

chairman<br />

Gérard Marchand<br />

Chairman<br />

10<br />

In <strong>2008</strong>, the group encountered variations<br />

in the prices of its primary raw materials<br />

on a scale that had never seen before. The<br />

spectacular increases in the first half of the<br />

year reached historical records during the<br />

summer. After that prices declined until<br />

the end of the year, to return by the start of<br />

2009 to more normal price levels.<br />

This exceptional context was constantly<br />

taken into account in the management<br />

decisions of the group, which was therefore<br />

able not only to bear these increases, but<br />

even to raise its margins.<br />

The group thus recorded excellent results<br />

for <strong>2008</strong>. Its revenue increased by around<br />

15 % and its recurring operating result by<br />

57 %.<br />

In practice, the improvement came entirely<br />

from the Chemicals business, and more<br />

particularly from products intended for<br />

the agricultural sector. Demand in this<br />

sector has remained very high, borne by<br />

the growth in the food needs of the world<br />

population.<br />

The group, one-third of whose activity is<br />

focused on these markets, historically in<br />

Europe but now also in the United States,<br />

therefore benefited from this excellent<br />

economic climate.<br />

The PVC & Alkalis activities recorded less<br />

impressive performances than those for<br />

2007, even if the sustained demand for<br />

alkali products significantly offset the<br />

impact of the decline in PVC.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The Specialities are also progressing. The<br />

good performance of gelatin, animal byproducts<br />

and the continued recovery of the<br />

organic chlorine derivatives compensated<br />

for a weak year in pharmaceutical<br />

intermediates.<br />

At the end of the year, Plastics Converting<br />

notably suffered from the difficulties<br />

of the construction sector. All building<br />

professions are affected, but it is once<br />

again that of profiles which has been<br />

hardest hit.<br />

harder-to-find credit with a balance sheet<br />

which is relatively unencumbered by debts.<br />

We are also continuing the cost-cutting<br />

efforts. The creation in the spring <strong>2008</strong> of<br />

a shared service centre for the accounting<br />

operations on the European level is one<br />

example of this. Naturally these efforts will<br />

continue in 2009.<br />

We are recording a net profit of<br />

140.5 million EUR, which is a new historical<br />

result for the group.<br />

11<br />

The events of <strong>2008</strong> and the economic crisis<br />

are not causing us to modify our strategy,<br />

which consists of having ultimately less<br />

than 30 % of commodities in our activities<br />

portfolio and retaining only the businesses<br />

where one can obtain at least a 12 % return<br />

on capital employed.<br />

The acquisitions of the year in the sector of<br />

plastics converting and in the specialities<br />

of our American subsidiary <strong>Tessenderlo</strong><br />

Kerley Inc. are in conformity with this line.<br />

These good results make it possible for<br />

your Board of Directors to propose to the<br />

General Meeting to raise the dividend to<br />

1.00 EUR net per ordinary share, i.e. an<br />

increase of slightly more than 5 %.<br />

On behalf of the Board, I wish to thank all<br />

employees and managerial staff whose<br />

excellent work has enabled us to present<br />

these results.<br />

We are poised to seize the new growth<br />

opportunities which are certain to present<br />

themselves. However, the economic crisis<br />

has led us to be more selective, so as to get<br />

through this period of more expensive and<br />

Gérard Marchand<br />

Chairman


MAKING<br />

IT<br />

FIT


The products and services of <strong>Tessenderlo</strong> <strong>Group</strong> match the<br />

requirements of users perfectly. Whenever possible, we offer<br />

our customers a total solution. Like at Dyka Plastics.<br />

Our specialists use a plan to calculate which plastic pipes and<br />

fittings are necessary for water, gas and electricity. The next<br />

morning, everything is ready to be picked up at a Dyka sales<br />

point of choice, as close to the customer as possible.<br />

13


annual report <strong>2008</strong><br />

Company profile<br />

14<br />

Chemistry between<br />

three business groups<br />

<strong>Tessenderlo</strong> <strong>Group</strong> is a diversified,<br />

international group active in many areas of<br />

the chemical industry, plastics converting,<br />

gelatin, pharma and natural derivatives.<br />

The group is characterised by an extensive<br />

integration of its activities.<br />

<strong>Tessenderlo</strong> <strong>Group</strong>’s activities are divided<br />

into three business groups:<br />

• Chemicals with two business units;<br />

inorganics and pvc/chlor-alkali;<br />

• Plastics converting and its business<br />

units profiles, plastic pipe systems and<br />

compounds;<br />

• Specialities with its business units<br />

fine chemicals, gelatin and natural<br />

derivatives.<br />

To emphasise the cohesion of some of the<br />

group’s activities and to link them even<br />

better to the strategy of the group, the<br />

business groups will be reshuffeld as<br />

from 1 January 2009:<br />

• Chemicals will, in addition to sulfates,<br />

phosphates and PVC/chlor-alkali, include<br />

the organic chlorine derivatives coming<br />

from fine chemicals. <strong>Tessenderlo</strong> Kerley<br />

moves to the Specialities business group.<br />

• Plastics converting remains the same;<br />

• Specialities adds <strong>Tessenderlo</strong> Kerley to<br />

its portfolio. It also includes pharma,<br />

gelatin and products of natural origin.<br />

Present in everyday<br />

life<br />

<strong>Tessenderlo</strong> <strong>Group</strong>’s products form an<br />

integral part of our everyday lives and<br />

are used in various applications, from<br />

high-quality fertilisers and animal feed to<br />

medicine and car dashboards. A little bit<br />

of <strong>Tessenderlo</strong> <strong>Group</strong> can also be found<br />

in sweets, perfumes, batteries, blood


<strong>Tessenderlo</strong> <strong>Group</strong><br />

bags, water treatment products, washing<br />

powders and window profiles – just to<br />

mention a few examples.<br />

This explains the group’s motto: ‘Bringing<br />

chemistry to life’.<br />

A few figures<br />

• A worldwide personnel count of<br />

about 8,200.<br />

• More than 100 establishments in over<br />

20 countries.<br />

• Consolidated revenues of 2.8 billion EUR<br />

in <strong>2008</strong>.<br />

• A net dividend per share set at 1.00 EUR<br />

in <strong>2008</strong> .<br />

<strong>Tessenderlo</strong> group as a<br />

market leader<br />

<strong>Tessenderlo</strong> <strong>Group</strong> occupies a position of<br />

leadership in a number of diverse markets.<br />

At the world level, the group is:<br />

• The largest producer of liquid<br />

sulphur-containing fertilisers, benzyl<br />

acetate, benzyl chloride, and alphahexylcinnamaldehyde;<br />

• The second largest supplier of<br />

phosphates for animal feed, potassium<br />

sulphate for specialised fertilisers and of<br />

triacetin;<br />

• The third largest manufacturer of highquality<br />

gelatins;<br />

• One of the leading suppliers of<br />

compounds for dashboard skins.<br />

At the European level the group is:<br />

• The number one producer of caustic<br />

potash;<br />

• The second largest supplier of ferric<br />

chloride<br />

• The fourth largest manufacturer of PVC<br />

compounds;<br />

• The fifth largest supplier of PVC.<br />

15


annual report <strong>2008</strong><br />

<strong>Tessenderlo</strong> <strong>Group</strong>’s<br />

strategy<br />

16<br />

At the general meeting of 5 June 2007<br />

<strong>Tessenderlo</strong> <strong>Group</strong>’s strategy for the<br />

coming years was modelled.<br />

This strategy can be summarised as<br />

follows:<br />

• Leading market positions in niche<br />

markets.<br />

• Strengthening and further<br />

diversification of a balanced and<br />

integrated activity portfolio.<br />

• Increase of the specialities share to<br />

70 % of the revenue by 2012 by:<br />

- further developing the Plastics<br />

Converting activities in Europe<br />

- strengthening the gelatin activity’s<br />

top-three position in the world<br />

- further developing the activities<br />

that combine customer service and<br />

by-product valorisation.<br />

• Continuously increase profitability.<br />

• A return on capital employed<br />

(ROCE) of minimum 12 % for all<br />

businesses by 2012.<br />

• Dividend policy aimed at stable<br />

growth.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

<strong>Tessenderlo</strong> <strong>Group</strong>’s<br />

assets<br />

• World leadership and European<br />

leadership for the vast majority of<br />

its niche markets’ products;<br />

• A large and diversified product<br />

range;<br />

• The industrial integration of the<br />

various production processes,<br />

focusing on valorisation of byproducts,<br />

which in turn become raw<br />

materials for new products;<br />

• The orientation to products with a<br />

high added value and a non-cyclical<br />

market;<br />

• A sound financial situation;<br />

• Close to end-user markets and a<br />

strong development of distribution<br />

networks in Plastics Converting;<br />

• <strong>Annual</strong> investments in the amount<br />

of 100 million EUR average (excl.<br />

acquisitions)<br />

• The devotion of experienced and<br />

highly qualified employees;<br />

• Permanent focus on cost control in<br />

order to maximise profitability<br />

17


annual report <strong>2008</strong><br />

International presence<br />

59 Production units<br />

1 Canada<br />

11 United States of America<br />

1 Argentina<br />

4 Great Britain<br />

7 Belgium<br />

5 Netherlands<br />

2 Poland<br />

1 Germany<br />

22 France<br />

3 Italy<br />

18<br />

2 China<br />

Sales offices &<br />

distribution centres<br />

Belgium<br />

Chile<br />

China<br />

Czech Republic<br />

France<br />

Germany<br />

Great Britain<br />

Hong Kong<br />

Hungary<br />

Italy<br />

Lebanon<br />

Mexico<br />

Netherlands<br />

Peru<br />

Poland<br />

Romania<br />

Slovakia<br />

Spain<br />

Switzerland<br />

Turkey<br />

Canada<br />

1<br />

United States of America<br />

11<br />

Argentina<br />

1


<strong>Tessenderlo</strong> <strong>Group</strong><br />

4 22 7 5 1 2 3<br />

Great Britain France Belgium Netherlands Germany Poland Italy<br />

19<br />

China<br />

2


annual report <strong>2008</strong><br />

<strong>Tessenderlo</strong> <strong>Group</strong><br />

<strong>Tessenderlo</strong> Chemie NV<br />

WYMAR<br />

INTL.<br />

(BE)<br />

TESSENDERLO NL<br />

HOLDING BV<br />

(NL)<br />

TESSENDERLO<br />

HOLDING UK<br />

(GB)<br />

TEFIPAR<br />

(FR)<br />

DYNAPLAST<br />

EXTRUCO<br />

82 % (CA)<br />

PB LEINER<br />

ARGENTINA<br />

(AR)<br />

PB GELATINS<br />

UK (GB)<br />

SAV (FR)<br />

SAPLAST (FR)<br />

TC<br />

ROTTERDAM<br />

(NL)<br />

TESSENDERLO<br />

FINE CHEMICALS<br />

(GB)<br />

PC LOOS<br />

(FR)<br />

CALAIRE<br />

CHIMIE (FR)<br />

20<br />

DYKA<br />

BV<br />

(NL)<br />

John<br />

Davidson<br />

Pipes<br />

(GB)<br />

TESSENDERLO<br />

FINANCE NV<br />

(BE)<br />

EUROCELL<br />

(GB)<br />

PLASTIVAL<br />

(FR)<br />

SOTRA-<br />

SEPEREF (FR)<br />

CHEMILYL<br />

(FR)<br />

AKIOLIS<br />

GROUP (FR)<br />

LVM<br />

LI<strong>MB</strong>URG<br />

(NL)<br />

THERMOPLASTIQUES<br />

COUSIN-TESSIER<br />

(FR)<br />

FERSO<br />

50 % (FR)<br />

TESSENDERLO<br />

CHEMIE<br />

MAASTRICHT (NL)<br />

PROFEX<br />

(FR)<br />

TESSENDERLO<br />

SERVICES (FR)<br />

PB GELATINS<br />

GmbH (DE)<br />

PB GELATINS<br />

PINGYANG Co Ltd<br />

(CN)<br />

TESSENDERLO<br />

TRADING<br />

SHANGHAI (CN)<br />

NYLOPLAST<br />

EUROPE<br />

(NL)


<strong>Tessenderlo</strong> <strong>Group</strong><br />

TESSENDERLO<br />

PARTICIP (IT)<br />

TESSENDERLO<br />

USA (US)<br />

LVM<br />

(BE)<br />

TESSENDERLO<br />

ITALIA (IT)<br />

PB LEINER<br />

USA (US)<br />

IMMO<br />

WATRO<br />

(BE)<br />

FARCHEMIA<br />

(IT)<br />

CHELSEA B.P.<br />

(US)<br />

TESSENDERLO<br />

KERLEY (US)<br />

JUPITER<br />

SULPHUR<br />

50 % (US)<br />

ALKEMIN<br />

49 % (MX)<br />

TAILE (CN)<br />

TCT<br />

POLSKA<br />

(PL)<br />

21<br />

H Holding<br />

C<br />

K<br />

S<br />

D<br />

Chemicals<br />

Plastics converting<br />

Specialities<br />

Service company<br />

MPR<br />

SERVICES<br />

(US)<br />

TESSENDERLO<br />

AGROCHEM<br />

(TR)<br />

DYKA<br />

PLASTICS<br />

(BE)<br />

DYKA<br />

POLSKA<br />

(PL)<br />

ZEOLINE<br />

50 % (BE)<br />

TERELUX<br />

(LU)<br />

TCI<br />

(BE)<br />

T-POWER<br />

33 %<br />

(BE)


annual report <strong>2008</strong><br />

Markets and applications<br />

<strong>Tessenderlo</strong> <strong>Group</strong>: Bringing Chemistry to Life<br />

CONSTRUCTION INDUSTRY<br />

PVC and Compounds C P plastic pipe systems, door and window profiles, facade<br />

cladding, panelling, cable sleeves and cable insulation,<br />

floor covering, conservatories<br />

Zeolites C double-glazing<br />

AGRICULTURE<br />

22<br />

Ammonium, calcium and<br />

potassium thiosulphate<br />

C<br />

Animal fats S animal nutrition<br />

liquid fertilisers for large-scale cultivation<br />

Caustic potash C horticulture, fertilisers for irrigation systems<br />

Cereal based by-products S animal nutrition<br />

Crop protection products C plant health of speciality crops<br />

Dehydrated proteins S fertilisers, composting<br />

Feed phosphates C animal feed ingredients<br />

Glycine and derivatives S animal feed, agrochemicals<br />

Organic chlorine derivatives S advanced intermediates for agrochemicals<br />

Potassium sulphate C specialised fertilisers, which are particularly suited<br />

for vegetable, flower, fruit and tobacco growing and<br />

fertirrigation<br />

Sulphuric acid C fertilisers, crop protection products<br />

Triazone: slow release nitrogen<br />

fertilisers<br />

C<br />

speciality and broadacre crops<br />

INDUSTRY<br />

Acetates C antifreeze products, for e.g. runways<br />

Animal fats S biodiesel, lipochemistry, green energy (combustion)<br />

Benzyl alcohol S paints<br />

Caustic potash C batteries, oildrilling, biodiesel<br />

Caustic soda C aluminium, rayon, paper, pulp<br />

Dehydrated proteins S green energy<br />

Electrolysis products C photography, leather tanning, water treatment, mining


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Ferric chloride C water treatment<br />

Gelatin S photographic paper and -film, paintballs, electro-plating<br />

Mono-ammonium phosphate C fire extinguisher, fire retardant<br />

Organic chlorine derivatives S paint, photography, coatings<br />

Potassium sulphate C plasterboards<br />

PVC and Compounds C P automotive industry: dashboards skins, airbag covers,<br />

seals, interior trim<br />

other: road safety cones, furniture, shoe soles,<br />

tarpaulins, cables, fencing systems,<br />

Sulphuric acid C batteries, car windows, billiard balls<br />

HEALTH AND HYGIENE<br />

Active pharmaceutical ingredients S medicines<br />

Caustic soda C detergents, soaps<br />

Chlorine C water disinfection, disinfectants, PVC<br />

Gelatin S capsules for e.g. drugs, skin cream, treatment of wounds<br />

Glycine S pharmaceutical products eg. buffer in isotonic solutions<br />

Organic chlorine derivatives S various pharmaceutical products for people, plants and<br />

animals, perfumes, shampoo, UV stabilisers<br />

Pharmaceutical intermediates S a wide range of medicines<br />

PVC and Compounds C P blood bags, infusion bags and tubes, catheters, gloves,<br />

bottles for shower and bath foam, toothbrush grip<br />

Sodium hypochlorite C sanitiser, water treatment, bleaching<br />

23<br />

HOUSEHOLD<br />

Animal fats S pet food<br />

Electrolysis products C detergents<br />

Dehydrated proteins S pet food<br />

Feed phosphates C pet food<br />

Gelatin S foodstuffs such as dairy and ‘light’ products,<br />

confectionery, energy bars and drinks<br />

Glycine S foodstuffs, aspics<br />

PVC and Compounds C P packaging films, tablecloths, shower curtains, credit<br />

cards, furniture, inflatable articles such as balls,<br />

swimming pools, boats, seals for refrigerators, tool<br />

handles.<br />

Caustic soda C detergents<br />

Zeolites C washing powders<br />

C Chemicals P Plastics Converting S Specialities


MAKING<br />

IT<br />

INSPIRING


<strong>Tessenderlo</strong> <strong>Group</strong> looks ahead. Every day we work on<br />

products that make life more comfortable and benefit the<br />

environment. These range from recyclable plastics for cars<br />

to low-calorie gelatins and environmental-friendly fertilisers.<br />

This is precisely why we want to inspire young people<br />

too.<br />

25


annual report <strong>2008</strong><br />

Highlights of <strong>2008</strong><br />

26<br />

March<br />

Eurocell, a UK subsidiary company<br />

of <strong>Tessenderlo</strong> <strong>Group</strong> and British<br />

market leader for the production and<br />

distribution of pvc profiles, acquires<br />

the distributor Peninsula Plastics and<br />

reinforces its position in the North West<br />

of England.<br />

April<br />

Eurocell acquires the assets of Sprint<br />

1233, formerly Plastmo Profiles Ltd<br />

(Northampton, UK). This acquisition<br />

will secure Eurocell’s position as the<br />

number one PVC-window profiles<br />

extruder in the UK, as well as<br />

complementing its existing product<br />

range<br />

<strong>Tessenderlo</strong> <strong>Group</strong> sets up a Shared<br />

Service Centre (SSC) in Leuven<br />

(Belgium) to centralise its accounting<br />

department at the European level. The<br />

aim of the SSC is to further optimise all<br />

its accounting processes and systems<br />

and standardise and harmonise them.<br />

The expansion of SSC will take place<br />

gradually between <strong>2008</strong> and 2011.<br />

September<br />

<strong>Tessenderlo</strong> <strong>Group</strong> announces<br />

changes in management, effective as<br />

from 1 January 2009. Frank Coenen<br />

is appointed Chief Operating Officer<br />

(COO) of <strong>Tessenderlo</strong> <strong>Group</strong>. He will<br />

lead the business groups Chemicals,<br />

Plastics Converting and Specialities,<br />

that respectively will be headed by<br />

Pol Deturck, Albert Vasseur and Jan<br />

Vandendriessche<br />

October<br />

<strong>Tessenderlo</strong> <strong>Group</strong> acquires the<br />

Dutch company Nyloplast Europe<br />

BV. Nyloplast manufactures<br />

large-diameter plastic fittings for<br />

pressureless pipe systems used for<br />

draining sewage and rain water. This


<strong>Tessenderlo</strong> <strong>Group</strong><br />

acquisition enables the Plastic Pipe<br />

Systems Business Unit to extend its<br />

range of products and services for total<br />

water management and to strengthen<br />

its position in Europe.<br />

November<br />

Caillaud, a French subsidiary company<br />

of <strong>Tessenderlo</strong> <strong>Group</strong> that specialises<br />

in the collection, processing and<br />

valorisation of organic by-products<br />

changes its name to Akiolis. This<br />

is with a view to the international<br />

development of its activities.<br />

December<br />

Eurocell Profiles Ltd (UK) acquires<br />

Cavalok Building Products.<br />

Cavalok manufactures window and door<br />

cavity closer systems made from postconsumer<br />

recycled PVC.<br />

is extended for 20 years. <strong>Tessenderlo</strong><br />

<strong>Group</strong> has made a clear choice for a<br />

sustainable approach and will invest in<br />

additional environmental activities.<br />

T-Power, a joint venture between<br />

<strong>Tessenderlo</strong> Chemie NV, Siemens<br />

Project Ventures GmbH, and<br />

International Power plc, achieved<br />

financial close of its 420 MW CCGT<br />

(Combined Cycle Gas Turbine) power<br />

plant in <strong>Tessenderlo</strong> (Belgium).<br />

The power plant will commence<br />

operation in 2011 and will increase the<br />

competitiveness of the production plant<br />

in <strong>Tessenderlo</strong>.<br />

The phosphates activities are clustered<br />

in a new dedicated organisation named<br />

Aliphos.<br />

27<br />

The environmental permit for the<br />

Ham and <strong>Tessenderlo</strong> plant (Belgium)


annual report <strong>2008</strong><br />

Chemicals<br />

The Chemicals business group is comprised of two business units:<br />

Inorganics and Chlor-alkali/PVC. It is characterised by an integrated<br />

production process in which the various end-products and by-products are<br />

utilised internally in order to create maximum added value. The business<br />

group’s products are used in industry and agriculture and have applications<br />

in a large number of aspects of everyday life, from batteries and paper to<br />

animal nutrition, speciality fertilisers and water treatment.<br />

28<br />

<strong>2008</strong> in a nutshell<br />

<strong>2008</strong> was a record year for the Chemicals business group following a very successful<br />

year in 2007. The lower results in Chlor-alkali/PVC were amply compensated for by<br />

Inorganics. Despite the high raw material prices, among other things due to rising<br />

oil prices in the first three quarters, profitability was improved. The Inorganics<br />

business unit in particular was able to improve margins for agricultural products.<br />

For the Chlor-Alkali activity, the margins for caustic potash and caustic soda were<br />

higher than in 2007. However, this could not compensate for the decline in the PVC<br />

activity. The results of the latter were unsatisfactory in the last quarter. The new<br />

strategy whereby <strong>Tessenderlo</strong> <strong>Group</strong> and the Chemicals business group focus more<br />

on specialities and less on commodities, has resulted in excellent performance in the<br />

United States with <strong>Tessenderlo</strong> Kerley Inc. (TKI) recording strong figures.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Key figures<br />

<strong>2008</strong> 2007<br />

Revenue (millions EUR) 1,402 1,027<br />

REBIT (millions EUR) 197 83<br />

ROCE (%) 33 18<br />

Capital expenditures (PP&E) (millions EUR) 28 37<br />

Headcount 1,965 2,009<br />

Market leadership<br />

• The largest producer of liquid sulphurcontaining<br />

fertilisers (thiosulphates) at<br />

world level.<br />

• The second largest supplier in the world<br />

of phosphates for animal feed and of<br />

potassium sulphate for specialised<br />

fertilisers<br />

• The largest producer of caustic potash<br />

in Europe.<br />

• The second largest producer of ferric<br />

chloride at European level.<br />

29<br />

Revenue breakdown over 10 years<br />

(millions EUR)<br />

1,500<br />

1,402<br />

1,200<br />

900<br />

IFRS<br />

600<br />

300<br />

0<br />

99<br />

00<br />

01<br />

02<br />

03<br />

04<br />

05<br />

06<br />

07<br />

08


annual report <strong>2008</strong><br />

Inorganics<br />

In <strong>2008</strong>, the Inorganics business unit was confronted with a historical increase in raw<br />

material prices. However, these increases could be passed on to the market through<br />

higher sales prices. Margins for agricultural products were finally restored after<br />

several difficult years. Sales of potassium sulphate for fertilisers remained at the<br />

level of 2007, while demand for animal feed phosphates fell in the second half of the<br />

year.<br />

30<br />

Activities and products<br />

The Inorganics business unit operates in<br />

a variety of different markets. Potassium<br />

sulphate is a fertiliser that is extremely<br />

suited for use in dry areas and for<br />

highly sensitive crops such as flowers,<br />

vegetables, fruit, and tobacco. <strong>Tessenderlo</strong><br />

<strong>Group</strong> invested mainly in potassium-based<br />

specialities for modern agriculture.<br />

Sulphur-based liquid fertilisers (including<br />

ammonium, potassium, calcium and<br />

magnesium thiosulphate) are used in<br />

North America as fertilisers for cereal and<br />

broad-acre crops, and for arboricultural<br />

and vegetable cultivation. Other sulphur<br />

derivatives are used for different industrial<br />

applications including mining, water and<br />

waste-water treatment and in a wide range<br />

of chemical processes.<br />

Mineral phosphates are used in the animal<br />

feed industry. The range of phosphate<br />

products is so diverse that <strong>Tessenderlo</strong><br />

<strong>Group</strong> is able to offer the required quality<br />

for all kinds of feed applications. The<br />

optimal digestibility of the animal feed<br />

phosphates allows a perfect balance to be<br />

struck between the development of the<br />

animal and respect for the environment.<br />

Trends and facts in <strong>2008</strong><br />

Raw material prices continued to rise until<br />

September. In some cases, prices were<br />

300 % higher than in 2007. <strong>Tessenderlo</strong><br />

<strong>Group</strong> succeeded in passing these price<br />

increases on to the market.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The range of<br />

fertilisers continues<br />

to evolve towards<br />

high-grade<br />

specialities<br />

Potassium sulphate volumes remained at<br />

their 2007 level. SoluPotasse®,<br />

a highly water-soluble potassium fertiliser,<br />

strengthened its position as world leader<br />

in irrigation fertilisation. GranuPotasse®,<br />

that is used extensively by fertiliser<br />

formulators, advanced strongly.<br />

This success is helping <strong>Tessenderlo</strong> <strong>Group</strong><br />

to drive its product range towards highgrade<br />

specialities.<br />

Given that the majority of sales is in euros,<br />

the exchange rate evolution of the American<br />

dollar had little impact on the results.<br />

Sales of animal feed phosphates dropped<br />

across Europe, with a dramatic fall in<br />

Central Europe. Due to the low prices for<br />

pork, East European farmers have reduced<br />

their pig inventories by 30 %. The shortage<br />

of animal feed phosphates in the first<br />

quarter of <strong>2008</strong>, combined with very high<br />

prices, has led to many feed producers to<br />

use the phytase enzyme alongside mineral<br />

phosphates.<br />

31


annual report <strong>2008</strong><br />

32<br />

Margins for<br />

agricultural products<br />

could be restored<br />

A closer look at<br />

<strong>Tessenderlo</strong> Kerley Inc.<br />

(US)<br />

<strong>Tessenderlo</strong> Kerley, Inc (TKI) and its<br />

business units in the United States<br />

achieved solid performance under very<br />

challenging conditions in the market place.<br />

Fertiliser volumes for <strong>2008</strong> were on an<br />

increase due to higher farm commodity<br />

prices in the first half of the year. TKI was<br />

able to maintain margins in <strong>2008</strong>.<br />

The speciality fertiliser products,KTS®<br />

(potassium thiosulphate), N-Sure® and<br />

Trisert® slow release nitrogen products as<br />

well as CaTs® (calcium thiosulphate) have<br />

enjoyed a strong year in <strong>2008</strong>. Demand has<br />

been strong in all cropping areas and in<br />

several cases exceeded supply in most of<br />

the broadacre and speciality crop areas.<br />

Fertilisers and crop<br />

protection products are<br />

doing very well in the US<br />

in <strong>2008</strong><br />

NovaSource®, TKI’s crop protection<br />

business unit, enjoyed a year of strong<br />

growth and above average profitability in<br />

<strong>2008</strong> as the result of the Surround® and<br />

Sinbar® product acquisitions made in<br />

late 2007. In addition, good growth was<br />

experienced in its existing business range.<br />

In <strong>2008</strong>, <strong>Tessenderlo</strong> Kerley Inc. acquired<br />

the assets of Agrochem in Turkey. It also<br />

acquired an interest in Wolf Mountain<br />

Products.<br />

MPR Services, Inc, TKI’s Solvent<br />

Services Business that supplies<br />

services to refineries for the treatment<br />

of flue gasses and solvents, continued its<br />

world-wide growth in both<br />

mobile services and permanently installed<br />

units. In addition to its international<br />

sales agents, MPR became the operating<br />

company for MPR Middle East WLL (MME),<br />

a joint venture between Gulf Technologies<br />

WLL and <strong>Tessenderlo</strong> NL Holding BV.,<br />

based in the Kingdom of Bahrain.<br />

MME will service the energy industry in the<br />

GCC and Egypt.<br />

The TKI Refinery Services model is being<br />

pursued with refineries in the U.S.A. TKI<br />

has production plants linked to refineries<br />

to recover sulphur and other residuals that<br />

are in turn used to manufacture sulphurbased<br />

fertilisers.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Strategy and prospects<br />

for 2009<br />

The volumes for potassium sulphate<br />

are expected to fall below <strong>2008</strong> levels in<br />

Europe. Farmers have trouble obtaining<br />

credit from their banks and will not be able<br />

to place orders.<br />

Sales of SoluPotasse® will continue to<br />

rise. The growing shortage of water and<br />

agricultural land forces farmers to switch<br />

to drip irrigation that requires more watersoluble<br />

fertilisers.<br />

It is yet to be seen how the world<br />

financial markets will affect<br />

<strong>Tessenderlo</strong> Kerley and its business<br />

unit’s performance in 2009. It will<br />

be a challenging year, one that will<br />

be influenced by commodity pricing,<br />

availability of raw materials, declining<br />

world oil prices and the availability of<br />

water in the Western US for agriculture<br />

enterprises. TKI will continue to<br />

develop and extend its activity model of<br />

diversification and profitable growth by<br />

acquisitions and maintain its position as a<br />

lower cost producer in its major markets.<br />

Prices will probably remain stable or<br />

drop slightly. However, margins will be<br />

maintained.<br />

With the set up of a dedicated division for<br />

feed ingredients, Aliphos, <strong>Tessenderlo</strong><br />

<strong>Group</strong> wants to optimise its production<br />

facilities for animal feed phosphates.<br />

Demand for animal feed is declining<br />

fast due to dropping meat consumption,<br />

the result of the worldwide economic<br />

crisis. Phosphate prices are expected to<br />

drop significantly compared to late <strong>2008</strong>.<br />

Volumes will however be similar to <strong>2008</strong><br />

levels because more mineral calcium will<br />

again be used in animal feed instead of the<br />

phytase enzyme.<br />

After a strong <strong>2008</strong>, Thio-Sul® (ammonium<br />

thiosulphate) fertiliser sales of TKI will<br />

come under pressure in the first quarter<br />

of 2009 due to carry-over inventory on the<br />

dealer/distributor level and further fear<br />

of prices moving downward in the market<br />

place. Lower farm commodity prices<br />

in relationship to input costs will be an<br />

influence in 2009.<br />

Allocation of speciality fertiliser products<br />

in the market place will continue through<br />

2009. The completion of the KTS®<br />

(potassium thiosulphate) and CaTs®<br />

(calcium thiosulphate) plant in Ham,<br />

Belgium in 2009 will help in alleviating a<br />

portion of the supply situation. TKI’s plant<br />

nutrients main challenge will be the<br />

33


annual report <strong>2008</strong><br />

availability of raw materials and the rising<br />

costs of these inputs.<br />

of the Specialities business group as from<br />

1 January 2009.<br />

34<br />

The challenges for the crop protection<br />

business unit in 2009 will be to expand<br />

the cropping applications for the new<br />

products; striving to become the least-cost<br />

producer in all of the NovaSource ® range<br />

and adding profitable new products to its<br />

existing business base.<br />

Unlike the other products of the Chemicals<br />

business group which can be considered as<br />

commodities, TKI products are specialised<br />

products for <strong>Tessenderlo</strong> <strong>Group</strong> and as<br />

such constitute an area of growth for the<br />

future. For this reason, financial reporting<br />

about TKI activities will be part<br />

Strategy for the<br />

inorganics business<br />

unit<br />

• Reduce production costs<br />

throughout the value chain as<br />

much as possible.<br />

• Seek alliances in order to<br />

strengthen our competitive<br />

position.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

PVC / Chlor-Alkali<br />

The PVC activity has experienced a difficult year. Until the start of the autumn,<br />

sales volumes were at the same level as in 2007. Prices were generally high but<br />

with gradually decreasing margins. Demand and margins plummeted in the fourth<br />

quarter.<br />

Activities and products<br />

Vinyl chloride monomer (VCM) is the main<br />

raw material in the production of polyvinyl<br />

chloride (PVC). VCM is produced from<br />

chlorine or hydrochloric acid and ethylene.<br />

Chlorine and hydrochloric acid are<br />

produced at the same site at <strong>Tessenderlo</strong><br />

(Belgium) making road transport<br />

unnecessary. Ethylene is bought in<br />

externally and delivered via a specially<br />

designed secure and environmentallyfriendly<br />

pipeline network.<br />

Netherlands and in Northern France.<br />

These two plants are among the largest<br />

in Europe, with a total capacity of 480,000<br />

tonnes.<br />

PVC is one of the most versatile plastic<br />

resins in the world. It has a very extensive<br />

range of applications, ranging from plastic<br />

pipe systems, window and door profiles,<br />

flexible and hard films and sheathings for<br />

cables and wires.<br />

Trends and facts in<br />

<strong>2008</strong><br />

35<br />

Chlorine is produced in the group’s<br />

electrolysis units, while hydrochloric<br />

acid is a by-product of the production of<br />

sulphates, allowing a unique integration of<br />

raw materials to be achieved. <strong>Tessenderlo</strong><br />

<strong>Group</strong>’s annual VCM production capacity is<br />

550,000 tonnes.<br />

The polymerisation of VCM to PVC occurs<br />

at two locations, in the South of the<br />

The crisis in the<br />

construction and<br />

automotive industry has<br />

resulted in a sharp<br />

decline in PVC use<br />

During the first six months of the year,<br />

sales volumes were slightly higher than in<br />

2007. Margins deteriorated as a result of


annual report <strong>2008</strong><br />

the continued increase of ethylene prices<br />

that follow the evolution of oil prices.<br />

Demand quickly slowed down after the<br />

summer and the fourth quarter turned<br />

out to be a catastrophe. Sales dropped by<br />

an average of around 30 %, a reflection of<br />

the crisis in the most cyclically sensitive<br />

sectors, such as the construction and<br />

automotive industries. In addition, the<br />

plummeting of raw material prices at the<br />

end of the year and scarce credit resulted<br />

in a general reduction of stocks.<br />

Outlook for 2009<br />

has resulted in a sharp downturn of the<br />

construction industry in Eastern Europe as<br />

well.<br />

In the long term, PVC will continue to<br />

be a competitive commodity business.<br />

Therefore, <strong>Tessenderlo</strong> <strong>Group</strong> is continuing<br />

to focus on cost reduction, increased<br />

productivity and the improvement of<br />

quality and service. This is the only way<br />

for <strong>Tessenderlo</strong> <strong>Group</strong> to strengthen its<br />

position as a specialist in the field of<br />

suspension PVC.<br />

36<br />

Forecasts remain unfavourable as long as<br />

the general economic climate does not pick<br />

up. This seems to be improbable for 2009.<br />

Ethylene prices will probably be negotiated<br />

on a monthly basis instead of every quarter.<br />

This means PVC prices will fluctuate even<br />

more. Furthermore, imports from the<br />

United States and Asia, where production<br />

costs are lower, also threaten prices.<br />

Focus on low costs and<br />

high productivity to<br />

strengthen our market<br />

position<br />

Strategy for the PVC<br />

activity<br />

Forecasts for PVC<br />

for 2009 are not<br />

very bright<br />

The European PVC market has become<br />

a mature market with minimal growth<br />

potential. The current financial crisis<br />

• Keep costs throughout the value<br />

chain as low as possible.<br />

• Offer maximum added value<br />

with existing products and<br />

resources.<br />

• Pursue maximum productivity.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Chlor-Alkali / PVC<br />

In <strong>2008</strong>, the profitability of the Chlor-Alkali activity was mainly determined by caustic<br />

soda and caustic potash. Although the margins of these products were higher than<br />

in the previous year, they were not sufficient to compensate for the deteriorating<br />

margins of the PVC activity. The project for the construction of an electricity power<br />

station by 2011 is on schedule.<br />

Activities and products<br />

The electrolysis departments of<br />

<strong>Tessenderlo</strong> <strong>Group</strong> have an annual capacity<br />

of 400,000 tonnes of chlorine. This is<br />

mainly used internally for the production<br />

of vinyl chloride monomer (VCM), used to<br />

make polyvinyl chloride (PVC), and in fine<br />

chemicals.<br />

Caustic potash and caustic soda are<br />

released during the production of chlorine.<br />

Caustic potash is used in food processing,<br />

fertilisers, alkali batteries, defrosting<br />

products for airports, detergents and<br />

other processes within the chemical<br />

industry. Caustic soda is used for water<br />

purification and in the manufacture of<br />

soaps and detergents. In addition to these<br />

areas, there are many applications in the<br />

chemical, the aluminium and the paper<br />

industry.<br />

From these electrolysis basic products,<br />

various products are derived which are<br />

used in photography, the food sector, water<br />

purification and the extraction of ores.<br />

Ferric chloride and aluminium chloride<br />

are also produced in addition to the classic<br />

electrolysis products. Both products are<br />

indispensable in the fast-growing water<br />

purification sector.<br />

Trends and facts in<br />

<strong>2008</strong><br />

The prices of caustic potash rose in the<br />

second half of the year above the level<br />

of 2006-2007 due to the shortage of the<br />

product in the United States. European<br />

stocks were practically consistently below<br />

the long-term average. Demand remained<br />

high until the autumn but dropped sharply<br />

in the last two months of the year.<br />

37


annual report <strong>2008</strong><br />

The prices of caustic<br />

potash and caustic soda<br />

were higher than in 2007<br />

This had no effect on the margins for the<br />

derivatives bleach and ferric chloride.<br />

The prices for sodium sulphide lagged<br />

behind.<br />

From the third quarter onwards, the prices<br />

of caustic potash rose to unprecedented<br />

heights, the result of an acute and<br />

worldwide shortage of the raw material<br />

potassium chloride. This meant demand<br />

could not be fully met.<br />

The construction of<br />

our own electricity power<br />

plant in <strong>Tessenderlo</strong><br />

has started<br />

38<br />

The margins of caustic soda as well as<br />

caustic potash both rose in comparison<br />

with 2007.<br />

The T-Power project has started for the<br />

construction of a 420 MW natural gas-fired<br />

electricity installation at the <strong>Tessenderlo</strong>


<strong>Tessenderlo</strong> <strong>Group</strong><br />

site. Completion is targeted by 2011, has<br />

started. The modern, high-performance<br />

power plant will result in a reduction of<br />

electricity transportation costs, and in<br />

addition, increase the competitiveness of<br />

the site in <strong>Tessenderlo</strong>.<br />

Outlook for 2009<br />

remains scarce and expensive. However,<br />

lower demand should soon restore the<br />

balance.<br />

The prices of caustic soda continued<br />

to rise at the beginning of 2009, and a<br />

considerable price reduction is unlikely in<br />

2009.<br />

The expansion of the ferric chloride<br />

capacity in <strong>Tessenderlo</strong> (Belgium) with<br />

30,000 tonnes has been delayed slightly<br />

and is sheduled for a spring start-up. This<br />

expansion will help meet the growing<br />

European demand for ferric chlorides<br />

mainly used as coagulants in the treatment<br />

of drinking water and the purification<br />

of wastewater. This investment also<br />

strengthens the position of <strong>Tessenderlo</strong><br />

<strong>Group</strong> as the number two producer of ferric<br />

chlorides in Europe.<br />

Increased capacity<br />

shall strengthen our<br />

position on the ferric<br />

chloride market for water<br />

purification<br />

The cost price of electricity may rise once<br />

again. Currently, potassium chloride<br />

used for the production of caustic potash<br />

The margins for caustic potash are less<br />

predictable. They will mainly depend on<br />

the evolution of supply and the price of<br />

potassium chloride.<br />

Strategy for the<br />

Chlor-Alkali activity<br />

• Reduce costs and offer<br />

maximum added value<br />

with existing products and<br />

resources.<br />

• Maximise our competitive<br />

advantages.<br />

• Invest in specific projects with a<br />

high added-value potential.<br />

39


annual report <strong>2008</strong><br />

Plastics Converting<br />

For over twenty years, <strong>Tessenderlo</strong> <strong>Group</strong> has resolutely pursued a<br />

downstream integration policy. With this goal in mind, the group has<br />

taken over several PVC converters holding numerous patents and<br />

registered trademarks in Europe and the United States. The products,<br />

comprising profiles and plastic pipe systems, are almost all intended for<br />

the construction and renovation sectors. Another activity that is closely<br />

linked to PVC processing is the production of compounds for the injection<br />

and extrusion market. The Plastics Converting business group is also<br />

responsible for distribution to end-users in a number of countries. This<br />

40<br />

enables it to improve its market position and profitability.<br />

<strong>2008</strong> in a nutshell<br />

Overall, <strong>2008</strong> was a difficult year for the Plastics Converting business group. Total<br />

sales fell by 3 %. Plastic Pipe Systems were initially affected less than Profiles and<br />

Compounds. However, the economic crisis also made its impact felt in this sector<br />

over the last quarter. The decline of the construction market which started in the<br />

United States in 2007, hit Great Britain and the European continent in the second half<br />

of <strong>2008</strong>. Activities dropped while raw material prices remained high, in line with the<br />

cost of oil. Lower oil prices at the end of last year will only be felt in 2009, with lower<br />

raw material prices and higher margins.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Key figures<br />

<strong>2008</strong> 2007<br />

Revenue (millions EUR) 776 816<br />

REBIT (millions EUR) 22 49<br />

ROCE (%) 7 13<br />

Capital expenditures (PP&E) (millions EUR) 29 33<br />

Headcount 3,517 3,349<br />

Market leadership<br />

• The number one producer of plastic<br />

pipe systems in Benelux and the third<br />

largest in France<br />

• The largest TPE compounder<br />

(thermoplastic elastomers) and<br />

the fourth largest producer of PVC<br />

compounds in Europe<br />

• British market leader for pvc-profiles<br />

• One of the leading suppliers of<br />

compounds for dasboards (Marvyflo®)<br />

at world level.<br />

41<br />

Revenue breakdown over 10 years<br />

(millions EUR)<br />

800<br />

600<br />

IFRS<br />

776<br />

400<br />

200<br />

0<br />

99<br />

00<br />

01<br />

02<br />

03<br />

04<br />

05<br />

06<br />

07<br />

08


annual report <strong>2008</strong><br />

Profiles<br />

The sharp decline of the construction market in 2007 spread across the whole of<br />

Europe in <strong>2008</strong>. Sales in the Profiles business unit dropped as a result of this decline<br />

by 3 %. Lower sales were also accompanied by an increase of raw material prices<br />

which reduced profitability.<br />

42<br />

Activities and products<br />

The Profiles business unit brings together<br />

the production of various PVC profiles for<br />

the construction industry, such as door,<br />

window and conservatory profiles, profiles<br />

for roofline, fences, the cladding of façades<br />

and various finishing products.<br />

Trends and facts in <strong>2008</strong><br />

The market slowed down substantially in<br />

Great Britain, especially in the second half<br />

of the year. Despite these unfavourable<br />

conditions, the Profiles business unit is<br />

continuing to invest in the development of<br />

its activities.<br />

This is reflected in the further growth of<br />

the distribution network that consisted<br />

of 90 depots at the end of the year, and a<br />

number of acquisitions:<br />

• Eurocell, a subsidiary of <strong>Tessenderlo</strong><br />

<strong>Group</strong> and the British market leader<br />

in the production and distribution<br />

of PVC window and roofline profiles,<br />

acquired distributor Peninsula Plastics<br />

in March. Peninsula Plastics recorded a<br />

turnover of more than 3 million pounds<br />

and has distribution branches in the<br />

northwest of England. The locations<br />

complement the existing Eurocell<br />

branch network, resulting in the<br />

company strengthening its presence<br />

in this part of the country.<br />

• In April, Eurocell announced the<br />

acquisition of the assets of Sprint<br />

1233, formerly known as Plastmo<br />

Profiles Ltd. based in Northampton.<br />

The acquisition and the transfer of the<br />

activities to the Alfreton production<br />

site increase production efficiency and<br />

Eurocell’s market share.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

• In December, Eurocell acquired<br />

Cavalok Building Products. Cavalok<br />

produces window and door cavity<br />

closer systems made from postconsumer<br />

recycled PVC. The range<br />

complements Eurocell’s existing<br />

products and serves to strengthen the<br />

company’s market position further.<br />

Substantial expansion<br />

of the product range and<br />

distribution network in<br />

Great Britain<br />

The product offering in Great Britain was<br />

further expanded to include a number<br />

of innovations. In <strong>2008</strong>, the range of<br />

composite doors was expanded with new<br />

products that do extremely well in terms of<br />

safety as well as looks. The Thermologik<br />

window system was introduced on the<br />

market to meet the new standards for<br />

energy-friendly homes. Two new systems<br />

for rotating and vertically sliding windows<br />

were also launched.<br />

Thanks to the acquisitions and new<br />

products, sales – expressed in pound<br />

sterling - in the UK rose by over 9 %,<br />

despite a slowdown of the market. Due to<br />

high raw material prices, profitability was<br />

much lower than previous years.<br />

In Eastern and Central Europe, where the<br />

market also slowed down, we consciously<br />

chose to scale down activities in regions<br />

where margins are too low. From the third<br />

quarter, this was reflected by 10 % lower<br />

sales compared to the same period in 2007.<br />

Profitability was also considerably lower.<br />

43


annual report <strong>2008</strong><br />

44<br />

In this context, the business unit<br />

concentrated its activities on the European<br />

continent in Benelux and France. The<br />

introduction of new window systems and<br />

the improvement of existing products meet<br />

new market requirements with respect to<br />

durable and energy-efficient construction<br />

materials.<br />

New window systems<br />

meet the demand<br />

for durable and<br />

energy-efficient<br />

building<br />

The strategy of creating synergies between<br />

Wymar (Belgium) and Plastival (France)<br />

gained momentum during <strong>2008</strong>.<br />

The situation in the United States was<br />

even less favourable than in 2007. The<br />

number of new-build and renovation<br />

projects alike dropped dramatically. With<br />

the introduction of new products, Chelsea<br />

Building Products (CBP) again succeeded<br />

in confining the sales decline to less than<br />

10 % while the market contracted overall<br />

by 20 %. Due to the dollar exchange<br />

rate, high raw material prices in the<br />

United States had a stronger impact on<br />

profitability than in Europe.<br />

In <strong>2008</strong>, efforts were made in the<br />

development of composite windows,<br />

where metal is replaced with plastic.<br />

This important innovation has the major<br />

benefit that own materials can be used and<br />

purchasing of metal can be limited.<br />

Sales of Chelsea<br />

Building Products (US)<br />

fell less than the market<br />

average<br />

Wymar, which produces PVC profiles for<br />

windows and doors, as well as interior and<br />

exterior finishing systems, is continuing<br />

to develop new, lead-free systems. The<br />

objective in the long term is to phase out<br />

lead as a material to stabilise PVC. Thanks<br />

to the wider range of products, sales of<br />

these new environment-friendly systems<br />

are increasing while the share of the<br />

traditional systems is dropping.<br />

In Canada, an oil-producing country, the<br />

impact of the economic crisis was only<br />

felt at the end of the year, when oil prices<br />

began to drop. Slightly higher sales could<br />

not compensate for raw material price<br />

increases which meant profitability also<br />

decreased in this country.<br />

In <strong>2008</strong>, the merger of the production units<br />

in Jonquière and Montreal on one site


<strong>Tessenderlo</strong> <strong>Group</strong><br />

in Montreal was completed. The site in<br />

Jonquière was closed.<br />

Innovations in <strong>2008</strong> included the<br />

development of new patio doors. These will<br />

be introduced onto the market in 2009.<br />

material prices following the drop in oil<br />

prices towards the end of <strong>2008</strong>, will provide<br />

the leverage to restore margins.<br />

The synergies between Wymar and Plastival<br />

will also bear fruits from 2009 onwards.<br />

Outlook for 2009<br />

Due to the worldwide economic<br />

uncertainty, it is very difficult to make<br />

predictions. Improvements in the<br />

construction sector are not predicted for<br />

the immediate future. Low margin levels<br />

in Central and Eastern Europe should bring<br />

<strong>Tessenderlo</strong> <strong>Group</strong> to reveiw its position in<br />

these markets.<br />

The development<br />

of new products<br />

continues<br />

To meet these challenges, the Profiles<br />

business unit will adjust its production<br />

capacity to market conditions where<br />

necessary. In the United States and Great<br />

Britain, the development of new products<br />

will continue. The distribution network in<br />

Great Britain will also be expanded further.<br />

Strategy for the<br />

Profiles business unit<br />

• Increase the profitability of<br />

the European continent region<br />

through operational excellence<br />

and synergies between the<br />

production units.<br />

• Expand and improve the<br />

distribution network in Great<br />

Britain to obtain further growth<br />

and higher profitability.<br />

• Continue to expand the product<br />

range in the United States<br />

and Canada, and increase<br />

profitability by maximising<br />

the synergies between the<br />

production units.<br />

45<br />

The focus in 2009 will be on increasing<br />

profitability. In this respect, lower raw


annual report <strong>2008</strong><br />

Plastic Pipe Systems<br />

The Plastic Pipe Systems business unit succeeded in limiting the drop in sales<br />

compared to <strong>2008</strong>, despite the weak economic cycle. A slight increase during the<br />

first three quarters could not fully compensate the decline in the fourth quarter.<br />

Profitability fell slightly due to high raw material prices which could not be passed on<br />

to the market swiftly enough.<br />

46<br />

Activities and products<br />

The Plastic Pipe Systems business unit<br />

produces pipes and fittings for water<br />

supply and drainage systems, and pipe<br />

systems for gas, telecommunications and<br />

other applications. The raw materials are<br />

PVC, polyethylene, and polypropylene.<br />

Trends and facts in <strong>2008</strong><br />

The business unit continued its strategic<br />

growth, based on the two known pillars:<br />

geographic expansion and a wider product<br />

range, especially in the field of water<br />

management.<br />

Geographic expansion<br />

and a wider product<br />

range continue to be<br />

the main growth pillars<br />

In this respect, an important acquisition<br />

was made in October. <strong>Tessenderlo</strong> <strong>Group</strong><br />

acquired Nyloplast Europe BV, a subsidiary<br />

of Nyloplast NV. The Dutch company<br />

Nyloplast Europe BV in ’s Gravendeel<br />

produces plastic fittings for pressureless<br />

piping systems in a large diameter for the<br />

European market. The systems are used


<strong>Tessenderlo</strong> <strong>Group</strong><br />

for draining sewage and rainwater. This<br />

major addition to the product range of<br />

special fittings strengthens the position of<br />

the Plastics Piping Systems business unit<br />

in Europe.<br />

With regard to Benelux, sales at Dyka<br />

Belgium to the construction and public<br />

works sectors rose by 4 %, despite a<br />

decline of gas-related activities. These<br />

favourable results can be explained by the<br />

broadening of the product range.<br />

Dyka sales in<br />

Belgium rose<br />

by 4 % despite<br />

the crisis<br />

In The Netherlands, activities were<br />

maintained at the satisfactory level of 2007<br />

but profitability fell slightly. The product<br />

offering was expanded here too. Services<br />

to customers were also improved by<br />

developing e-business and adapting the<br />

sales network. Specifically, a number of<br />

depots were transferred to more accessible<br />

locations and opening hours were adapted<br />

to the customers’ requirements.<br />

Conditions in France were extremely<br />

unfavourable. While the situation in the<br />

beginning of the year was more or less<br />

respectable, the market plummeted in<br />

the second half of the year. This had an<br />

extremely negative impact on sales as well<br />

as profitability.<br />

The market in Great Britain also<br />

experienced the impact of the economic<br />

crisis. However, John Davidson Pipes (JDP)<br />

was able to maintain sales at the 2007 level<br />

in pound sterling. Despite the slight decline<br />

in profitability, the situation in Great Britain<br />

continues to remain favourable.<br />

Strong growth of<br />

activities in Central and<br />

Eastern Europe<br />

This also applies to the situation in Poland.<br />

Operating out of the production units in<br />

Poland, activities in Central and Eastern<br />

Europe were able to be developed further,<br />

thanks to higher product supply and a<br />

larger distribution network. At the current<br />

time, there are 13 depots in Poland, 3<br />

in the Czech Republic and 1 in Slovakia.<br />

47


annual report <strong>2008</strong><br />

Sales rose by 20 % and profitability also<br />

increased, despite higher raw material<br />

prices. For Plastic Pipe Systems, this<br />

region has the advantage that it is less<br />

subject to the worldwide crisis than<br />

Western Europe.<br />

Outlook for 2009<br />

The influence of the recession on the<br />

construction and public works sectors<br />

is difficult to forecast. The impact on<br />

the Plastic Pipe ystems is expected<br />

to be less due to the strong focus on<br />

water management and interest in new<br />

developments. The Plastic Pipe Systems<br />

business unit will therefore continue its<br />

trusted growth strategy as planned.<br />

Furthermore, the acquisition of Nyloplast<br />

Europe BV will contribute in full to our<br />

results from 2009 onwards.<br />

Innovating<br />

systems available<br />

in all countries<br />

from 2009<br />

48


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The so-called biaxially oriented pipe<br />

systems, which are produced by Sotra-<br />

Seperef in France, have firmly established<br />

themselves on the French market. They<br />

will also be available in other countries<br />

from 2009. The production process for this<br />

type of piping systems requires that the<br />

molecular structure of PVC is modified in<br />

order to improve the mechanical properties<br />

of the pipe. In particular, a biaxially<br />

oriented pipe system withstands a higher<br />

internal pressure than a normal PVC pipe<br />

with the same wall thickness. This makes<br />

it possible to reduce the amount of raw<br />

materials required.<br />

Polyethylene pipe systems for geothermal<br />

applications is another innovative product<br />

that performs well on the French market.<br />

These will also be available in other<br />

countries from 2009.<br />

Dyka Rainclean, a new high-performance<br />

system for the temporary collection and<br />

storage of rainwater will be introduced in<br />

2009. It filters and treats rainwater that is<br />

recovered from roads and car parks, before<br />

draining into the ground.<br />

In order to offer optimal service in the<br />

field of water management, the team<br />

that performs the necessary calculations<br />

for customers and develops water<br />

management systems has been expanded.<br />

Important steps were made in research<br />

and development to design new lead-free<br />

canalisation systems. Practically no lead is<br />

currently used to stabelise PVC.<br />

Strategy for the<br />

Plastic Pipe Systems<br />

business unit<br />

• Further expand the distribution<br />

network and improve customer<br />

service.<br />

• Offer complete systems<br />

whenever possible by expanding<br />

the product range.<br />

• Maximise synergies between<br />

the production units.<br />

• Strengthen our presence and<br />

growth in the Central and<br />

Eastern European markets.<br />

49


annual report <strong>2008</strong><br />

Compounds<br />

Like the other activities in the Plastics Converting business group, Compounds<br />

also suffered in <strong>2008</strong> from the slowdown in the construction activity. Moreover, this<br />

business unit also suffered the impact of lower car sales. PVC compounds were hit<br />

the worst. The thermoplastic elastomers were also subject to the crisis. However,<br />

sales to the construction sector and the automotive industry rose.<br />

50<br />

Activities and products<br />

The Compounds business unit produces a<br />

variety of ready-to-use PVC mixtures and<br />

mixtures of thermoplastic elastomers.<br />

These are mainly intended for the injection<br />

and extrusion markets, with applications<br />

in the construction industry (roller<br />

blinds, façade cladding, window fittings),<br />

the automotive sector (airbag covers,<br />

dashboard skins, interior trims and sealing<br />

systems) and the market for consumer<br />

goods (handles for household appliances,<br />

pens and toothbrushes).<br />

Trends and facts in <strong>2008</strong><br />

With regard to PVC compounds, sales<br />

volumes dropped by more than 10 %. A<br />

first explanation is the slowdown in the<br />

construction sector, but high raw material<br />

prices also played a role. Furthermore,<br />

demand fell as a result of consolidation<br />

within the companies that process the<br />

compounds.<br />

Lower demand and<br />

higher raw material<br />

prices have an adverse<br />

effect on margins for<br />

PVC compounds<br />

Lower sales volumes and increased<br />

supply in the market resulted in narrower<br />

margins. Efforts to restore them inevitably<br />

had a negative impact on sales volumes.<br />

Saplast (France) suffered the most from<br />

this, both on the home market and in<br />

export countries.<br />

The margins for plasticised PVC<br />

compounds were under even more


<strong>Tessenderlo</strong> <strong>Group</strong><br />

pressure than those for non-plasticised.<br />

Prices of softening agents used in these<br />

products rose sharply during <strong>2008</strong>.<br />

The number of applications of<br />

thermoplastic elastomers (TPEs)<br />

continued to rise despite the economic<br />

context affecting this activity too. However,<br />

TCT Polska (Poland) and Thermoplastiques<br />

Cousin-Tessier (France) managed to<br />

increase sales by 5 % in <strong>2008</strong>, both in<br />

the construction sector as well as the<br />

automotive industry.<br />

Number of<br />

TPE applications<br />

increases thanks to<br />

innovation<br />

On the other hand, the profitability of this<br />

activity was lower as a result of higher raw<br />

material prices. These could only be passed<br />

on in higher sales prices towards the end of<br />

the year.<br />

An important new compound was<br />

introduced in <strong>2008</strong> to replace polyurethane<br />

for the covering of car steering wheels.<br />

Marvyflo®, a compound intended for<br />

dashboards, was confronted with higher<br />

raw material prices and a drop in demand.<br />

The higher raw material prices could only<br />

be charged to the market during the second<br />

half of the year. In addition, the separate<br />

management team for Marvyflo® which<br />

was created in 2007, was able to improve<br />

industrial performance and customers<br />

service.<br />

51


annual report <strong>2008</strong><br />

Outlook for 2009<br />

The expectations for the PVC compounds<br />

market are not very favourable. There is<br />

no indication that any of these sectors<br />

will improve in the near future, and<br />

especially not in the construction industry.<br />

These activities are faced with two major<br />

challenges. Firstly, to increase margins<br />

to an acceptable level as a result of the<br />

decreasing raw material prices. Secondly,<br />

the production structures must be adjusted<br />

to the lower volumes and the future<br />

evolution of the market.<br />

Production structures<br />

for PVC compounds<br />

must be adjusted to<br />

lower demand<br />

Margins are also a major concern for the<br />

thermoplastic elastomers. It is expected<br />

that they will reach their normal level<br />

in 2009, considering the higher sales<br />

prices and the lower raw material prices.<br />

The impact of the economic crisis will<br />

52


<strong>Tessenderlo</strong> <strong>Group</strong><br />

undoubtedly be felt. However, lower<br />

volumes will be avoided thanks to several<br />

new applications. The compounds listed<br />

above for covering car steering wheels and<br />

a number of developments in the sealants<br />

sector are examples.<br />

A new range of products will be introduced<br />

in 2009, based on the Dow Chemical’s<br />

‘Infuse’ polymers which <strong>Tessenderlo</strong><br />

<strong>Group</strong> is producing under licence for the<br />

European market.<br />

Marvyflo® is counting<br />

on interest from the<br />

automotive sector,<br />

also in China<br />

looks promising, with a growing share<br />

of the dashboard skins market. In 2009,<br />

<strong>Tessenderlo</strong> <strong>Group</strong> hopes to considerably<br />

increase its sales to the automotive<br />

industry in China. Although this sector<br />

is currently experiencing difficulties, the<br />

growth prospects are still quite attractive.<br />

Strategy for the<br />

Compounds business<br />

unit<br />

• Reduce costs by producing<br />

as effectively as possible and<br />

through operational excellence.<br />

53<br />

Specifically for Marvyflo®, increased<br />

demand from the automotive industry<br />

is key. Currently, preparations are being<br />

made to have Marvyflo®, certified for<br />

new car models that will be marketed<br />

in the near future. Although this activity<br />

will decrease slightly in 2009 due to the<br />

contracting automotive market, the future<br />

• Focus on speciality compounds.<br />

• Further strengthen our<br />

presence in the automotive<br />

industry by increasing our<br />

presence in the United States<br />

and especially Asia.


annual report <strong>2008</strong><br />

Specialities<br />

The Specialities business group consists of a number of diverse activities which<br />

differ by the added value that they create. The Fine Chemicals business unit<br />

deals partially with raw materials that are produced by <strong>Tessenderlo</strong> <strong>Group</strong><br />

itself. These raw materials are transformed into specialist products for the<br />

agro-chemical, pharmaceutical and perfume industries. The Gelatin business<br />

unit turns the skins and bones of cattle and pigs into high-quality gelatin<br />

for use in the food and pharmaceutical industries. The Natural Derivatives<br />

business unit processes animal and vegetable by-products for use as raw<br />

materials in pet food and in the soap industry.<br />

54<br />

<strong>2008</strong> in a nutshell<br />

The Fine Chemicals business unit did not perform so well in <strong>2008</strong>. While the<br />

operating result of organic chlorine derivatives was satisfactory, the intermediates<br />

and active ingredients for the pharmaceutical industry performed less favourably. On<br />

the other hand, the Gelatin business unit had an excellent year. Despite the economic<br />

crisis, demand for gelatin continues to grow, in part as a result of new applications<br />

and developments. The Natural Derivatives business unit recorded a satisfactory<br />

year. In the quest for new activities of a high added value, further diversification into<br />

the valorising by-products based on cereal crops was initiated.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Key figures<br />

<strong>2008</strong> 2007<br />

Revenue (millions EUR) 587 563<br />

REBIT (millions EUR) 35 32<br />

ROCE (%) 10 10<br />

Capital expenditures (PP&E) (millions EUR) 28 29<br />

Headcount 2,755 2,763<br />

Market leadership<br />

• The largest producer of benzyl<br />

acetate, benzyl chloride, alphahexylcinnamaldehyde<br />

at world level<br />

• The number two producer of benzyl<br />

alcohol worldwide<br />

• The third largest manufacturer of highquality<br />

gelatins worldwide<br />

55<br />

Revenue breakdown over 10 years<br />

(millions EUR)<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

IFRS<br />

587<br />

99<br />

00<br />

01<br />

02<br />

03<br />

04<br />

05<br />

06<br />

07<br />

08


annual report <strong>2008</strong><br />

Fine Chemicals<br />

The intermediates and active ingredients for the pharmaceutical industry did not<br />

perform so well in <strong>2008</strong>. In addition, contrary to expectations, the ‘organic chlorine<br />

derivates’ activity was unable to sufficiently sustain the positive trend of 2007. The<br />

Fine Chemicals business unit was hardest hit by the impact of the weak dollar. The<br />

competitive loss and the lower margins which were the result of this in the first half<br />

of the year were compensated in the second half of the year.<br />

56<br />

Activities and products<br />

A first segment comprises the<br />

manufacturing of intermediates and active<br />

pharmaceutical ingredients. The business<br />

unit is the preferred supplier to important<br />

international pharmaceutical companies.<br />

<strong>Tessenderlo</strong> <strong>Group</strong>’s glycine and glycine<br />

derivates mainly have applications in the<br />

pharmaceutical industry.<br />

The second segment comprises organic<br />

chlorine derivatives, whose production is<br />

mostly based on toluene combined with<br />

chlorine produced by <strong>Tessenderlo</strong> <strong>Group</strong><br />

itself. Toluene derivatives are produced<br />

for customers in the agro-chemical,<br />

pharmaceutical and perfume industries.<br />

Close cooperation between the various<br />

<strong>Tessenderlo</strong> <strong>Group</strong> units makes it possible<br />

to work in a highly flexible manner<br />

1. Intermediates and active<br />

ingredients for the<br />

pharmaceutical industry<br />

Trends and facts in <strong>2008</strong><br />

The results for the intermediates and<br />

active ingredients for the pharmaceutical<br />

industry are lower than in 2007. However,<br />

these activities performed much better<br />

than planned in the first half of <strong>2008</strong><br />

because a number of customers ordered<br />

higher quantities than initially planned. On<br />

the other hand, demand in the second half<br />

of the year was lower for this very reason.<br />

Furthermore, many customers delayed


<strong>Tessenderlo</strong> <strong>Group</strong><br />

their purchases in view of the economic<br />

situation.<br />

<strong>Tessenderlo</strong> <strong>Group</strong> is committed to<br />

providing quality on a continuous basis<br />

to ensure that its products meet the<br />

standards and guidelines in its various<br />

markets. Within this context, the sites in<br />

Italy and France were audited in <strong>2008</strong> by<br />

the Pharmaceutical and Medical Devices<br />

Agency (PMDA) of the Japanese Ministry<br />

of Health. The PMDA inspections are<br />

known to be the strictest in the world. The<br />

outcome of these audits was excellent<br />

- just like the other audits performed in<br />

<strong>2008</strong>.<br />

With regard to food safety, all current<br />

studies concerning HACCP (Hazard<br />

Analysis Critical Control Points)<br />

were completed at the Belgian site in<br />

<strong>Tessenderlo</strong>.<br />

Strict and successful<br />

audits confirm quality<br />

guarantee<br />

<strong>2008</strong>. In the beginning of the year, imports<br />

from China of glycine for the manufacture<br />

of additives for food and pet feed came to<br />

a standstill. This meant that <strong>Tessenderlo</strong><br />

<strong>Group</strong> was able to produce large volumes<br />

of glycine, and sales doubled in comparison<br />

with the same period in 2007.<br />

The business poured further investments<br />

in the optimal treatment of waste flows.<br />

Specifically, a number of incineration<br />

installations were renovated or improved.<br />

Focus on waste<br />

treatment is key<br />

in investment<br />

programme<br />

Due to increasing demand, the Farchemia<br />

site in Italy has taken a new production unit<br />

for benzoyl peroxide into service. Benzoyl<br />

peroxide is used in the pharmaceutical<br />

industry to produce ointments to treat acne<br />

for example.<br />

57<br />

The sale of glycine for pharmaceutical<br />

applications – of which <strong>Tessenderlo</strong> <strong>Group</strong><br />

is the last remaining manufacturer in<br />

Europe – was overall at a normal level in<br />

Outlook for 2009<br />

The expiry of the patent protection for<br />

a very successful drug will cause sales<br />

volumes to drop considerably in 2009.


annual report <strong>2008</strong><br />

The good news is that a number of other<br />

active ingredients have been in the<br />

development pipeline since 2007 and<br />

<strong>2008</strong>. These products will not be able<br />

to compensate for the decline in 2009.<br />

However, they do offer good prospects<br />

from 2010<br />

and the British pound during the first<br />

half of the year. This resulted in lower<br />

competitiveness and margins. Raw<br />

material prices were also unpredictable.<br />

In a market with ample supply, these<br />

price increases could not be passed on<br />

completely to customers.<br />

58<br />

Products in the<br />

development portfolio<br />

can compensate for<br />

patent loss as of 2010<br />

In the meantime, <strong>Tessenderlo</strong> <strong>Group</strong> will<br />

continue to promote itself as a company<br />

that is not only strong in the field of<br />

research and development, but can also<br />

offer its customers pilot capacity. As such,<br />

the company can guarantee quality as well<br />

supply commitments.<br />

2. Organic chlorine derivatives<br />

Trends and facts in <strong>2008</strong><br />

While 2007 saw a revival of the ‘organic<br />

chlorine derivatives’ activity, this positive<br />

trend could not be benefitted from<br />

sufficiently in <strong>2008</strong>.<br />

Same as the intermediates for the<br />

pharmaceutical industry, organic chlorine<br />

derivatives also suffered from the volatile<br />

exchange rates of the American dollar<br />

Volatile exchange rates<br />

and raw material<br />

prices had an adverse<br />

effect on competitiveness<br />

and margins<br />

The situation improved initially in the<br />

second half of the year. Sales prices and<br />

margins rose. However, demand for all<br />

products dropped drastically in December.<br />

With regard to investments in <strong>2008</strong>, the<br />

site in Pieve (Italy) decided that one of the<br />

two hydroelectric power stations will be<br />

renovated. Besides a slight increase of the<br />

power capacity, the major advantage is<br />

the fact that the company will obtain green<br />

energy certificates for this investment.<br />

Works are scheduled to begin in 2009<br />

and will be carried out during the winter<br />

months for three years, in order to reduce<br />

interruptions in manufacturing to a<br />

minimum.<br />

Contrary to earlier announcements<br />

made as part of the industrial plan for


<strong>Tessenderlo</strong> <strong>Group</strong><br />

the company, the electrolysis will not be<br />

discontinued in Pieve. Sufficient sales<br />

have materialised in the meantime for<br />

the electrolysis products, in line with the<br />

available capacity.<br />

However, the production of<br />

chlorobenzenes will be discontinued as<br />

announced but this will be later than<br />

initially planned. An extra investment for<br />

the production of synthetic hydrochloric<br />

acid will be implemented first, as decided<br />

in <strong>2008</strong>. The production of chlorobenzene<br />

can then be discontinued at the end of<br />

2009 or the beginning of 2010.<br />

Improvement of cost<br />

structure should not<br />

influence productivity<br />

and capacity<br />

Outlook for 2009<br />

Competition from China and India is<br />

expected to increase in all areas, from basic<br />

chemicals to the advanced pharmaceutical<br />

intermediates. In view of the economic<br />

situation and the fluctuating raw material<br />

prices, it is impossible to make any<br />

predictions for the future.<br />

However, next year we shall continue to<br />

work towards improving the cost structure<br />

but without affecting productivity or<br />

production capacity.<br />

The products of the Organic Chlorine<br />

Derivates business unit have evolved to<br />

become commodity products and are now<br />

more closely related to the products, the<br />

activities and the strategy of the Chemicals<br />

business group. As such, they will be part<br />

of the latter as from 1 January 2009.<br />

Strategy for the Fine<br />

Chemicals business<br />

unit<br />

• Intermediates and active<br />

ingredients for the<br />

pharmaceutical industry<br />

Strengthen the position as<br />

a supplier of intermediates<br />

and active ingredients for the<br />

pharmaceutical industry.<br />

• Organic chlorine derivatives<br />

Reduce the cost structure<br />

throughout the entire value<br />

chain and maximise added<br />

value in order to increase<br />

profitability.<br />

Consolidate the activities and<br />

integrate them in the Chemicals<br />

business group as from 2009.<br />

59


annual report <strong>2008</strong><br />

Gelatin<br />

<strong>2008</strong> was another outstanding year for the Gelatin business unit, despite the<br />

worldwide economic downturn in the second half of the year. The results rose<br />

sharply. The reversal that began in 2007 continued in this sector. This positive trend<br />

was strengthened by the continued growth of the demand for gelatin.<br />

60<br />

Activities and products<br />

The Gelatin business unit produces a wide<br />

range of quality gelatins based on the<br />

bones and skin of pigs and cattle. About<br />

two thirds of the gelatin is intended for<br />

the food industry. Gelatine is a gelling<br />

agent and an important source of protein,<br />

and it contains no cholesterol, fat or<br />

carbohydrates. It is also converted into<br />

specific foodstuffs for diabetics and<br />

products with a low glycaemic index, and<br />

it is produced for the pharmaceutical<br />

industry (capsules) and a wide range<br />

of technical applications (such as<br />

photography).<br />

good prices for the by-products fats and<br />

phosphates. In the beginning of the year,<br />

sales prices of gelatin dropped due to<br />

ample market supply. The second half of<br />

the year was characterised by a shortage<br />

of rind as a raw material and this resulted<br />

in lower production levels in Europe. This<br />

resulted in a lower supply of rind gelatin on<br />

the market with prices gradually rising and<br />

payment terms tightening.<br />

Demand for<br />

gelatin rose<br />

despite the<br />

economic crisis<br />

Trends and facts in <strong>2008</strong><br />

The results of the Gelatin business unit<br />

rose by 20 % in comparison with 2007.<br />

This growth was mainly a result of the<br />

At the same time, demand in various<br />

markets evolved favourably. The estimated<br />

world production output grows by around<br />

4 % each year.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

• In the new economies, including China,<br />

the use of gelatin in the food sector<br />

continues to rise. The use of gelatin in<br />

confectionery, which was initially only a<br />

European and American phenomenon,<br />

is now more widespread in Asia too.<br />

technical assistance for the production<br />

and commercial activities, other market<br />

segments could be approached for the<br />

gelatins of the Chinese production unit,<br />

such as the food sector and capsules for<br />

the pharmaceutical industry.<br />

• Demand from the pharmaceutical<br />

industry continues to grow due to the<br />

gradual aging of the population.<br />

• The impact of digital photography<br />

in the market for classic silver<br />

systems for film has been dealt<br />

with in the meantime. This is being<br />

compensated by the growing demand<br />

for photographic paper, although the<br />

quality requirements of the gelatin are<br />

lower for these applications.<br />

Our American sites also experienced the<br />

shortage of rind in the second half of the<br />

year, but to a lesser extent than in Europe.<br />

Lower production levels and their impact<br />

on sales prices were less significant there.<br />

For the joint venture in China, further<br />

major efforts were made to improve<br />

the quality of the produced gelatin. This<br />

resulted in higher sales prices. Although<br />

the results for the whole year are still<br />

negative, positive figures were recorded<br />

in the fourth quarter. Thanks to the<br />

Chinese site will be<br />

break-even in 2009.<br />

Quality improvement<br />

opens new markets<br />

Research into new applications and<br />

product development continued in <strong>2008</strong>.<br />

• The important role that gelatin plays<br />

to reduce calories, especially when<br />

combined with lower fat use, resulted<br />

in a number of new applications in the<br />

food industry, such as meat and cheese<br />

production, and bakery applications.<br />

The research into the healthy, biological<br />

role of gelatin and related products led<br />

to the first upscaling steps.<br />

The role of<br />

gelatin in healthy<br />

food continues<br />

to grow<br />

61


annual report <strong>2008</strong><br />

• The development of gelatins that<br />

dissolve easily and are therefore more<br />

user-friendly is ongoing.<br />

• The gelatin hydrolysates with a low<br />

molecular weight are on the threshold<br />

of production. These types of gelatin<br />

hydrolysates have a low gel strength<br />

which means they dissolve more<br />

easily and are absorbed faster by the<br />

body. This is extremely important for<br />

applications such as energy drinks.<br />

of gelatin films. These have been<br />

translated into the different production<br />

preparations and will be used for a<br />

further qualification in the pharma<br />

sector.<br />

• In <strong>2008</strong>, the first steps were made<br />

towards technological innovation of the<br />

gelatin production process. This will be<br />

continued in 2009.<br />

Outlook for 2009<br />

62<br />

• In the past year, new insights have been<br />

obtained into the dissolving behaviour<br />

It is expected that sales prices will<br />

continue to rise due to the growing


<strong>Tessenderlo</strong> <strong>Group</strong><br />

demand. This means that the higher<br />

raw material and energy prices will be<br />

compensated. In the second half of <strong>2008</strong>,<br />

price increases were introduced with a<br />

delay which means that the adjusted sales<br />

prices will only have their full effect in the<br />

figures for 2009.<br />

Impact of higher<br />

sales prices will only be<br />

felt fully in 2009<br />

Strategy for the<br />

Gelatin business unit<br />

• To strengthen the position of<br />

<strong>Tessenderlo</strong> <strong>Group</strong> as one of the<br />

world’s top 3 players.<br />

• To look out for new<br />

opportunities in Asia and South<br />

America.<br />

There is a possibility that fewer cattle<br />

hides will be available on the raw materials<br />

market. The consumption of leather in the<br />

automotive sector has dropped as a result<br />

of the economic crisis and this means that<br />

skin by-products for the gelatin industry<br />

are more scarce. A solution is being sought<br />

for this.<br />

• To put in place optimal<br />

synergies between the six<br />

production units with a focus on<br />

increased cost-efficiency.<br />

63<br />

Additional investments will be made in<br />

China in order to maintain quality at a high<br />

level. The joint venture in China is expected<br />

to break even in 2009.<br />

The Gelatin business unit is striving<br />

towards further profit growth through<br />

acquisitions, the starting up of new<br />

sites and/or the optimal use of vertical<br />

integration opportunities.


annual report <strong>2008</strong><br />

Natural Derivatives<br />

In <strong>2008</strong>, the French subsidiary Caillaud was renamed the Akiolis <strong>Group</strong>, with its head<br />

office in Le Mans. The new legal structure reflects the various activities of the group<br />

and provides the foundation for the international development of Akiolis in the future.<br />

This also includes a new and complementary scope, i.e. the valorising of by-products<br />

based on cereal crops. This diversification is possible thanks to the know-how of the<br />

group in the field of collecting, processing and selling valorised animal by-products.<br />

This means Akiolis is able to expand its offering for producers of pet foods and<br />

animal feed.<br />

64<br />

Activities and products<br />

In this respect, Akiolis supplies:<br />

Via the French subsidiary Akiolis,<br />

<strong>Tessenderlo</strong> <strong>Group</strong> plays an important role<br />

in collecting and processing animal byproducts.<br />

Akiolis is the number two on the<br />

French market and the third largest player<br />

in Europe.<br />

- bones for the extraction of gelatines<br />

- proteins and animal fats for use in<br />

pet food<br />

- animal fats for the soap industry and<br />

lipochemistry<br />

- animal proteins for fertilisers<br />

In the field of animal by-products,<br />

Akiolis is active in two different but<br />

complementary sectors.<br />

• The valorisation of animal by-products<br />

which are suitable for consumption.<br />

• As a rendering plant, it handles the<br />

collection and the processing of risk<br />

waste, and protects hygiene on cattle<br />

farms. The processed products are<br />

mainly used as fuel by the cement<br />

industry.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Diversification towards<br />

the valorisation<br />

of by-products based<br />

on cereal crops<br />

Since <strong>2008</strong>, Akiolis is also active in the<br />

valorisation of the by-products of cereal<br />

crops from the food industry. These<br />

products are meant for the production of<br />

animal feed and pet food.<br />

Trends and facts in <strong>2008</strong><br />

The results of Akiolis are overall<br />

satisfactory, thanks to the combined<br />

effect of a number of contradictory<br />

developments:<br />

- a slight drop of volumes as a result<br />

of a structural decline of cattle<br />

farming in France;<br />

- an improvement of the margins<br />

thanks to very high market prices for<br />

animal fats in the first ten months of<br />

the year;<br />

- higher production costs as a result<br />

of more expensive energy and the<br />

restructuring costs related to the<br />

closing of four sites.<br />

As far as production is concerned, the<br />

market share in the fertiliser sector grew<br />

considerably. The market prices for animal<br />

fats remained high and this was very<br />

favourable for the results of the rendering<br />

plant activities for slaughterhouses that<br />

make use of the services of Akiolis.<br />

In <strong>2008</strong>, major restructuring took place<br />

after sites were acquired or demergered.<br />

Furthermore, two production plants in the<br />

west of France were closed. The rendering<br />

plant activities in this region and the<br />

supply of raw materials to be rationalised,<br />

increased the productivity of the collection<br />

and processing installations.<br />

The rationalisation<br />

of rendering<br />

plant activities led<br />

to higher<br />

productivity<br />

Productivity also grew as a result of<br />

better management of the industrial<br />

processes, combined with the introduction<br />

of new information technology systems,<br />

and thanks to an improved approach to<br />

collection in all subsidiaries.<br />

65


annual report <strong>2008</strong><br />

Simultaneously, the group continued to<br />

develop new markets. The collection and<br />

processing of used household oil from<br />

restaurants was extended to two additional<br />

regions: the west and the Paris region.<br />

In addition, a manager was hired for the<br />

methanisation activity.<br />

Akiolis has focused extra attention on<br />

searching for markets that offer the<br />

highest possible added value for the<br />

finished products, especially within the pet<br />

food industry. New markets were explored<br />

abroad. Furthermore, new applications<br />

were presented for existing products, such<br />

as the use of degreased bones for filtering<br />

in the sugar industry.<br />

Outlook for 2009<br />

Akiolis must adjust to the consequences<br />

of the worldwide crisis in raw materials. In<br />

this respect, the market price for animal<br />

fats dropped by more than 50 % at the<br />

end of <strong>2008</strong>. However, the restructuring<br />

efforts implemented in recent years should<br />

alleviate the impact of this crisis, especially<br />

for the meat-related activities.<br />

66


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Restructuring efforts in<br />

recent years are helping<br />

to alleviate the impact<br />

of the crisis in raw<br />

materials<br />

Furthermore, the biofuel project using<br />

animal fats is planned to start in 2009. This<br />

project was delayed in <strong>2008</strong> because the<br />

French government changed its subsidy<br />

policy for this activity. Government aid<br />

continues. However in the future it will be<br />

linked to the environmental impact and<br />

more specifically to CO 2<br />

emissions. The<br />

subsidies will also focus on the production<br />

of second-generation biofuels. Akiolis<br />

meets both conditions.<br />

Strategy for the<br />

Natural Derivatives<br />

business unit<br />

• Strengthen our market position<br />

in the sector of collection and<br />

processing of animal byproducts.<br />

• Develop new applications such<br />

as the biofuel, pet food and<br />

methanising projects.<br />

67<br />

In July 2009, the rendering plant activities<br />

were completely privatised and they will no<br />

longer be a public service.<br />

Akiolis continues its policy of consolidation<br />

by dealing with ISO certification for the<br />

various sites in a straightforward manner,<br />

by implementing the new IT system<br />

across the entire group, and by focusing<br />

recruitment efforts.<br />

Finally, our efforts in the field of<br />

methanising should result in specific<br />

projects across the whole of France.


MAKING<br />

IT<br />

LASTING


Sustainable entrepreneurship is an<br />

ongoing assignment for <strong>Tessenderlo</strong> <strong>Group</strong>. We are committed<br />

to the environment, and the safety and health of our employees<br />

and the population, in all our activities. We constantly<br />

measure the impact of our activities on humans and nature,<br />

and strive to reduce this to a minimum.<br />

69


annual report <strong>2008</strong><br />

Commitments<br />

Human Resources<br />

70<br />

Employment<br />

In <strong>2008</strong>, the headcount rose from 8,121<br />

to 8,237. The workforce mainly increased<br />

in Plastics Converting, through the<br />

acquisition of Nyloplast in the Netherlands<br />

and the ongoing development of the<br />

Eurocell activities in Great-Britain. This<br />

rise largely exceeded the slight drop of<br />

the workforce in the other activities of the<br />

group.<br />

Within Chemicals headcount slightly<br />

fell as a result of previously initiated<br />

restructurings. As in Plastics Converting,<br />

the workforce in Specialities increased<br />

due to an acquisition. Additionally, organic<br />

growth of the activities positively influenced<br />

the headcount in Plastics Converting.<br />

Human Resources<br />

policy<br />

The Management Committee is strongly<br />

convinced that high-performing employees<br />

are crucial for success and for achieving<br />

the strategic objectives in a complex and<br />

ever-changing economic context.<br />

To implement this vision in concrete<br />

terms, the HR department has been<br />

developed further at group level and the<br />

roles of Corporate Talent Management,<br />

Compensation & Benefits, and Operational<br />

Design & Development, and HR projects<br />

have been created.<br />

The core mission consists of the following:<br />

• to attract and retain the best available<br />

employees


<strong>Tessenderlo</strong> <strong>Group</strong><br />

• to detect and develop talent in the<br />

company for future management<br />

positions, and to develop and maintain<br />

the necessary know-how<br />

• to support changes within the company<br />

and the organisation structure<br />

• to implement a remuneration policy that<br />

motivates employees and that is in line<br />

with market conditions<br />

• to strengthen constructive co-operation<br />

within the entire company<br />

Corporate Talent<br />

Management<br />

To accomplish this, a Performance<br />

Management Cycle for the entire<br />

<strong>Tessenderlo</strong> <strong>Group</strong> will be implemented<br />

in 2009. This is a process of motivating<br />

and inspiring managers and employees<br />

to perform actions that contribute to the<br />

achievement of the team, department<br />

and organisations goals and to the<br />

71<br />

Employment per business group<br />

Employment per country<br />

0<br />

500<br />

1,000<br />

1,500<br />

2,000<br />

2,500<br />

3,000<br />

3,500<br />

4,000<br />

0<br />

500<br />

1,000<br />

1,500<br />

2,000<br />

2,500<br />

Chemicals<br />

1,965<br />

France<br />

2,277<br />

Specialities<br />

2,755<br />

Belgium<br />

United Kingdom<br />

2,073<br />

1,393<br />

Plastics Converting<br />

3,517<br />

North America<br />

Netherlands<br />

685<br />

660<br />

Total<br />

8,237<br />

Italy<br />

289<br />

South America<br />

199<br />

Germany<br />

90<br />

China<br />

304<br />

Others<br />

267<br />

Total<br />

8,237


annual report <strong>2008</strong><br />

72<br />

implementation of its strategies in an<br />

effective and efficient way, with respect<br />

for individual growth and aspirations<br />

and shared values. This Performance<br />

Management Cycle will be the basic tool<br />

for Training and Development, Reward and<br />

Talent Review & Succession Planning.<br />

In addition, the recruitment process is set<br />

to be made more professional in light of<br />

the ongoing war for talent by promoting the<br />

employer branding of the group and the<br />

introduction of competence management.<br />

Furthermore, the implementation of a<br />

Succession Planning cycle for the top<br />

management will also get underway, linked<br />

to the strategic objectives in the short and<br />

medium-long term of the Business.<br />

In addition, investments are also being<br />

made in Training Development. One of<br />

the principal projects is the offering of an<br />

International Customised Management<br />

Development Programme for our<br />

executives. In co-operation with a number<br />

of external partners, including the Vlerick<br />

Leuven Ghent Management School we are<br />

offering an 18-day programme, spread over<br />

a year. The programme is a tailor-made<br />

mini-<strong>MB</strong>A and consists of 6 modules with<br />

a due focus on business understanding,<br />

personal leadership, personal mastery and<br />

project management.<br />

Moreover, many other training initiatives<br />

exist for all employees at all levels for<br />

acquiring technical knowledge and skills,<br />

using IT tools, languages, communication<br />

techniques and people management skills.<br />

Compensation &<br />

Benefits<br />

In <strong>2008</strong>, a variable pay system was<br />

introduced for the group’s top management<br />

as part of the implementation of the<br />

Performance Management project. In<br />

addition, preparations were made for the<br />

introduction in 2009 of a variable bonus<br />

plan for all managers.<br />

The salary house that was built for all<br />

Business activities was benchmarked<br />

to ensure internal fairness and external<br />

competitiveness of the remuneration<br />

package.<br />

The expatriation policy is constantly being<br />

adapted to the ever-changing social trends<br />

in this respect, and pension schemes<br />

are adapted to the changes of statutory<br />

regulations in the various countries.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Organisation Design &<br />

Development<br />

In <strong>2008</strong>, the development of common tools<br />

such as Job Descriptions and Job Grading<br />

began for all companies of the group, in<br />

order to optimise the change processes and<br />

the efficiency of the HR policy with regard to<br />

the ongoing evolution of the organisation.<br />

Job classification which had already been<br />

developed for the top management and<br />

managers of the Chemicals business<br />

group was also implemented in the other<br />

business groups in <strong>2008</strong>.<br />

Evolution of the average employment figures for Belgium and abroad<br />

73<br />

10,000<br />

8,000<br />

Total : 8,230<br />

6,000<br />

Abroad : 6,151<br />

4,000<br />

2,000<br />

Belgium : 2,079<br />

0<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong>


annual report <strong>2008</strong><br />

Environment, quality, safety and risk management<br />

74<br />

Manufacturing in a way that is<br />

environmentally responsible, taking into<br />

account the health and safety of employees<br />

and the population, is a fundamental<br />

requirement for every industrial activity.<br />

For this very reason, <strong>Tessenderlo</strong> <strong>Group</strong><br />

is committed to protecting people and<br />

the environment as a key consideration<br />

in its day-to-day policy. In this respect,<br />

we aspire to go further than the statutory<br />

requirements. To accomplish this objective,<br />

the group makes available considerable<br />

funds each year.<br />

To lend substance to this policy,<br />

<strong>Tessenderlo</strong> <strong>Group</strong> relies on internationally<br />

recognised principles, including<br />

Responsible Care, Best Available<br />

Techniques, ISO 14001, OHSAS 18001 and<br />

NFPA standards. These serve as a guide for<br />

optimisation.<br />

Incidents must be avoided at any cost -<br />

every accident can be prevented in theory.<br />

This can be achieved by putting in place the<br />

necessary precautions. Multi-disciplinary<br />

teams analyse the situation in the field on<br />

a continuous basis for this purpose. It is a<br />

key element of the ‘learning organisation’.<br />

Strict health and safety and environmental<br />

standards apply for the various sites of<br />

the group, including those with a low-risk<br />

classification. These standards are applied<br />

through an active risk management policy,<br />

the company’s own audits and insurance<br />

audits.<br />

Trends and facts in<br />

<strong>2008</strong><br />

Environmental care<br />

Each year, extensive investments are<br />

made in environmental projects in each<br />

of the various sites. Thanks to this<br />

policy, emission levels have already been<br />

substantially reduced in the past.<br />

In <strong>2008</strong>, <strong>Tessenderlo</strong> <strong>Group</strong> also invested<br />

in various projects that benefit the<br />

environment.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Product stewardship<br />

As part of the preparations for REACH,<br />

the new chemicals policy of the European<br />

Union, the focus in <strong>2008</strong> was on the<br />

so-called phase-in substances. A total<br />

of more than 500 substances were preregistered<br />

for 18 legal entities with the<br />

European Chemical Agency (ECHA). The<br />

highest number of registrations was for<br />

the pharmaceutical subsidiaries Calaire<br />

Chemie (France) and Farchemia (Italy).<br />

Mobility and Transport with regard to the<br />

ADR regulations.<br />

The voluntary commitment by the PVC<br />

industry, which has been signed by the<br />

group, delivered the expected results. For<br />

more information about the commitment,<br />

and the results, please log on to<br />

www.vinyl2010.org. www.vinyl2010.org.<br />

In addition, within the framework of<br />

REACH, consortiums were set up where<br />

producers and importers jointly prepare<br />

the applications for the registration of<br />

certain substances. One example is that<br />

of the chlor-alkali products. <strong>Tessenderlo</strong><br />

<strong>Group</strong> will play a leading role in a number<br />

of consortiums, such as the consortium for<br />

caustic potash as just one example.<br />

Risk analyses were carried out in<br />

collaboration with the production units, on<br />

products that are used in food and animal<br />

feeds.<br />

In <strong>2008</strong>, the <strong>Tessenderlo</strong> site was visited<br />

by the Organisation for the Prevention of<br />

Chemical Weapons (OPCW). The inspection<br />

was completed without remarks. A<br />

successful audit was also carried out by<br />

the Federal Government Department for<br />

Water, air and soil<br />

In <strong>2008</strong>, several of the group’s sites<br />

carried out investments to further reduce<br />

emission levels into the atmosphere and<br />

effluent discharges to the lowest possible<br />

levels.<br />

The re-licensing application for the three<br />

sites of <strong>Tessenderlo</strong> Chemie in Limburg<br />

(Belgium) was successfully completed in<br />

December <strong>2008</strong>. The Flemish government<br />

has renewed the environmental permits<br />

for a period of twenty years. This was<br />

made possible thanks to the intensive<br />

dialogue between the company and the<br />

government.<br />

75


annual report <strong>2008</strong><br />

Under the terms of the agreements,<br />

salt discharges will be reduced to<br />

one tenth of current levels by 2014 at<br />

the latest. For this purpose,<br />

10 million EUR are being invested<br />

in the modification of the production<br />

installations in the plant at Ham. In<br />

addition, 20 million EUR will be invested<br />

in cleaning up sludge basins, and the<br />

company will co-operate to clean up the<br />

historic pollution of the banks of the local<br />

streams Laak and Winterbeek.<br />

Focus on energy<br />

The necessary energy surveys were<br />

carried out in <strong>2008</strong> in the companies that<br />

signed the Flemish Covenant on Energy<br />

Benchmarking. These surveys serve as the<br />

basis for the energy plans for the period<br />

<strong>2008</strong>-2012.<br />

A better insight into the energy situation<br />

resulted in further energy savings in<br />

several places.<br />

76<br />

Thanks to the new production process used<br />

in Ham, considerably less sludge needs<br />

to be stored. This means that 30 hectares<br />

of land will become available for new<br />

industrial estates. In joint agreement with<br />

the Flemish and the Limburg authorities,<br />

<strong>Tessenderlo</strong> <strong>Group</strong> is keen to convert the<br />

vacant space in Ham into industrial land.<br />

Its location along the Albert canal is an<br />

important advantage.<br />

Quality department<br />

In <strong>2008</strong>, the quality department continued<br />

to assist the various departments in<br />

implementing and maintaining the quality<br />

management systems in accordance<br />

with the international standards, and<br />

maintaining the required certificates for<br />

the marketing of products in the various<br />

markets.<br />

With regard to the historic soil<br />

contamination of the factory sites in<br />

Limburg, the extent of the contamination<br />

has been outlined in descriptive soil<br />

surveys as agreed with the public<br />

authorities. These surveys specify the risks<br />

as well as the necessity to clean up the soil.<br />

At the same time, the soil decontamination<br />

activities that were already underway, are<br />

being continued.<br />

Health, safety and risk management<br />

The production units of <strong>Tessenderlo</strong> <strong>Group</strong><br />

made major investments in health and<br />

safety in <strong>2008</strong>. For example, a new digital<br />

work permit system was introduced at<br />

the sites in West-Limburg (Belgium).<br />

Preparations for maintenance works now<br />

occur in a uniform and structured manner.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

These preparations are an important step<br />

in the safe execution of any given project.<br />

In the factory, a focus of attention is<br />

made to go out to communicate on<br />

health and safety, for example at the<br />

toolbox meetings. Small panel groups<br />

are put together to discuss specific<br />

health and safety topics on the shop floor.<br />

Opportunities for improving health and<br />

safety are also discussed during the health<br />

and safety observation and communication<br />

tours.<br />

The standard training for operators also<br />

focuses on health and safety. The socalled<br />

TOPS project (Training Operators)<br />

also gives practical tips on working safely,<br />

alongside basic health and safety aspects.<br />

The Risk Management Department carried<br />

out health and safety audits in the past<br />

year in the following plants:<br />

• China:<br />

Taile Chemical Industry (Lianyungang)<br />

PB Gelatins (Ping Yang)<br />

• Poland:<br />

Dyka Warehouses (Wroclaw and Lotz)<br />

• The Netherlands :<br />

Nyloplast (‘s-Gravendeel)<br />

Many other sites were audited by<br />

an external insurance company, in<br />

collaboration with the Risk Management<br />

Department. All of these served to confirm<br />

that the initiatives of <strong>Tessenderlo</strong> <strong>Group</strong><br />

to increase the health and safety of its<br />

employees, the company, the surroundings<br />

and the environment, are effective. Another<br />

very positive conclusion is that this is a<br />

continuous and dynamic process. The<br />

following factories were audited in <strong>2008</strong>:<br />

• United States:<br />

Jupiter Sulphur LLC (Ponca City)<br />

77


annual report <strong>2008</strong><br />

78<br />

<strong>Tessenderlo</strong> Kerley (Coffeyville)<br />

PB Leiner (Davenport)<br />

• France:<br />

Caillaud (Saint Langis)<br />

France Gras (Le Sourn)<br />

Point (Viriat)<br />

Plastival (Clerval)<br />

• The Netherlands:<br />

LVM Limburg BV (Beek)<br />

<strong>Tessenderlo</strong> Chemie Maastricht<br />

<strong>Tessenderlo</strong> Chemie Rotterdam<br />

• Italy:<br />

<strong>Tessenderlo</strong> Italia (Pieve Vergonte,<br />

Ceppo Morelli and Megolo)<br />

Farchemia (Treviglio)<br />

• Germany:<br />

PB Gelatins GmbH (Nienburg)<br />

• Poland:<br />

Dyka Polska (Wroclaw)<br />

TCT Polska (Sochaczew)<br />

• Belgium:<br />

PB Gelatins (Vilvoorde)<br />

The Risk Management Department<br />

primarily focused its attention on<br />

prevention. For example, a DVD was<br />

distributed with examples of good and bad<br />

human conduct on the shop floor. The DVD<br />

is available to be used in all departments<br />

of the group for training purposes. The<br />

department also gave presentations to<br />

the commercial teams on product liability<br />

and how problems can be avoided. The<br />

department also continued work on<br />

the development of health and safety<br />

standards for <strong>Tessenderlo</strong> <strong>Group</strong> as a<br />

whole.<br />

Community relations<br />

A crucial aspect of corporate social<br />

responsibility is good community relations<br />

in the way <strong>Tessenderlo</strong> <strong>Group</strong> maintains<br />

with the local community around the<br />

various sites. It is very important that<br />

the company and local residents have a<br />

good relationship. Openness and good<br />

communications play a key role in this<br />

respect. A good example of this are the<br />

open house days when local residents<br />

are informed about the activities at the<br />

production sites.<br />

The social role of the company goes even<br />

further than the immediate surroundings.<br />

It is especially important that youngsters<br />

receive objective information about<br />

the chemical industry in general and<br />

<strong>Tessenderlo</strong> <strong>Group</strong> in particular.<br />

They must be made aware of the major<br />

role this industry plays in their daily lives.<br />

A close co-operation with educational<br />

authorities is important to accomplish this.<br />

This specifically translates into company<br />

visits and a variety of initiatives that bridge<br />

the gap between industry and education.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Outlook for 2009<br />

Environmental care<br />

With respect to water, over the years ahead<br />

the sites in Limburg will focus on adapting<br />

the waste water circuit. This is the result<br />

of changes to the production process in the<br />

Ham factory. Further investments will also<br />

be made for effluent treatment at several<br />

other sites of the group.<br />

The necessary soil decontamination<br />

projects are also getting underway for the<br />

sites of <strong>Tessenderlo</strong> Chemie in Limburg.<br />

This is the follow-up to the descriptive<br />

soil surveys that outline the historic soil<br />

contamination.<br />

Various measures to protect the soil<br />

and further reduce emissions into the<br />

atmosphere will also be implemented.<br />

Furthermore, several energy-saving<br />

measures are also scheduled.<br />

With regard to product stewardship,<br />

considerable efforts will be made in the<br />

context of the European REACH legislation<br />

(Registration, Evaluation, Authorisation<br />

and limitations of Chemicals). The<br />

so-called Euclid documents detailing<br />

physiochemical, toxic and ecotoxic<br />

characteristics are being prepared for the<br />

substances with production levels in excess<br />

of 1,000 tonnes.<br />

The mandatory SIEF activities (Substance<br />

Information Exchange Forum) will also be<br />

carried out and followed up. This forum<br />

has been set up for all manufacturers<br />

and importers that have registered or<br />

pre-registered hazardous substances.<br />

They must exchange all available<br />

information amongst themselves to prevent<br />

unnecessary tests on animals. They must<br />

also ensure that the classification and<br />

labelling of substances occurs in a uniform<br />

manner.<br />

The IT tools required to work efficiently<br />

with the REACH regulations will be<br />

implemented in 2009 and the following<br />

years. Communication to customers and<br />

suppliers is also an important issue.<br />

Furthermore in respect to product<br />

stewardship, the European integration of<br />

the Surround® crop protection products<br />

will also be continued in 2009.<br />

The GHS regulations (Global Harmonised<br />

System) will also be implemented. This<br />

worldwide uniform system relates to the<br />

labelling and hazard signs on product<br />

labels. This is gradually being introduced<br />

since1 January 2009.<br />

79


annual report <strong>2008</strong><br />

80<br />

Moreover, an electronic system will be<br />

developed to make the Material Safety<br />

Data Sheets (MSDS) of hazardous products<br />

available to customers and to follow this up<br />

within the organisation.<br />

Health, safety and risk management<br />

In 2009, the health and safety theme<br />

‘Working together for more safety’ will<br />

be launched. The importance of a good<br />

co-ordination between maintenance and<br />

manufacturing when preparing work will<br />

be emphasised.<br />

Next to the human aspects, and in<br />

particular the health and safety<br />

conduct of employees, the safety of the<br />

installations will also be reviewed in<br />

detail and further improved. The training<br />

programme with customised training<br />

sessions will be developed further. Special<br />

attention will be paid to emergency<br />

planning in 2009.<br />

The risk analysis that was started in <strong>2008</strong><br />

for the Chemicals business group, will be<br />

developed further in 2009 and extended<br />

to include other business groups and<br />

business units. In this respect, efforts<br />

will be made to map out and evaluate<br />

a large variety of risks. This will enable<br />

<strong>Tessenderlo</strong> <strong>Group</strong> to reduce risks where<br />

possible and to manage these risks more<br />

effectively.<br />

The internal audits will continue with the<br />

same frequency as in 2009, with new risk<br />

assessment visits and revisits.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Corporate Governance<br />

Transparent<br />

management<br />

<strong>Tessenderlo</strong> Chemie subscribes to the nine<br />

principles of Corporate Governance stated<br />

in the Belgian Corporate Governance Code.<br />

In fulfilment of this, the Board of Directors<br />

approved its Corporate Governance Charter<br />

(the ‘Charter’) on 10 November 2005<br />

and an update on 8 November 2007. The<br />

Charter can be consulted on our website<br />

www.tessenderlogroup.com.<br />

Compliance with the recommendations<br />

contained in the Belgian Corporate<br />

Governance Code and fine-tuning the<br />

working of the Board of Directors, the<br />

special committees and the Management<br />

Committee (*) to fulfil the requirements<br />

of Corporate Governance is an ongoing<br />

process. <strong>Tessenderlo</strong> Chemie undertakes,<br />

therefore, to review the Charter at regular<br />

intervals and to modify it where necessary.<br />

Board of Directors<br />

81<br />

By introducing organisational and<br />

operational rules, the decision-making<br />

process within the Board of Directors,<br />

the special committees set up under the<br />

auspices of the Board of Directors, and<br />

the Management Committee becomes<br />

more transparent, taking into account the<br />

interests of the company, its shareholders<br />

and others directly or indirectly involved in<br />

events affecting the company, the so-called<br />

‘stakeholders’.<br />

Role and responsibilities<br />

The Board of Directors is the highest administrative<br />

body of the company, which has<br />

full powers under Article 18 of the Articles<br />

of Association. The Board of Directors is a<br />

body with collective responsibility, which<br />

reports to the General Meeting on its<br />

activities.<br />

(*) To date, it has been decided not to exercise the option offered under Article 524bis of the Belgian<br />

Companies Code to set up an Executive Committee.


annual report <strong>2008</strong><br />

82<br />

The role of the Board of Directors consists<br />

in ensuring the long-term success<br />

of <strong>Tessenderlo</strong> Chemie and <strong>Tessenderlo</strong><br />

<strong>Group</strong>. The Board of Directors promotes<br />

and guarantees entrepreneurial leadership<br />

and ensures that risks can be assessed and<br />

managed. The Board of Directors decides<br />

on the values and the strategy of the company,<br />

its risk profile, and the key elements<br />

of its policy. The Board of Directors also<br />

exercises major monitoring and compliance<br />

responsibilities.<br />

The company is validly represented either<br />

by the Chairman of the Board of Directors<br />

or by two directors acting jointly.<br />

Composition<br />

Non-executive directors:<br />

• Michel Nicolas (June 2010)<br />

• François Schwartz (June 2011)<br />

• Jacques Zyss (June 2010)<br />

Independent non-executive directors*:<br />

• Valère Croes (June 2009)<br />

• Paul de Meester (June 2011)<br />

• Jaak Gabriels (June 2011)<br />

• Baudouin Michiels (June 2011)<br />

• Bernard Pache (June 2011)<br />

• Thierry Piessevaux (June 2011)<br />

• Alain Siaens (June 2010)<br />

• Karel Vinck (June 2011)<br />

The Board of Directors is supported by<br />

Adrien Carton de Wiart, in his capacity as<br />

the Secretary General of the company.<br />

At 31 December <strong>2008</strong>, the <strong>Tessenderlo</strong><br />

Chemie Board of Directors was composed<br />

as follows:<br />

Chairman, executive director:<br />

Gérard Marchand (appointment ends June<br />

2010)<br />

Remuneration policy<br />

Pursuant to Article 21 of the Articles<br />

of Association, as modified by the<br />

extraordinary meeting of 5 June 2007, it<br />

is the responsibility of the <strong>Tessenderlo</strong><br />

Chemie Board of Directors to make<br />

(*) Pursuant to paragraph 4.10 of the Charter, a director is regarded as being independent, if he or she at the<br />

very least satisfies the independence criteria contained in Article 526 ter of the Belgian Companies Code. When<br />

assessing independence, the conditions outlined in Annex A to the Belgian Corporate Governance Code will<br />

also be considered. According to the information at the disposal of the Board of Directors, the independent<br />

directors of <strong>Tessenderlo</strong> Chemie meet the above-mentioned independence criteria. No exceptions were<br />

reported to the Board.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

proposals concerning the remuneration<br />

granted to Board members.<br />

and 3,000 EUR for the director chairing the<br />

Committee.<br />

A special committee set up within<br />

the Board of Directors, namely the<br />

Remuneration Committee, formulates<br />

proposals to the Board of Directors<br />

concerning:<br />

• The remuneration for participating in<br />

the four annual Board meetings;<br />

• The remuneration granted for<br />

assignments related to special<br />

mandates.<br />

The Remuneration Committee also<br />

assesses the implementation of the various<br />

decisions taken on this matter.<br />

Non-executive directors receive fixed<br />

remuneration and reimbursement of<br />

travel expenses to meetings. Total annual<br />

remuneration amounts to 53,679 EUR<br />

per mandate, excluding reimbursement<br />

of travel expenses. Attendance fees<br />

amounting to 1,240 EUR are also granted<br />

per meeting of the Remuneration<br />

Committee and the Appointments<br />

Committee and, if the situation arises, the<br />

Independent Directors Committee to be set<br />

up pursuant to Article 524 of the Belgian<br />

Companies Code. With regard to the<br />

Audit Committee, the attendance fees per<br />

meeting amount to 2,000 EUR per director<br />

The executive director receives a<br />

remuneration package consisting of three<br />

different components proposed by the<br />

Remuneration Committee, namely:<br />

• A fixed remuneration of 590,352 EUR in<br />

<strong>2008</strong> compared to 560,320 EUR in 2007;<br />

• A variable remuneration of 472,282 EUR<br />

relating to <strong>2008</strong> compared to a bonus of<br />

425,843 EUR in 2007;<br />

• The granting of stock options under<br />

the stock option plan for group<br />

topmanagement.<br />

In common with all employees, the<br />

executive director also participates in the<br />

company’s benefits plan.<br />

Operation<br />

Pursuant to Article 16 of the <strong>Tessenderlo</strong><br />

Chemie Articles of Association, the Board<br />

of Directors convenes whenever it deems<br />

necessary, following notice given by the<br />

Chairman or if requested by any two<br />

directors. The Board of Directors may only<br />

validly deliberate if the majority of the<br />

directors is present or represented. The<br />

Board of Directors strives to take decisions<br />

by unanimous vote. If unanimity cannot be<br />

reached, the decision is taken by simple<br />

83


annual report <strong>2008</strong><br />

84<br />

majority, with the meeting Chairman<br />

having the deciding vote.<br />

During 2007, the Board of Directors<br />

convened five times. Average attendance in<br />

<strong>2008</strong> was 75 % against 92 % in 2007.<br />

Special committees<br />

General<br />

The Board of Directors may set up special<br />

committees under its auspices to analyse<br />

certain specific matters and to advise the<br />

Board. However, the ultimate decisionmaking<br />

authority remains with the Board of<br />

Directors in accordance with the statutory<br />

provisions and the Memorandum and<br />

Articles of Association.<br />

The <strong>Tessenderlo</strong> Chemie Board of Directors<br />

has set up an Appointments Committee,<br />

a Remuneration Committee, and an Audit<br />

Committee.<br />

recommendations of the special committee<br />

in question.<br />

Appointments Committee<br />

The task of the Appointments Committee<br />

consists in advising the Board of Directors<br />

on and assisting it with the appointment of<br />

directors, or assisting the CEO with and advising<br />

on the appointment of Management<br />

Committee members. The Appointments<br />

Committee ensures that the (re)appointment<br />

procedures are carried out in a professional<br />

and objective manner. However,<br />

the ultimate decision-making authority<br />

remains with the General Meeting or the<br />

Board of Directors respectively.<br />

At 31 December <strong>2008</strong>, the Appointments<br />

Committee was composed as follows:<br />

• Paul de Meester (Chairman)<br />

• Baudouin Michiels<br />

• Jacques Zyss.<br />

A special committee strives to take<br />

decisions by unanimous vote. If unanimity<br />

cannot be reached, the decision is taken by<br />

simple majority.<br />

Following each committee meeting, the<br />

Board of Directors receives a verbal or<br />

written report of the deliberations and<br />

The Appointments Committee convened<br />

once during the year under review. As in<br />

2007, the attendance rate was 100 %.<br />

Remuneration Committee<br />

The task of the Remuneration Committee<br />

consists in advising the Board of Directors


<strong>Tessenderlo</strong> <strong>Group</strong><br />

on and assisting it with formulating the<br />

remuneration policy for the executive and<br />

non-executive directors and Management<br />

Committee members. However, the ultimate<br />

decision-making authority remains<br />

with the General Meeting as far as the directors<br />

are concerned, and with the Board<br />

of Directors in the case of Management<br />

Committee members.<br />

At 31 December <strong>2008</strong>, the Remuneration<br />

Committee was composed as follows:<br />

obligation relates to <strong>Tessenderlo</strong> <strong>Group</strong> as<br />

a whole and refers to financial reporting,<br />

internal control and risk management, in<br />

addition to the internal and external audit<br />

process.<br />

At 31 December <strong>2008</strong>, the Audit Committee<br />

was composed as follows:<br />

• Valère Croes (Chairman)<br />

• Thierry Piessevaux<br />

• François Schwartz.<br />

• Valère Croes (Chairman)<br />

• Paul de Meester<br />

• Alain Siaens<br />

• Jacques Zyss<br />

The Financial Director, the Internal<br />

Auditor, the Management Controller and<br />

the Statutory Auditor may be invited to attend<br />

Audit Committee meetings.<br />

85<br />

The Remuneration Committee convened<br />

once during the year under review. As in<br />

2007, the attendance rate was 100 %.<br />

The Audit Committee convened three times<br />

during the year under review. As in 2007<br />

the attendance rate was 100 %.<br />

Audit Committee<br />

The task of the Audit Committee consists<br />

in providing the Board of Directors with assistance<br />

with and advice on its supervisory<br />

responsibilities concerning compliance in<br />

the most general sense.<br />

The compliance task of the Audit<br />

Committee and the associated reporting


annual report <strong>2008</strong><br />

86<br />

Eddy Vandenbriele<br />

Frank Coenen Albert Vasseur Pol Deturck<br />

Adrien Carton de Wiart Christian Vrebosch<br />

Gérard Marchand<br />

Jan Vandendriessche<br />

Management Committee<br />

Role and responsibilities<br />

The operational management of the<br />

company is entrusted by the Board of<br />

Directors to the Chief Executive Officer<br />

(CEO). The CEO is assisted by the members<br />

of the Management Committee.<br />

The operational management of the<br />

company includes, inter alia:<br />

• the day-to-day management of the<br />

company;<br />

• preparing and implementing decisions<br />

taken by the Board of Directors;<br />

• organising the internal audit, without<br />

prejudicing the supervisory function<br />

exercised by the Board of Directors;<br />

• preparing the budget and financial<br />

reporting, following these up, and<br />

explaining them to the Board of<br />

Directors;<br />

• preparing the annual accounts in<br />

accordance with the company’s<br />

accounting principles and valuation<br />

rules.<br />

Composition<br />

At 31 December <strong>2008</strong>, the <strong>Tessenderlo</strong><br />

Chemie Management Committee was


<strong>Tessenderlo</strong> <strong>Group</strong><br />

composed as follows:<br />

• Gérard Marchand – Chairman<br />

• Frank Coenen – Chemicals business<br />

group<br />

• Albert Vasseur – Plastics Converting<br />

business group<br />

• Jozef Housen – Gelatin business unit<br />

• Jan Vandendriessche – Fine Chemicals<br />

business unit<br />

As of 1 January 2009, the <strong>Tessenderlo</strong><br />

Chemie Management Committee is<br />

composed as follows:<br />

• Gérard Marchand – Chairman<br />

• Frank Coenen – Chief Operating Officer<br />

• Albert Vasseur – Plastics Converting<br />

business group<br />

• Jan Vandendriessche – Organic<br />

Specialities business group<br />

• Pol Deturck – Chemicals business<br />

group<br />

The ordinary meetings of the Management<br />

Committee are also attended by the<br />

Secretary General, Adrien Carton de Wiart,<br />

the Director ICT, Internal Audit and Human<br />

Resources, Eddy Vandenbriele and the<br />

CFO, Christian Vrebosch.<br />

Remuneration policy<br />

The remuneration of Management<br />

Committee members is determined on the<br />

basis of the recommendations made by the<br />

Remuneration Committee.<br />

The remuneration package and the<br />

composition thereof are analysed annually<br />

on the basis of a study conducted by a<br />

specialised external agency, in order<br />

to take into account prevailing market<br />

conditions.<br />

The fixed remuneration must be situated at<br />

internationally competitive levels with the<br />

objective of promoting complete motivation<br />

and loyalty of managers towards the group.<br />

The variable component amounting to<br />

on average 30 % of total remuneration<br />

sets quantitative and qualitative targets<br />

to be met by managers, taking into<br />

account the specific circumstances in<br />

the sector of activities or business units,<br />

which they manage. In common with all<br />

senior executives at the subsidiaries,<br />

Management Committee members are<br />

also entitled to participate in the annual<br />

stock option plan. The apportionment of<br />

subscription rights is entrusted to the<br />

Remuneration Committee.<br />

The pension plan, in which the executive<br />

director and the Management Committee<br />

members participate, is the same plan<br />

as that for all employees and executives<br />

of the company and is of the type<br />

‘defined benefits obligations’. The annual<br />

remuneration for the Management<br />

Committee, including remuneration for<br />

the executive director, amounts to 2.555<br />

million EUR including the bonus for <strong>2008</strong>.<br />

In 2007 the remuneration amounted to<br />

2.410 million EUR, bonus included.<br />

87


annual report <strong>2008</strong><br />

88<br />

Stock options<br />

In 2007 the group issued a first section of<br />

160,000 warrants, as part of a five-year<br />

plan relating to a maximum of 800,000<br />

warrants that could be subscribed for.<br />

These subscription rights can only be<br />

exercised after three years and this for two<br />

successive years. The list of beneficiaries,<br />

namely the Management Committee and<br />

the senior executives of the group (the<br />

‘Executive Team’), is established by the<br />

Board of Directors every year. The Board<br />

of Directors entrusts the Remuneration<br />

Committee with apportioning subscription<br />

rights among beneficiaries. The<br />

subscription rights are registered and<br />

non-transferable, except in the event of<br />

death. This issue enables the group’s<br />

senior executives to be connected with<br />

its financial results and this in the long<br />

term. The issued and offered subscription<br />

rights needed to be accepted fully or<br />

partially before 10 February 2009. The<br />

price at which the subscription rights can<br />

be exercised was set at 23.08 EUR. For the<br />

subplans for France and the USA the prices<br />

are respectively 22.07 EUR and 22.09 EUR.<br />

At 31 December <strong>2008</strong>, the situation of<br />

the total of the number of warrants,<br />

which can still validly be exerted by the<br />

‘Executive Team’, is the following: 258,595<br />

in total, including 77,460 for Management<br />

Committee members and 181,135 for<br />

senior executives of the group.<br />

Operation<br />

In principle, the Management Committee<br />

convenes once a month. The Management<br />

Committee may only validly deliberate,<br />

if half of its members are present or<br />

represented. The Management Committee<br />

strives to take decisions by unanimous vote.<br />

The Management Committee reports to<br />

the Board of Directors on the principal<br />

decisions it has taken.<br />

During the year under review, the<br />

Management Committee convened eleven<br />

times. Attendance was 100 %.<br />

Conflict of interests<br />

regulation<br />

Paragraphs 4.9 and 6.6 of the Charter<br />

set out the conflict of interests regulation<br />

applicable to the Board of Directors and<br />

the Management Committee respectively.<br />

During the year under review, the Board<br />

of Directors was informed of a conflict of<br />

interest affecting one of its members as it<br />

was noted in the notarial deed concerning<br />

the emission of warrants.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Policy on inside<br />

information and market<br />

manipulation<br />

Chapter 8 of the Charter sets out the<br />

company’s policy on inside information and<br />

market manipulation.<br />

The Board of Directors has appointed the<br />

Secretary General, Adrien Carton de Wiart,<br />

as Compliance Officer. In his absence, the<br />

Director ICT, Internal Audit and Human<br />

Resources will perform the function of<br />

Compliance Officer.<br />

The Compliance Officer is responsible<br />

for overseeing compliance with the<br />

policy outlined by the company on inside<br />

information and market manipulation and<br />

acts as a point of contact for enquiries<br />

concerning the application of the policy.<br />

External Audit<br />

The position of statutory auditor is fulfilled<br />

by Klynveld Peat Marwick Goerdeler<br />

Bedrijfsrevisoren (KPMG), represented by<br />

Ludo Ruysen. Its mandate will expire in<br />

June 2010.<br />

audit committee and board of directors.<br />

Worldwide audit and other audit related<br />

fees for <strong>2008</strong> in relation to services<br />

provided by KPMG Bedrijfsrevisoren<br />

amounted to 0.70 million EUR (2007:<br />

0.47 million EUR), which was composed<br />

of audit services for the annual financial<br />

statements of 0.39 million EUR (2007:<br />

0.32 million EUR) and audit related<br />

services of 0.31 million EUR (2007:<br />

0.15 million EUR).<br />

Audit and other fees for <strong>2008</strong> in relation<br />

to services provided by other offices of the<br />

KPMG network amounted to 0.64 million<br />

EUR (2007: 0.55 million EUR) which was<br />

composed of audit services for the annual<br />

financial statements of 0.45 million EUR<br />

(2007: 0.47 million EUR), tax services of<br />

0.19 million EUR (2007: 0.08 million EUR).<br />

Dividends policy<br />

The dividend policy remains unchanged. In<br />

fact: one-third of the net consolidated profit<br />

average is paid out as dividend. However,<br />

this policy can be adjusted in order to<br />

ensure that the dividend grows or at least<br />

remains stable.<br />

89<br />

Fees for auditing the annual financial<br />

statements of <strong>Tessenderlo</strong> Chemie NV<br />

and its subsidiaries are determined by<br />

the general meeting of shareholders after<br />

review and approval by the company’s<br />

For the financial year <strong>2008</strong>, a net dividend<br />

of 1.00 EUR per share will be proposed to<br />

the General Meeting of June 2, 2009, which<br />

is an increase of 5.3 % compared to last<br />

year’s dividend.


MAKING<br />

IT<br />

CONVINCING


<strong>Tessenderlo</strong> <strong>Group</strong> inspires confidence. Among<br />

customers and also among shareholders and investors. For<br />

many products we are the market leader in Europe and even<br />

in the world. In addition, <strong>Tessenderlo</strong> <strong>Group</strong> is financially a<br />

healthy company. Costs are monitored very closely. Our<br />

dividend policy is focused on stable growth.<br />

91


annual report <strong>2008</strong><br />

Information for<br />

shareholders<br />

<strong>Tessenderlo</strong> Chemie shares<br />

92<br />

<strong>Tessenderlo</strong> Chemie shares are listed on The shares are included in the<br />

the Brussels Stock Exchange with code ‘Kempen SNS Smaller European Social<br />

TESB. They are traded on the continuous Responsibility Index’. This index only<br />

market and are included in the following includes companies that fulfill stringent<br />

indices: BEL Mid and Next 150.<br />

criteria and practices in terms of business<br />

ethics and social and environmental<br />

performance.<br />

Shareholder structure on 31 December <strong>2008</strong><br />

Shareholder Share Last notification<br />

SNPE SA (FR) 25.93 % 30 October <strong>2008</strong><br />

M&G Investment Management Ltd (UK) 4.03 % 24 October <strong>2008</strong><br />

ID Sparinvest A/S (DK) 3.03 % 31 October <strong>2008</strong><br />

Sub-total 32,99 %<br />

Staff (Nominative shares) 1.28 %<br />

Free float (100 -25,93) 74,07 %


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The total number of shares constituting<br />

the issued capital of <strong>Tessenderlo</strong> Chemie<br />

NV is 27,713,288. Including the shares that<br />

may be issued as a result of the exercise of<br />

warrants, the total is 27,971,883.<br />

In <strong>2008</strong>, JP Morgan Chase & Co that<br />

officially notified to own a stake of at least<br />

3 % in the share capital of <strong>Tessenderlo</strong><br />

Chemie NV, fell below the 3 % threshold.<br />

Stock market data as at 31 December<br />

2004* 2005 2006 2007 <strong>2008</strong><br />

Number of shares 27,210,399 27,269,568 27,419,876 27,626,444 27,713,288<br />

Farthest prices<br />

Fixed ordinary share (EUR) 27.24/33 36.00/25.75 26.03/32.53 31.27/47.2 20.05/38.21<br />

93<br />

Market continuous<br />

Closing price (EUR) 31.14 27.35 32.3 33.2 21.63<br />

Average daily volume 35,536 59,890 64,063 97,787 103,308<br />

Velocity (in %)** 51.38 56.44 59.58 90.26 95.43<br />

Volume 9,203,713*** 15,391,688 16,336,185 24,935,571 26,446,820<br />

* As from 2004 figures are stated according to IFRS<br />

** Sum of the velocities of the 12 months of the year<br />

*** Exclusive the sale of 4,693,794 shares of EMC Parbel<br />

Financial data per share (consolidated accounts)<br />

on 31 December<br />

2004* 2005 2006 2007 <strong>2008</strong><br />

Data per share (EUR)<br />

Value of shareholders’ equity 27.77 28.41 25.96 29.04 32.55<br />

Profit (+) / Loss (-) 1.97 1.29 -0.89 4.69 5.08<br />

Net cash flow 7.19 5.91 5.21 8.99 10.11<br />

Net dividend per ordinary share 0.90 0.90 0.90 0.95 1.00<br />

Capital (millions EUR) 134.00 135.00 136.00 137.02 138.00<br />

Capitalisation at the end of year (millions EUR) 847.30 745.80 885.70 917.20 599.40<br />

* As from 2004 figures are stated according to IFRS


annual report <strong>2008</strong><br />

Dividend<br />

On 2 June 2009, a proposal will be put to<br />

the <strong>Annual</strong> General Meeting to approve a<br />

net dividend of 1.00 EUR (coupon n° 72).<br />

This corresponds to a gross dividend<br />

of 1.3333 EUR. The net dividend for<br />

shares with VVPR strips attached will be<br />

1.1333 EUR. The net dividend of 1.00 EUR<br />

means an increase of 5.3 % compared with<br />

financial year 2007.<br />

The net dividend will be payable as<br />

from June 9, 2009 either per transfer to<br />

registered and dematerialised shares, or<br />

against handing-over of the coupon for<br />

materialised shares (and if necessary from<br />

strips VVPR) to Belgian banks and financial<br />

institutions, the financial service being<br />

ensured by ING Belgium.<br />

94<br />

Financial communication and<br />

investor relations<br />

Road shows and events<br />

Each year, the financial managers work<br />

with the Corporate Communication<br />

department on a number of initiatives to<br />

raise awareness of <strong>Tessenderlo</strong> <strong>Group</strong><br />

among institutional and private investors.<br />

Between ‘roadshows’, the group regularly<br />

participates in events for investors and<br />

organises company visits and meetings<br />

with the group management.<br />

The group also invites analysts on a regular<br />

base in order to comment on the results<br />

and future developments. In a ddition the<br />

group organises conferences calls for<br />

analysts to explain the quarterly results.<br />

Financial calendar<br />

Financial year <strong>2008</strong> Announcement of results 12 March 2009<br />

General Meeting 2 June 2009<br />

Payment of dividend 9 June 2009<br />

First quarter 2009 Announcement of quarterly results 23 April 2009<br />

First half year 2009 Announcement of quarterly results 27 August 2009<br />

Third quarter 2009 Announcement of quarterly results 5 November 2009


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Full financial and non-financial information<br />

about the group is available on the website<br />

at www.tessenderlogroup.com. Anyone<br />

wishing to receive <strong>Tessenderlo</strong> <strong>Group</strong> press<br />

releases by e-mail may register on the<br />

mailing list on this website.<br />

The <strong>Tessenderlo</strong> Chemie share price is<br />

published on www.tessenderlogroup.<br />

com and on the Euronext website: www.<br />

euronext.com.<br />

Contacts<br />

The following people are available to<br />

answer any questions about <strong>Tessenderlo</strong><br />

<strong>Group</strong>:<br />

Investors and analysts<br />

Christian Vrebosch (CFO)<br />

Tel: +32 2 639 18 87<br />

E-mail:<br />

christian.vrebosch@tessenderlo.com<br />

Providers of financial<br />

information<br />

Providers of <strong>Tessenderlo</strong> <strong>Group</strong> financial<br />

information publish under the following<br />

codes:<br />

Shareholders<br />

Jo Verspecht<br />

Tel: +32 2 639 18 31<br />

E-mail: jo.verspecht@tessenderlo.com<br />

95<br />

• Bloomberg: TESB BB<br />

• Reuters: TESBt.BR<br />

• Datastream: B:TES<br />

• TBM: 23IT081<br />

• SEDOL: 4-884-006<br />

• ALPHA: TES<br />

• ISIN: BE 000 3 555 639<br />

“The stock market price of<br />

<strong>Tessenderlo</strong> Chemie shares<br />

generally held its own in relation<br />

to the Belgian or European stock<br />

exchange indices and continued to<br />

do so until November <strong>2008</strong>. As of<br />

this time, prices of chemical shares<br />

sustained a downward sweep as<br />

a result of the uncertainty as to<br />

the performance of industrial<br />

businesses for the months ahead.”<br />

Gérard Marchand<br />

CEO


annual report <strong>2008</strong><br />

Shareholders equity & Stock market capitalisation<br />

(millions EUR)<br />

2, 000<br />

1,000<br />

Shareholders’ equity<br />

96<br />

0<br />

Stock market<br />

capitalisation<br />

Net dividend per share (EUR)<br />

<br />

IFRS<br />

1.00<br />

<br />

<br />

<br />

<br />

<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong><br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

<strong>2008</strong>


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Return on dividends reinvested<br />

200<br />

150<br />

100<br />

50<br />

Dec. 03<br />

2004<br />

2005<br />

97<br />

40<br />

30<br />

20<br />

10<br />

Jan. 08<br />

Feb. 08<br />

March 08<br />

April 08<br />

May 08<br />

June 08<br />

July 08<br />

Aug. 08<br />

Sept. 08<br />

Oct. 08<br />

Nov. 08<br />

Dec. 08<br />

2006<br />

2007<br />

Dec. 08<br />

Change in the <strong>Tessenderlo</strong> Chemie share price<br />

in <strong>2008</strong> (EUR)


MAKING<br />

IT<br />

WORK


Co-operation means working together. Effective<br />

communication between employees is the key<br />

to success. Like at PB Gelatins in Vilvoorde. All maintenance<br />

works are discussed and planned at the weekly team meeting<br />

between the managers of maintenance and production.<br />

99


financial report <strong>2008</strong><br />

CONSOLIDATED FINANCIAL REPORT<br />

CONSOLIDATED INCOME STATEMENT<br />

(Millions EUR) note <strong>2008</strong> 2007<br />

Revenue 2,765.0 2,405.9<br />

Cost of sales -2,165.9 -1,873.6<br />

Gross profit 599.1 532.3<br />

Distribution expenses -144.6 -165.2<br />

Sales and marketing expenses -62.7 -77.4<br />

Administrative expenses -126.1 -125.2<br />

Other operating income and expenses 4 -26.6 -12.2<br />

Profit from operations before non-recurring items 239.1 152.3<br />

100<br />

Gain on disposals 5 12.8 58.4<br />

Restructuring (incl. impairment losses) 5 -18.2 -15.6<br />

Environmental provisions 5 -14.2 -2.8<br />

Other 5 -7.3 -4.9<br />

Profit (+) / loss (-) from operations 212.2 187.4<br />

Finance expenses 8 -29.8 -23.9<br />

Finance income 8 8.2 6.3<br />

Finance expenses - net -21.6 -17.6<br />

Share of result of investments accounted<br />

for using the equity method<br />

13 11.5 6.0<br />

Profit (+) / loss (-) before tax 202.1 175.8<br />

Income tax expense 9 -61.7 -47.1<br />

Profit (+) / loss (-) for the period 140.4 128.7<br />

Attributable to:<br />

- Equity holders of the <strong>Group</strong> 140.5 128.9<br />

- Minority interests -0.1 -0.2<br />

Basic earnings per share (EUR) 21 5.08 4.69<br />

Diluted earnings per share (EUR) 21 5.08 4.68


<strong>Tessenderlo</strong> <strong>Group</strong><br />

CONSOLIDATED STATEMENT OF RECOGNISED INCOME AND EXPENSE<br />

(Millions EUR) note <strong>2008</strong> 2007<br />

Translation differences 20 -8.8 -12.4<br />

Net income (+) / expense (-) recognised directly in equity -8.8 -12.4<br />

Profit (+) / loss (-) for the period 140.4 128.7<br />

Total recognised income (+) and expense (-) for the period 131.6 116.3<br />

Attributable to:<br />

Equity holders of the <strong>Group</strong> 131.7 116.5<br />

Minority interests -0.1 -0.2<br />

Total recognised income (+) and expense (-) for the period 131.6 116.3<br />

101


financial report <strong>2008</strong><br />

CONSOLIDATED BALANCE SHEET<br />

(Millions EUR) note <strong>2008</strong> 2007<br />

ASSETS<br />

Non-current assets 810.1 823.8<br />

Property, plant and equipment 10 652.0 677.8<br />

Goodwill 11 38.3 37.2<br />

Intangible assets 12 39.9 36.9<br />

Investments accounted for using the equity method 13 39.6 24.0<br />

Investments 14 5.2 6.1<br />

Deferred tax assets 15 17.7 26.3<br />

Trade and other receivables 16 17.4 15.5<br />

Current assets 1,002.1 859.4<br />

Inventories 17 473.7 339.9<br />

Trade and other receivables 16 469.5 424.0<br />

Derivative financial instruments 25 5.4 1.9<br />

Cash and cash equivalents 18 53.5 93.6<br />

Non current assets classified as held for sale 19 0.7 0.0<br />

Total assets 1,812.9 1,683.2<br />

102<br />

(Millions EUR) note <strong>2008</strong> 2007<br />

EQUITY & LIABILITIES<br />

Equity<br />

Equity attributable to equity holders of the <strong>Group</strong> 20 900.0 800.2<br />

Issued capital 20 138.0 137.0<br />

Share premium 20 43.3 42.0<br />

Reserves 20 313.4 238.6<br />

Retained earnings 20 405.3 382.6<br />

Minority interests 20 2.0 2.0<br />

Total equity 902.0 802.2<br />

Liabilities<br />

Non-current liabilities 267.7 269.3<br />

Financial liabilities 22 96.7 122.6<br />

Employee benefits 23 40.9 46.4<br />

Provisions 24 85.7 63.1<br />

Deferred tax liabilities 15 44.4 37.2<br />

Current liabilities 643.2 611.7<br />

Financial liabilities 22 251.4 214.8<br />

Trade and other payables 25 388.9 385.9<br />

Current tax liabilities 2.0 2.4<br />

Provisions 24 0.9 8.6<br />

Total liabilities 910.9 881.0<br />

Total equity and liabilities 1,812.9 1,683.2


<strong>Tessenderlo</strong> <strong>Group</strong><br />

CONSOLIDATED CASH FLOW STATEMENT<br />

(Millions EUR) note <strong>2008</strong> 2007<br />

OPERATING ACTIVITIES<br />

Profit (+) / loss (-) from operations 212.2 187.4<br />

Depreciation, impairment and amortisation 144.8 128.9<br />

Changes in provisions 9.3 -5.7<br />

Loss / (profit) on sale of non-current assets -12.4 -56.2<br />

Non cash items -1.4 0.5<br />

Changes in inventories -149.1 -1.7<br />

Changes in trade and other receivables -52.8 8.9<br />

Changes in trade and other payables 2.6 18.1<br />

Cash generated from operating activities 153.2 280.2<br />

Interest paid -14.6 -17.9<br />

Interest received 2.8 4.2<br />

Income tax (paid) / received -57.6 -48.0<br />

Dividends received from investments accounted for using the<br />

30 10.2 4.9<br />

equity method<br />

Cashflow from operating activities 94.0 223.4<br />

INVESTING ACTIVITIES<br />

Acquisition of property, plant and equipment 10 -94.2 -98.6<br />

Acquisition of intangible assets 12 -7.2 -5.5<br />

Acquisition of investments accounted for using the equity method 3 -3.1 -<br />

Acquisition of businesses, net of cash acquired 3 -18.5 -25.8<br />

Acquisition of investments -0.4 -<br />

Proceeds from sale of property, plant and equipment 15.1 11.0<br />

Proceeds from sale of intangible assets - 1.0<br />

Proceeds from sale of subsidiaries, net of cash disposed of 3 - 3.6<br />

Proceeds from sale of investments accounted for using the equity 3 - 68.7<br />

method<br />

Proceeds from sale of investments 0.1 -<br />

Proceeds from government grants - 12.5<br />

Cashflow from investing activities -108.2 -33.1<br />

103<br />

FINANCING ACTIVITIES<br />

Increase/(decrease) of issued capital 20 2.3 6.5<br />

Increase/(decrease) of financial liabilities 10.1 -105.7<br />

(Increase)/decrease of long term receivables -2.4 0.9<br />

Dividends paid to shareholders 20 -35.0 -33.5<br />

Cashflow from financing activities -25.0 -131.8<br />

Net increase/(decrease) in cash and cash equivalents -39.2 58.5<br />

Effect of exchange rate differences -0.9 -1.2<br />

Cash and cash equivalents at the beginning of the year 18 93.6 36.3<br />

Cash and cash equivalents at the end of the year 18 53.5 93.6


financial report <strong>2008</strong><br />

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS<br />

104<br />

Summary of significant accounting policies 1<br />

Segment reporting 2<br />

Acquisitions and disposals 3<br />

Other operating income and expenses 4<br />

Non-recurring items 5<br />

Payroll and related benefits 6<br />

Additional information on operating expenses by nature 7<br />

Finance income and expense 8<br />

Income tax expense 9<br />

Property, plant and equipment 10<br />

Goodwill 11<br />

Intangible assets 12<br />

Investments accounted for using the equity method 13<br />

Investments 14<br />

Deferred tax assets and liabilities 15<br />

Trade and other receivables 16<br />

Inventories 17<br />

Cash and cash equivalents 18<br />

Non-current assets held for sale 19<br />

Equity 20<br />

Earnings per share 21<br />

Financial liabilities 22<br />

Employee benefits 23<br />

Provisions 24<br />

Trade and other payables 25<br />

Financial instruments 26<br />

Operating leases 27<br />

Guarantees and commitments 28<br />

Contingencies 29<br />

Related parties 30<br />

Information on the auditors’ assignment and related fees 31<br />

Subsequent events 32<br />

Consolidated companies 33<br />

Critical accounting estimates and judgements 34


<strong>Tessenderlo</strong> <strong>Group</strong><br />

1. Summary of significant accounting policies<br />

<strong>Tessenderlo</strong> Chemie NV (hereafter referred to as the « Company ») is a company domiciled in Belgium.<br />

The consolidated financial statements for the year ended 31 December <strong>2008</strong> comprise the Company and<br />

its subsidiaries (together referred to as the « <strong>Group</strong> ») and the <strong>Group</strong>’s interests in associates and jointly<br />

controlled entities.<br />

The IFRS financial statements were authorised for issue by the Board of Directors of <strong>Tessenderlo</strong><br />

Chemie NV on Thursday 12 March 2009.<br />

(A) Statement of compliance<br />

The consolidated financial statements have been prepared in accordance with International Financial<br />

<strong>Report</strong>ing Standards (formerly named IAS) issued by the International Accounting Standards Board<br />

(IASB) as adopted by the European Union.<br />

(B) Basis of preparation<br />

The financial statements are presented in euro, rounded to the nearest million. They are prepared on<br />

the historical cost basis except for derivative financial instruments and investments available-for-sale,<br />

which are stated at fair value.<br />

105<br />

Non-current assets and disposal groups held for sale are stated at the lower of carrying amount and fair<br />

value less costs to sell.<br />

The preparation of financial statements in conformity with IFRSs requires management to make<br />

judgements, estimates and assumptions that affect the application of policies and reported amounts<br />

of assets and liabilities, income and expenses. The estimates and associated assumptions are based<br />

on historical experience and various other factors that are believed to be reasonable under the<br />

circumstances, the results of which form the basis of making the judgements about carrying values of<br />

assets and liabilities that are not readily apparent from other sources. Actual results may differ from<br />

these estimates.<br />

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting<br />

estimates are recognised in the period in which the estimate is revised if the revision affects only that<br />

period, or in the period of the revision and future periods if the revision affects both current and future<br />

periods.<br />

Judgements made by management in the application of IFRS that have significant effect on the financial<br />

statements and estimates with a significant risk of material adjustment in the next year are discussed in<br />

note 34.<br />

The consolidated financial statements are presented before the effect of the profit appropriation of the<br />

Company proposed to the General Assembly of shareholders.<br />

The accounting policies set out hereafter have been applied consistently by the <strong>Group</strong> to all periods<br />

presented in these consolidated financial statements.


financial report <strong>2008</strong><br />

(C) Principles of consolidation<br />

Companies controlled by the <strong>Group</strong> (i.e. in which the <strong>Group</strong> has, directly, or indirectly, an interest of<br />

more than one half of the voting rights or is able to exercise control over the operations, further also<br />

“subsidiaries”) have been fully consolidated. In assessing control, potential voting rights that presently<br />

are exercisable or convertible are taken into account. The financial statements of subsidiaries are<br />

included in the consolidated financial statements from the date that control commences until the date<br />

that control ceases. Separate disclosure is made of minority interests.<br />

Investments in associates and jointly controlled entities (joint ventures) are included in the consolidated<br />

financial statements using the equity method. The investments in associates are those in which the<br />

<strong>Group</strong> has significant influence over the financial and operating policies, but which it does not control.<br />

In general, it is the case when the <strong>Group</strong> holds between 20 % and 50 % of the voting rights. The equity<br />

method is used as from the date that significant influence commences until the date that significant<br />

influence ceases. When the <strong>Group</strong>’s share of losses exceeds its interest in an associate, the <strong>Group</strong>’s<br />

carrying amount is reduced to nil and recognition of further losses is discontinued except to the extent<br />

that the <strong>Group</strong> has incurred legal or constructive obligations in respect of the associate.<br />

106<br />

All intercompany transactions, balances and unrealised gains and losses on transactions between group<br />

companies have been eliminated. Unrealised gains arising from transactions with associates and jointly<br />

controlled entities are eliminated to the extent of the <strong>Group</strong>’s interest in the entity. Unrealised losses<br />

are eliminated in the same way as unrealised gains, but only to the extent that there is no evidence of<br />

impairment.<br />

(D) Foreign currency<br />

• Foreign currency transactions<br />

Foreign currency transactions are accounted for at exchange rates prevailing at the date of the<br />

transaction. Monetary assets and liabilities denominated in foreign currencies are translated at balance<br />

sheet date rate. The resulting gains and losses of these transactions are recognised in the income<br />

statement of the period.<br />

Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value<br />

are translated to euro at foreign exchange rates ruling at the dates the fair value was determined. For<br />

available for sale non-monetary assets, foreign exchange gains and losses are not separated from the<br />

total fair value changes.<br />

• Foreign currency translation<br />

Assets and liabilities of foreign entities included in the consolidation are translated to euro at the<br />

foreign exchange rates ruling at the balance sheet date. The income statement of the foreign entities is<br />

translated to euro at the annual average foreign exchange rates (approximating the foreign exchange<br />

rates prevailing at the dates of the transactions). The components of equity attributable to equity holders<br />

of the <strong>Group</strong> are translated at historical rates. Exchange differences arising from the translation of the<br />

equity attributable to the equity holders of the <strong>Group</strong> to euro at year-end exchange rates are taken to<br />

“Translation reserves” in Equity.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

• Exchange rates<br />

The following exchange rates have been used in preparing the financial statements:<br />

Closing rate<br />

Average rate<br />

1 EUR equals : <strong>2008</strong> 2007 <strong>2008</strong> 2007<br />

Brazilian real 3.2332 2.7490 2.6701 2.6622<br />

Canadian dollar 1.6998 1.4449 1.5600 1.4678<br />

Chinese yuan 9.4956 10.7524 10.2211 10.4178<br />

Czech crown 26.8750 26.6280 24.9519 27.7656<br />

Hungarian forint 266.7000 253.7300 251.5800 251.3500<br />

Polish zloty 4.1535 3.5935 3.5143 3.7837<br />

Pound sterling 0.9525 0.7333 0.7969 0.6843<br />

Slovak koruna 30.1260 33.5830 31.2576 33.7745<br />

Swiss franc 1.4850 1.6547 1.5871 1.6427<br />

US dollar 1.3917 1.4721 1.4705 1.3705<br />

(E) Intangible assets<br />

• Research and development<br />

Expenditure on research activities, undertaken with the prospect of gaining new scientific or technical<br />

knowledge and understanding, is recognised in the income statement as an expense as incurred.<br />

107<br />

Expenditure resulting from development activities, whereby research findings are applied to a plan or<br />

design for production of new or substantially improved products and processes, is capitalised if the<br />

product or process is technically and commercially feasible and the company has sufficient resources to<br />

complete development.<br />

The capitalised expenditure includes the cost of materials, direct labour and an appropriate proportion<br />

of overheads. Other development expenditure is recognised in the income statements as an expense<br />

as incurred. Capitalised development is stated at cost less accumulated amortisation (see below) and<br />

impairment losses (see accounting policy J).<br />

• Emission allowances<br />

The cost of acquiring emission allowances is recognised as intangible asset, whether they have been<br />

purchased or received free of charge (in the latter the acquisition cost is zero). A provision is set up to<br />

cover obligations to refund allowances depending on emissions if, during a given period, the number of<br />

allowances required exceeds the total number of allowances received. This provision is measured at the<br />

estimated amount of the expenditure required to settle the obligation.<br />

• Other intangible assets<br />

Other intangible assets, acquired by the <strong>Group</strong>, are stated at cost less accumulated amortisation (see<br />

below) and impairment losses (see accounting policy J).


financial report <strong>2008</strong><br />

• Subsequent expenditure<br />

Subsequent expenditure on capitalised intangible assets is capitalised only when it increases the future<br />

economic benefits embodied in the specific asset to which it relates. All other expenditure is expensed<br />

as incurred.<br />

• Amortisation<br />

Intangible assets with a finite life are amortised using the straight-line method over their estimated<br />

useful lives.<br />

The estimated useful lives of the respective asset categories are as follows:<br />

Development<br />

Software<br />

Concessions, licenses, patents and other<br />

5 years<br />

3 to 5 years<br />

10 to 20 years<br />

Intangible assets with an indefinite useful life are tested for impairment on an annual basis.<br />

(F) Goodwill<br />

108<br />

• Goodwill<br />

Goodwill represents the excess of the cost of an acquisition over the fair value of the company’s share of<br />

the net identifiable assets of the acquired subsidiary, jointly controlled entity or associate at the date of<br />

acquisition.<br />

All goodwill has been frozen on the 1st of January 2004 and is not amortised anymore, but tested at<br />

least annually for impairment and whenever there is an indicator that the unit to which the goodwill has<br />

been allocated may be impaired (see accounting policy J).<br />

Goodwill is expressed in the currency of the subsidiary, jointly controlled entity or associate to which it<br />

relates.<br />

• Negative goodwill<br />

Negative goodwill represents the excess of the fair value of the company’s share of the net identifiable<br />

assets acquired over the cost of acquisition. Any negative goodwill is recognised directly in the income<br />

statement.<br />

• Subsequent measurement<br />

Goodwill is measured at cost less accumulated impairment losses. In respect of equity accounted<br />

investees, the carrying amount of goodwill is included in the carrying amount of the investment.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

(G) Property, plant and equipment<br />

• Owned assets<br />

Items of property, plant and equipment (further also “PP&E”) are stated at cost less accumulated<br />

depreciation and impairment losses. Cost includes the purchase price and any costs directly attributable<br />

to bringing the asset to the location and condition necessary for it to be capable of operating in the<br />

manner intended by management (e.g. non refundable tax, transport and the costs of dismantling and<br />

removing the items and restoring the site on which they are located, if applicable). The cost of a selfconstructed<br />

asset is determined using the same principles as for an acquired asset and includes the<br />

cost of materials, direct labour and an appropriate proportion of indirect costs. Borrowing costs directly<br />

attributable to the acquisition, construction or production of an asset, requiring a long preparation, are<br />

included in the cost of the asset.<br />

Where parts of an item of property, plant and equipment have different useful lives, they are accounted<br />

for as separate items of property, plant and equipment.<br />

• Subsequent expenditure<br />

Subsequent expenditure incurred in replacing or renewing components of some items of property,<br />

plant and equipment is accounted for as the acquisition of a separate asset and the replaced asset is<br />

written off. Capitalisation of subsequent expenditure is only done when it increases the future economic<br />

benefits embodied in the item of property, plant and equipment. Repair and maintenance, which do not<br />

increase the future economic benefits of the asset to which they relate, are expensed as incurred.<br />

109<br />

• Depreciation<br />

Depreciation is charged to the income statement as from the date the asset is available for use, on<br />

a straight-line basis over the estimated useful lives of each part of an item of property, plant and<br />

equipment.<br />

The estimated useful lives of the respective asset categories are as follows:<br />

Improvements to land<br />

Buildings<br />

Building improvements<br />

Plant installations<br />

Machinery and equipment<br />

Furniture and office equipment<br />

Extrusion and tooling equipment<br />

Laboratory and research – infrastructure<br />

Vehicles<br />

Computer equipment<br />

10 to 20 years<br />

20 to 40 years<br />

10 to 20 years<br />

6 to 20 years<br />

5 to 15 years<br />

4 to 10 years<br />

3 to 7 years<br />

3 to 5 years<br />

4 to 10 years<br />

3 to 5 years<br />

Land is not depreciated as it is deemed to have an indefinite life.


financial report <strong>2008</strong><br />

• Government grants<br />

Government grants relating to the purchase of property, plant and equipment are deducted from the<br />

carrying amount of the related asset when there is reasonable assurance that they will be received and<br />

the company will comply with the conditions attached to it. They are recognised in the income statement<br />

as other operating income on a straight-line basis over the estimated useful life of the associated asset.<br />

(H) Leased assets<br />

Leases of property, plant and equipment where the company assumes substantially all the risks and<br />

rewards of ownership are classified as finance leases. Finance leases are capitalised at the lower of<br />

the fair value and the present value of the minimum lease payments at inception of the lease, less<br />

accumulated depreciation (see accounting policy G) and impairment losses (see accounting policy J).<br />

Each lease payment is allocated between the liability and finance charges so as to achieve a constant<br />

periodic rate of interest on the outstanding finance balance. The corresponding obligations, net of<br />

finance charges, are included in other long-term payables. The interest element is charged to the<br />

income statement as a finance charge over the lease period. Property, plant and equipment acquired<br />

under finance lease contract is depreciated over the useful life of the asset (see accounting policy G).<br />

110<br />

Leases of assets under which the lessor substantially retains all the risks and rewards of ownership are<br />

classified as operating leases. The payments made under operating leases are charged to the income<br />

statement on a straight-line basis over the term of the lease.<br />

(I) Investments<br />

Each category of investment is accounted for at trade date.<br />

• Investments in equity securities<br />

Investments in equity securities are undertakings in which the <strong>Group</strong> does not have significant<br />

influence or control. This is generally evidenced by ownership of less than 20 % of the voting rights.<br />

Such investments are designated as available for sale financial assets and are recorded at their fair<br />

value unless the fair value cannot be reliably determined in which case they are carried at cost less<br />

impairment losses. The fair value is the quoted bid price at balance sheet date. Changes in fair value are<br />

directly recognised in equity, except for impairment losses. On disposal of an investment, the cumulative<br />

gain or loss previously recognised directly in equity is recognised in profit or loss.<br />

• Other investments<br />

The other investments mainly include cash guarantees.<br />

(J) Impairment<br />

At each balance sheet date, the <strong>Group</strong> reviews the carrying amounts of the <strong>Group</strong>’s assets, other than<br />

inventories (see accounting policy K) and deferred tax assets (see accounting policy R), to determine<br />

whether there is any indication of impairment. If such an indication exists, the asset’s recoverable


<strong>Tessenderlo</strong> <strong>Group</strong><br />

amount is estimated. An impairment loss is recognised whenever the carrying amount of an asset or its<br />

cash-generating unit exceeds its recoverable amount. Impairment losses are recognised in the income<br />

statement.<br />

Goodwill, intangible assets with indefinite useful life and intangible assets not yet available for use<br />

were tested for impairment at 1 January 2004, the date of transition to IFRS, even if no indication of<br />

impairment existed.<br />

Impairment losses recognised in respect of cash-generating units are allocated first to reduce the<br />

carrying amount of any goodwill allocated to cash-generating units and then, to reduce the carrying<br />

amount of other assets in the unit on a pro rata basis.<br />

• Calculation of recoverable amount<br />

The recoverable amount is the higher of the fair value less costs to sell and its value in use. The value in<br />

use is the net present value of the estimated future cash flows from the use of an asset. The recoverable<br />

amount is calculated at the level of the cash-generating unit to which the asset belongs. In assessing<br />

the value in use, the estimated future cash flows are discounted to their present value using a discount<br />

rate that reflects current market assessments of the time value of money and the risks specific to the<br />

asset, to the business etc.<br />

• Reversal of impairment<br />

111<br />

If there has been a change in the estimates used to determine the recoverable amount on assets other<br />

than goodwill, the carrying amount is partially or totally re-established through the non-recurring items<br />

in the income statement, to the extent that the asset’s carrying amount does not exceed the carrying<br />

amount that would have been determined, net of depreciation or amortisation, if no impairment loss had<br />

been recognised.<br />

An impairment loss in respect of goodwill cannot be reversed.<br />

(K) Inventories<br />

Inventories are stated at the lower of cost and net realisable value. The cost is determined by the<br />

weighted average cost method.<br />

The cost of finished goods and work in progress comprises raw materials, other production materials,<br />

direct labour, other direct cost and an allocation of fixed and variable overhead based on normal<br />

operating capacity. Cost of inventories includes the purchase, conversion and other costs incurred<br />

to bring the inventories to their present location and condition. Net realisable value represents the<br />

estimated selling price, less all estimated costs of making the product ready for sale.<br />

(L) Trade and other receivables<br />

Trade and other receivables are stated at amortised cost less appropriate allowances for nonrecoverable<br />

amounts.


financial report <strong>2008</strong><br />

(M) Cash and cash equivalents<br />

Cash includes cash in hand and cash with banks. Cash equivalents are short-term, highly liquid<br />

investments that are readily convertible into known amounts of cash, have a remaining maturity date of<br />

three months or less and are subject to an insignificant risk of change in value.<br />

(N) Issued capital<br />

• Ordinary shares<br />

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of ordinary<br />

shares and share options are recognised as a reduction from equity, net of any tax effects.<br />

• Repurchase of issued capital<br />

When share capital recognised as equity is repurchased, the amount of the consideration paid, including<br />

directly attributable costs, is recognised as a change in equity. Repurchased shares are classified as<br />

treasury shares and presented as a deduction from total equity. When treasury shares are sold or<br />

reissued subsequently, the amount received is recognised as an increase in equity, and the resulting<br />

surplus or deficit on the transaction is transferred to/from retained earnings.<br />

112<br />

• Dividends<br />

Dividends are recognised as a liability in the period in which they are declared.<br />

(O) Financial liabilities<br />

Financial liabilities are recognised initially at cost, less attributable transaction costs. Subsequent<br />

to initial recognition, interest-bearing loans and borrowings are stated at amortised cost with any<br />

difference between cost and redemption value being recognised in the income statement over the period<br />

of borrowings on an effective interest basis.<br />

(P) Provisions<br />

Provisions are recognised in the balance sheet when the company has a present obligation (legal or<br />

constructive) as a result of a past event, it is probable that an outflow of resources embodying economic<br />

benefits will be required to settle the obligation and a reliable estimate can be made of the amount of<br />

the obligation.<br />

If the effect is material, provisions are determined by discounting the expected future cash flows at a<br />

rate that reflects current market assessments of the time value of money and, where appropriate, the<br />

risks specific to the liability.<br />

• Restructuring<br />

A provision for restructuring is recognised when the company has approved a detailed and formal<br />

restructuring plan, and the restructuring has either commenced or has been announced to those<br />

affected by it. Future operating costs are not provided for.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

• Environmental obligations<br />

Environmental provisions are based on legal and constructive obligations from past events,<br />

in accordance with applicable legal requirements.<br />

• Onerous contracts<br />

A provision for onerous contracts is recognised when the expected benefits to be derived by the company<br />

from a contract are lower than the unavoidable cost of meeting its obligations under the contract. Such<br />

provision is measured at the present value of the lower of the expected cost of terminating the contract<br />

and the expected net cost of continuing with the contract. Before a provision is established, the <strong>Group</strong><br />

recognises any impairment loss on the assets associated with that contract.<br />

• Others<br />

Includes provisions for litigations and warranties.<br />

(Q) Employee benefits<br />

• Post employment benefits<br />

Post employment benefits include pensions and medicare benefits. The <strong>Group</strong> operates a number of<br />

defined benefits and defined contribution plans throughout the world, the assets of which are generally<br />

held in separate pension funds. Separate trusts and insurers generally hold the pension plans.<br />

113<br />

- Defined contribution plans:<br />

Contributions to defined contribution pension plans are recognised as an expense in the income<br />

statement as incurred.<br />

- Defined benefit plans:<br />

For defined benefit plans, the pension accounting costs are assessed separately for each plan using the<br />

projected unit credit method. Under this method, the cost of providing pensions is charged to the income<br />

statement in order to spread the regular cost over the service lives of employees in accordance with<br />

the advice of qualified actuaries who carry out a full valuation of the plans. The amounts charged to the<br />

income statement consist of current service cost, interest cost, the expected return on any plan assets,<br />

actuarial gains and losses and past service costs.<br />

The pension obligation recognised in the balance sheet is determined as the present value of the defined<br />

benefit obligation (using interest rates of high quality corporate bonds which have terms to maturity<br />

approximating the terms of the related liability) adjusted for unrecognised actuarial gains and losses,<br />

less unrecognised past service costs and less the fair value of the plan assets.<br />

All actuarial gains and losses as at 1 January 2004, the date of transition to IFRS, were recognised. In<br />

respect of actuarial gains and losses that arise subsequent to 1 January 2004 in calculating the <strong>Group</strong>’s<br />

obligation in respect of a plan, to the extent that any cumulative unrecognised actuarial gain or loss


financial report <strong>2008</strong><br />

exceeds 10 % of the greater of the present value of the defined benefit obligation and the fair value of<br />

plan assets, that portion is recognised in the income statement over the expected average remaining<br />

working lives of the employees participating in the plan. Otherwise, the actuarial gain or loss is not<br />

recognised.<br />

Where the calculation results in a benefit to the <strong>Group</strong>, the recognised asset is limited to the net total<br />

of any unrecognised actuarial losses and past service costs and the present value of any future refunds<br />

from the plan or reductions in future contributions to the plan.<br />

• Termination benefits (pre-retirement plans, other termination obligations)<br />

These benefits arise as a result of the company’s decision to terminate the employment of an employee<br />

or group of employees before the normal retirement date or of an employee’s decision to accept<br />

voluntary redundancy in exchange for those benefits.<br />

These benefits are accrued for at the moment of notification.<br />

• Equity compensation benefits<br />

114<br />

A stock option plan allows senior management to acquire shares of the Company. The option’s exercise<br />

price equals the lowest of the average market price of the underlying shares in the 30 trading days<br />

preceding the offer date or the market price on the last day preceding the offer date. These share-based<br />

payments are recognised in the financial statements based on the fair value of the awards measured at<br />

grant date, spread over the vesting period. When the options are exercised, equity is increased by the<br />

amounts of the proceeds received.<br />

• Short-term benefits<br />

Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as<br />

the related service is provided.<br />

A liability is recognised for the amount expected to be paid under short-term cash bonus or profitsharing<br />

plans if the <strong>Group</strong> has a present legal or constructive obligation to pay this amount as a result of<br />

past service provided by the employee and the obligation can be estimated reliably.<br />

(R) Income tax<br />

Income tax on the profit or loss for the year comprises current and deferred tax. Income tax is<br />

recognised in the income statement except to the extent that it relates to items recognised directly to<br />

equity, in which case it is recognised in equity.<br />

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or<br />

substantially enacted at the balance sheet date, and any adjustment to tax payable in respect of previous<br />

years.<br />

Deferred tax is provided using the balance sheet liability method, for temporary differences arising<br />

between the carrying values of assets and liabilities for financial reporting purposes and the basis used<br />

for taxation purposes. The following temporary differences are not provided for: the initial recognition<br />

of assets or liabilities that affects neither accounting nor taxable profit and differences relating to


<strong>Tessenderlo</strong> <strong>Group</strong><br />

investments in subsidiaries to the extent that will probably not reverse in the foreseeable future. The<br />

amount of deferred tax provided is based on the expected manner of realisation or settlement of the<br />

carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the balance<br />

sheet date.<br />

A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will<br />

be available against which the deductible temporary differences, unused tax losses and credits can be<br />

utilised. A deferred tax asset is reduced to the extent that it is no longer probable that related tax benefit<br />

will be realised.<br />

Additional income taxes that arise from the distribution of dividends are recognised at the same time as<br />

the liability to pay the related benefit.<br />

(S) Trade and other payables<br />

Trade and other payables are stated at cost.<br />

(T) Income<br />

• Revenue<br />

For the sale of goods, revenue is recognised in the income statement when the significant risks and<br />

rewards of ownership have been transferred to the buyer.<br />

115<br />

Revenue is recognised when there are no significant uncertainties regarding recovery of the<br />

consideration due, when the associated costs and possible return of goods can be estimated reliably and<br />

when there is no continuing management involvement with the goods and the amount of revenue can be<br />

estimated reliably.<br />

• Financial income<br />

Financial income comprises interest receivable on funds invested, dividend income, foreign exchange<br />

gains and gains on derivative financial instruments.<br />

Interest income is recognised in the income statement as it accrues, taking into account the effective<br />

yield on the asset.<br />

Dividend income is recognised in the income statement on the date the entity’s right to receive payments<br />

is established.<br />

(U) Expenses<br />

• Financial expenses<br />

Financial expenses comprise interest payable on borrowings, foreign exchange losses and losses on<br />

derivative financial instruments.<br />

All interest and other costs incurred in connection with borrowings are expensed as incurred as part<br />

of financial expenses. The interest expense component of finance lease payments is recognised in the<br />

income statement using the effective interest rate method.


financial report <strong>2008</strong><br />

(V) Derivative financial instruments<br />

The <strong>Group</strong> uses derivative financial instruments to hedge its exposure to foreign exchange and interest<br />

rate risks arising from operational, financial and investment activities. In accordance with its treasury<br />

policy, the <strong>Group</strong> does not hold or issue derivative financial instruments for trading purposes.<br />

Derivative financial instruments are recognised initially at cost. Subsequent to initial recognition,<br />

derivative financial instruments are stated at fair value. The gain or loss on remeasurement to fair value<br />

is recognised immediately in profit or loss.<br />

(W) Non-current assets held for sale and discontinued operations<br />

Immediately before classification as held for sale, the remeasurement of the assets (and all assets and<br />

liabilities in a disposal group) is brought up-to-date in accordance with applicable IFRSs. Then, on initial<br />

classification as held for sale, non-current assets and disposal groups are recognised at the lower of<br />

carrying amount and fair value less costs to sell.<br />

Impairment losses on initial classification as held for sale are included in the profit or loss. The same<br />

applies to gains and losses on subsequent remeasurement.<br />

116<br />

A discontinued operation is a component of the <strong>Group</strong>’s business that represents a separate major line<br />

of business or a geographical area of operations or is a subsidiary acquired exclusively with a view to<br />

resale.<br />

Classification as a discontinued operation occurs upon disposal or when the operation meets the criteria<br />

to be classified as held for sale, if earlier. A disposal group that is to be abandoned may also qualify.<br />

(X) Earnings per share<br />

The <strong>Group</strong> presents basic and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS<br />

is calculated by dividing the profit or loss attributable to equity holders of the <strong>Group</strong> by the weighted<br />

average number of ordinary shares outstanding during the period.<br />

The diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders and<br />

the weighted average number of ordinary shares outstanding for the effects of all dilutive potential<br />

ordinary shares, which comprise share options granted to the management.<br />

(Y) Segment reporting<br />

A segment is a distinguishable component of the <strong>Group</strong> that is engaged either in providing products<br />

or services (business groups), or in providing products or services within a particular economic<br />

environment (geographical segment), which is subject to risks and rewards that are different from those<br />

of other segments.<br />

Segment information is produced according to two different criteria: a primary segment reporting<br />

format is based on the <strong>Group</strong>’s sector of activity (business groups), a secondary segment reporting<br />

format is based on the main geographical regions.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

(Z) Recently issued IFRS<br />

To the extent that new IFRS requirements are expected to be applicable in the future, they have been<br />

summarised hereafter.<br />

• IFRS 8 Operating segments<br />

IFRS 8 “Operating segments” introduces the “management approach” to segment reporting. IFRS 8,<br />

which becomes mandatory for the <strong>Group</strong>’s 2009 financial statements, will require the disclosure of<br />

segment information based on the internal reports regularly reviewed by the <strong>Group</strong>’s Chief Operating<br />

Decision Makers in order to assess each segment’s performance and to allocate resources to them.<br />

Currently the <strong>Group</strong> presents segment information in respect of its business and geographical segments<br />

(see note 2 “Segment reporting”). IFRS 8 is not expected to trigger a material change to the <strong>Group</strong>’s<br />

current segment reporting.<br />

• Revised IAS 23 Borrowing costs<br />

Revised IAS 23 “Borrowing costs” removes the option to expense borrowing costs and requires that an<br />

entity capitalises borrowing costs directly attributable to the acquisition, construction or production of<br />

a qualifying asset as part of the cost of that asset. The revised IAS 23 will become mandatory for the<br />

<strong>Group</strong>’s 2009 financial statements and will not constitute a change in accounting policy for the <strong>Group</strong>.<br />

• IFRIC 13 Customer Loyalty Programs<br />

117<br />

IFRIC 13 “Customer Loyalty Programs” addresses the accounting by entities that operate, or otherwise<br />

participate in, customer loyalty programs for their customers. It relates to customer loyalty programs<br />

under which the customer can redeem credits for awards such as free or discounted goods or services.<br />

The <strong>Group</strong> has not yet determined the potential impact of the interpretation, which becomes mandatory<br />

for the <strong>Group</strong>’s 2009 financial statements.<br />

• Revised IAS 1 Presentation of financial statements<br />

Revised IAS 1 Presentation of Financial Statements (2007) (endorsed by the European Union) introduces<br />

the term total comprehensive income, which represents changes in equity during a period other than<br />

those changes resulting from transactions with owners in their capacity as owners. Total comprehensive<br />

income may be presented in either a single statement of comprehensive income (effectively combining<br />

both the income statement and all non-owner changes in equity in a single statement), or in an<br />

income statement and a separate statement of comprehensive income. Revised IAS 1, which becomes<br />

mandatory for the <strong>Group</strong>’s 2009 consolidated financial statements, is not expected to have an impact on<br />

the presentation of the consolidated financial statements.<br />

• Amendments to IAS 32 Financial Instruments: Presentation and IAS 1 Presentation<br />

of Financial Statements – Puttable Financial Instruments and Obligations Arising on<br />

Liquidation<br />

Amendments to IAS 32 Financial Instruments: Presentation and IAS 1 Presentation of Financial<br />

Statements – Puttable Financial Instruments and Obligations Arising on Liquidation (endorsed by the


financial report <strong>2008</strong><br />

European Union) requires puttable instruments, and instruments that impose on the entity an obligation<br />

to deliver to another party a pro rata share of the net assets of the entity only on liquidation, to be<br />

classified as equity if certain conditions are met. The <strong>Group</strong> has not yet determined the potential impact<br />

of the amendments, which become mandatory for the <strong>Group</strong>’s 2009 consolidated financial statements,<br />

with retrospective application required.<br />

• Revised IFRS 3 Business Combinations (<strong>2008</strong>)<br />

118<br />

Revised IFRS 3 Business Combinations (<strong>2008</strong>) incorporates the following changes that are likely to be<br />

relevant to the <strong>Group</strong>’s operations:<br />

- The definition of a business has been broadened, which is likely to result in more acquisitions being<br />

treated as business combinations.<br />

- Contingent consideration will be measured at fair value, with subsequent changes therein<br />

recognised in profit or loss.<br />

- Transaction costs, other than share and debt issue costs, will be expensed as incurred.<br />

- Any pre-existing interest in the acquiree will be measured at fair value with the gain or loss<br />

recognised in profit or loss.<br />

- Any non-controlling (minority) interest will be measured at either fair value, or at its proportionate<br />

interest in the identifiable assets and liabilities of the acquiree, on a transaction-by-transaction<br />

basis.<br />

The <strong>Group</strong> has not yet determined the potential impact of the revised IFRS 3, which becomes mandatory<br />

for the <strong>Group</strong>’s 2010 consolidated financial statements.<br />

• Amended IAS 27 Consolidated and Separate Financial Statements (<strong>2008</strong>)<br />

Amended IAS 27 Consolidated and Separate Financial Statements (<strong>2008</strong>) requires accounting for<br />

changes in ownership interests by the <strong>Group</strong> in a subsidiary, while maintaining control, to be recognised<br />

as an equity transaction. When the <strong>Group</strong> loses control of a subsidiary, any interest retained in the<br />

former subsidiary will be measured at fair value with the gain or loss recognised in profit or loss.<br />

The amendments to IAS 27, which become mandatory for the <strong>Group</strong>’s 2010 consolidated financial<br />

statements, are not expected to have any material impact on the <strong>Group</strong>’s consolidated financial<br />

statements.<br />

• Amendment to IFRS 2 Share-based Payment – Vesting Conditions and Cancellations<br />

Amendment to IFRS 2 Share-based Payment – Vesting Conditions and Cancellations (endorsed by the<br />

European Union) clarifies the definition of vesting conditions, introduces the concept of non-vesting<br />

conditions, requires non-vesting conditions to be reflected in grant-date fair value and provides the<br />

accounting treatment for non-vesting conditions and cancellations. The amendments to IFRS 2, that<br />

will become mandatory for the <strong>Group</strong>’s 2009 consolidated financial statements, with retrospective<br />

application, are not expected to have any material impact on the <strong>Group</strong>’s consolidated financial<br />

statements.<br />

• IFRIC 15 Agreements for the Construction of Real Estate<br />

IFRIC 15 Agreements for the Construction of Real Estate concludes that revenues for real estate<br />

construction projects will have to be recognised using the completed contract method in many cases,


<strong>Tessenderlo</strong> <strong>Group</strong><br />

except for specific situations where the percentage of completion method of revenue recognition can<br />

be applied. This is the case when a contract relates to the sale of assets, but during the construction of<br />

these assets revenue recognition criteria are met on a continuous basis (in relation to the completed<br />

part of the project). IFRIC 15, which becomes mandatory for the <strong>Group</strong>’s 2009 consolidated financial<br />

statements, with retrospective application, is not expected to have any material impact on the <strong>Group</strong>’s<br />

consolidated financial statements.<br />

• IFRIC 16 Hedges of a Net Investment in a Foreign Operation<br />

IFRIC 16 Hedges of a Net Investment in a Foreign Operation discusses a number of issues in relation<br />

to hedging currency risks on foreign operations (net investment hedges). IFRIC 16 specifically confirms<br />

only the risk from differences between the functional currencies of the parent and the subsidiary can be<br />

hedged. Additionally, currency risks can only be hedged by every (direct or indirect) parent company, as<br />

long as the risk is only hedged once in the consolidated financial statements. IFRIC 16 also determines<br />

the hedge instrument of a net investment hedge can be held by every group company, except for foreign<br />

operation itself. The <strong>Group</strong> has not yet determined the potential impact of IFRIC 16, which becomes<br />

mandatory for the <strong>Group</strong>’s 2009 consolidated financial statements, with prospective application.<br />

• IFRIC 17 Distributions of Non-cash Assets to Owners<br />

IFRIC 17 Distributions of Non-cash Assets to Owners addresses the treatment of distributions in kind<br />

to shareholders. Outside the scope of IFRIC 17 are distributions in which the assets being distributed<br />

are ultimately controlled by the same party or parties before and after the distribution (common control<br />

transactions). A liability has to be recognised when the dividend has been appropriately authorised and<br />

is no longer at the discretion of the entity, to be measured at the fair value of the non-cash assets to be<br />

distributed. IFRIC 17, which becomes mandatory for the <strong>Group</strong>’s 2010 consolidated financial statements,<br />

with prospective application, is not expected to have any material impact on the <strong>Group</strong>’s consolidated<br />

financial statements.<br />

119<br />

• IFRIC 18 Transfers of Assets from Customers<br />

IFRIC 18 Transfers of Assets from Customers addresses the accounting by access providers for<br />

property, plant and equipment contributed to them by customers. Recognition of the assets depends on<br />

who controls it. When the asset is recognised by the access provider, it is measured at fair value upon<br />

initial recognition. The timing of the recognition of the corresponding revenue depends on the facts<br />

and circumstances. IFRIC 18, which becomes mandatory for the <strong>Group</strong>’s 2010 consolidated financial<br />

statements, with prospective application, is not expected to have any material impact on the <strong>Group</strong>’s<br />

consolidated financial statements.<br />

• Amendments to IFRS 1 First-time Adoption of IFRSs and IAS 27 Consolidated and<br />

Separate Financial Statements – Cost of an Investment in a Subsidiary, Jointly-controlled<br />

Entity or Associate<br />

Amendments to IFRS 1 First-time Adoption of IFRSs and IAS 27 Consolidated and Separate Financial<br />

Statements – Cost of an Investment in a Subsidiary, Jointly-controlled Entity or Associate (endorsed by<br />

the European Union) revises, amongst others, the accounting for ‘pre-acquisition dividends’ received<br />

from participating interests. Those dividends should be recognised as revenue, but such dividends may


financial report <strong>2008</strong><br />

imply an indicator for the impairment of the participating interest. The amendment, which becomes<br />

mandatory for the <strong>Group</strong>’s 2009 consolidated financial statements, with prospective application, is not<br />

expected to have any material impact on the <strong>Group</strong>’s consolidated financial statements.<br />

• Amendment to IAS 39 Financial Instruments: Recognition and Measurement – Eligible<br />

Hedged Items<br />

Amendment to IAS 39 Financial Instruments: Recognition and Measurement – Eligible Hedged Items<br />

provides additional guidance concerning specific positions that qualify for hedging (‘eligible hedged<br />

items’). The <strong>Group</strong> has not yet determined the impact of the amendment to IAS 39, which becomes<br />

mandatory for the <strong>Group</strong>’s 2010 consolidated financial statements, with retrospective application.<br />

• Improvements to IFRSs (<strong>2008</strong>)<br />

Improvements to IFRSs (<strong>2008</strong>) (endorsed by the European Union) is a collection of minor improvements<br />

to existing standards. The <strong>Group</strong> has not yet determined the potential impact of this collection, which<br />

becomes mandatory for the <strong>Group</strong>’s 2009 consolidated financial statements.<br />

120


<strong>Tessenderlo</strong> <strong>Group</strong><br />

2. Segment reporting<br />

The segment reporting is based on two segment reporting formats. The primary reporting format<br />

represents the three business groups of the <strong>Group</strong>’s internal financial reporting, the secondary reporting<br />

format represents the <strong>Group</strong>’s two main geographical markets.<br />

Segment assets and liabilities include items directly attributable to a segment as well as those that can<br />

be allocated on a reasonable basis.<br />

Segment capital expenditures include the cost of acquiring property, plant and equipment and intangible<br />

assets.<br />

Inter-segment pricing is determined on an arm’s length basis.<br />

Business segments<br />

The <strong>Group</strong> is reporting three business segments (business groups). Each includes several business<br />

units:<br />

- The “Chemicals” business group includes the Inorganics, Chlor-alkali and PVC business units.<br />

- The “Specialities” business group includes the Fine Chemicals, Gelatin and Natural Derivatives<br />

business units.<br />

- The “Plastics Converting” business group includes the Profiles, Plastic Pipe Systems and<br />

Compounds business units.<br />

121<br />

Geographical segments<br />

The three business segments (business groups) operate worldwide, however mainly in two geographical<br />

areas, Europe and the USA.<br />

Segment revenue is based on the geographical location of customers, while segment assets and<br />

liabilities are based on the geographical location of the assets.


financial report <strong>2008</strong><br />

Chemicals<br />

<strong>2008</strong> 2007<br />

122<br />

KEY DATA BY PRIMARY REPORTING SEGMENT<br />

Revenue (internal and external) 1,502.5 1,122.8<br />

Revenue (internal) 100.7 95.7<br />

Revenue 1,401.8 1,027.1<br />

Profit (+) / loss (-) from operations before non-recurring items (REBIT) 197.5 82.7<br />

Non-recurring items -15.0 -4.7<br />

Profit (+) / loss (-) from operations (EBIT) 182.5 78.0<br />

Return on revenue (REBIT/revenue) 14.1% 8.1%<br />

Finance costs - -<br />

Share of result of investments accounted for using the equity method 7.7 2.9<br />

Income tax expense - -<br />

Profit (+) / loss (-) for the period - -<br />

Segment assets 776.8 627.2<br />

Investments accounted for using the equity method 19.4 10.4<br />

Investments - -<br />

Deferred tax assets - -<br />

Cash and cash equivalents - -<br />

Other unallocated receivables - -<br />

Total Assets - -<br />

Segment liabilities 280.5 240.3<br />

Financial liabilities - -<br />

Deferred tax liabilities - -<br />

Equity - -<br />

Total Equity & Liabilities - -<br />

Capital expenditures: PP&E and intangible assets 29.1 39.5<br />

Amortisation and depreciation -40.9 -41.4<br />

Impairment losses on intangible assets and property, plant and equipment - -<br />

Number of employees at year end (headcount) 1,965 2,009<br />

Europe<br />

<strong>2008</strong> 2007<br />

KEY DATA BY SECONDARY REPORTING SEGMENT<br />

Revenue by market 2,125.2 1,881.4<br />

Segment assets 1,470.2 1,376.3<br />

Segment liabilities 488.3 472.9<br />

Capital expenditures: PP&E and intangible assets 90.8 91.4<br />

The unallocated segment assets mainly include the office buildings and receivables within<br />

the holding companies.<br />

The unallocated segment liabilities comprise mainly the payables within those holding companies.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Specialities Plastics Converting Unallocated <strong>Tessenderlo</strong> <strong>Group</strong><br />

<strong>2008</strong> 2007 <strong>2008</strong> 2007 <strong>2008</strong> 2007 <strong>2008</strong> 2007<br />

593.8 569.2 776.5 831.7 - - 2,872.8 2,523.7<br />

7.1 6.8 - 15.3 - - 107.8 117.8<br />

586.7 562.4 776.5 816.4 - - 2,765.0 2,405.9<br />

34.6 31.9 22.4 49.2 -15.4 -11.5 239.1 152.3<br />

8.2 -9.8 -19.5 -1.8 -0.6 51.4 -26.9 35.1<br />

42.8 22.1 2.9 47.4 -16.0 39.9 212.2 187.4<br />

5.9% 5.7% 2.9% 6.0% - - 8.6% 6.3%<br />

- - - - - - -21.6 -17.6<br />

3.8 3.1 - - - - 11.5 6.0<br />

- - - - - - -61.7 -47.1<br />

- - - - - - 140.4 128.7<br />

413.5 401.5 454.3 491.3 51.6 13.2 1,696.2 1,533.2<br />

15.6 13.6 - - 4.6 - 39.6 24.0<br />

- - - - 5.2 6.1 5.2 6.1<br />

- - - - 17.7 26.3 17.7 26.3<br />

- - - - 53.5 93.6 53.5 93.6<br />

- - - - 0.7 - 0.7 -<br />

- - - - - - 1,812.9 1,683.2<br />

103.2 109.9 101.0 122.9 33.7 33.3 518.4 506.4<br />

- - - - 348.1 337.4 348.1 337.4<br />

- - - - 44.4 37.2 44.4 37.2<br />

- - - - 902.0 802.2 902.0 802.2<br />

- - - - - - 1,812.9 1,683.2<br />

30.8 31.5 32.4 33.5 9.1 - 101.4 104.5<br />

-33.3 -40.8 -32.3 -34.8 -3.1 -2.8 -109.6 -119.8<br />

-6.4 -12.3 - - - -12.3 -6.4<br />

2,755 2,763 3,517 3,349 - - 8,237 8,121<br />

123<br />

USA Rest of the world <strong>Tessenderlo</strong> <strong>Group</strong><br />

<strong>2008</strong> 2007 <strong>2008</strong> 2007 <strong>2008</strong> 2007<br />

296.7 260.2 343.1 264.3 2,765.0 2,405.9<br />

185.0 120.4 41.0 36.5 1,696.2 1,533.2<br />

23.1 27.3 7.0 6.2 518.4 506.4<br />

7.0 9.8 3.6 3.3 101.4 104.5


financial report <strong>2008</strong><br />

3. Acquisitions and disposals<br />

Acquisitions – Activities / Subsidiaries<br />

• In April <strong>2008</strong>, Eurocell ltd, a UK subsidiary within the business unit Profiles, acquired the assets of<br />

Sprint 1233, formerly Plastmo Profiles Ltd (Northampton, UK). Taking over the interests of Plastmo<br />

will allow Eurocell to benefit from improved production efficiencies and economies of scale.<br />

In December <strong>2008</strong>, Eurocell ltd acquired the assets and operations of Cavalok Building Products.<br />

Cavalok Building Products is the only manufacturer of BBA-accredited cavity closure systems<br />

made from 100% post-consumer recycled PVC-u. This acquisition will extend the Eurocell product<br />

offering and will help deliver significant operational efficiency benefits.<br />

As Plastmo and Cavalok were immediately integrated in the Eurocell operations, no separate<br />

reporting is maintained on their contributions to the profit of the <strong>Group</strong>, however in <strong>2008</strong> these are<br />

considered to have been immaterial.<br />

• In June <strong>2008</strong>, Akiolis <strong>Group</strong>, a French subsidiary within the business unit Natural Derivatives,<br />

acquired SR Collecte sas and Collectoco sarl. In August <strong>2008</strong>, Akiolis <strong>Group</strong> also acquired<br />

Recup’Food Sarl. These acquisitions will allow Akiolis <strong>Group</strong> to realise economies of scale.<br />

124<br />

These acquisitions by Akiolis <strong>Group</strong> did not have a significant contribution to the <strong>2008</strong> profit of the<br />

<strong>Group</strong>. If the acquisition date of SR Collecte sas, Collectoco sarl and Recup’Food Sarl had been<br />

1 January <strong>2008</strong>, the impact on the revenue and profit of the <strong>Group</strong> would have been insignificant as<br />

well.<br />

• In September <strong>2008</strong>, <strong>Tessenderlo</strong> Kerley acquired the assets, marketing and distribution channels of<br />

Agrochem (Izmir, Turkey). Agrochem has been a key distributor for <strong>Tessenderlo</strong> Kerley in the area<br />

for the past 14 years and has been manufacturing <strong>Tessenderlo</strong> Kerley plant nutrient solutions.<br />

This acquisition did not have a significant contribution to the <strong>2008</strong> profit of the <strong>Group</strong>. If the<br />

acquisition date had been 1 January <strong>2008</strong>, the impact of this acquisition on the revenue and the<br />

profit of the <strong>Group</strong> would have been insignificant as well.<br />

• In October <strong>2008</strong>, the <strong>Group</strong> reached an agreement with Nyloplast NV to take over all shares<br />

of its subsidiary Nyloplast Europe BV (‘s Gravendeel, the Netherlands). Nyloplast Europe BV<br />

manufactures large diameter plastic fittings for presureless pipe systems for the European market.<br />

The systems are used for draining sewage and rain water. This extension of the range of products<br />

and services will strengthen the position of the Plastic Pipe Systems business unit in Europe and<br />

further develop its strategy for growth.<br />

The acquisition of Nyloplast Europe BV did not yet have a significant impact on the <strong>2008</strong> revenue or<br />

profit of the <strong>Group</strong>. If the acquisition date had been 1 January <strong>2008</strong>, the revenue of the <strong>Group</strong> would<br />

be higher by approximately 11.7 million EUR.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The table below summarises the impact of these agreements on the financial position of the <strong>Group</strong>:<br />

Pre-acquisition<br />

carrying<br />

amounts<br />

Fair value<br />

adjustments<br />

Recognised<br />

values on<br />

acquisition<br />

Property, plant and equipment 5.7 5.9 11.6<br />

Intangible assets 0.1 2.1 2.2<br />

Non-current assets 5.8 8.0 13.8<br />

Inventories 4.5 -0.8 3.7<br />

Trade and other receivables 4.2 - 4.2<br />

Cash and cash equivalents -1.6 - -1.6<br />

Current assets 7.1 -0.8 6.3<br />

Trade and other payables 5.0 - 5.0<br />

Current liabilities 5.0 0.0 5.0<br />

Non-current liabilities 0.7 1.4 2.1<br />

Net assets 7.2 5.8 13.0<br />

Goodwill on acquisition 5.1<br />

Negative goodwill on acquisition -1.2<br />

Consideration (paid)/received, satisfied in cash -16.9<br />

Cash acquired/(disposed) of -1.6<br />

Net cash (outflow)/inflow -18.5<br />

125<br />

The fair value adjustments performed at acquisition date are based on valuation studies performed<br />

as well internally as by external experts. The intangible assets at acquisition date mainly relate to the<br />

valuation of customer lists (note 12).<br />

Acquisitions – Investments accounted for using the equity method<br />

In October <strong>2008</strong> <strong>Tessenderlo</strong> Kerley acquired 30 % of the shares of Wolf Mountain Products LLC, Lindon,<br />

Utah (USA). <strong>Tessenderlo</strong> Kerley also has an option to purchase an additional 20 % interest in Wolf<br />

Mountain Products during the first half of 2014. Wolf Mountain Products offers a broad range of high<br />

quality bark and wood-based products used as soil amendments, ground covers and playground chips.<br />

This acquisition did not yet have a significant contribution to the <strong>2008</strong> profit of the <strong>Group</strong>. If the<br />

acquisition date would have been 1 January <strong>2008</strong>, the impact on the profit of the <strong>Group</strong> would also have<br />

been insignificant.


financial report <strong>2008</strong><br />

The table below summarises the impact of this agreement on the financial position of the <strong>Group</strong>:<br />

Pre-acquisition<br />

carrying<br />

amounts<br />

Fair value<br />

adjustments<br />

Recognised<br />

values on<br />

acquisition<br />

Equity 2.4 8.0 10.4<br />

Share <strong>Group</strong> (30%) 0.7 2.4 3.1<br />

Goodwill on acquisition 0.0<br />

Consideration (paid)/received, satisfied in cash -3.1<br />

Cash acquired/(disposed) of 0.0<br />

Net cash (outflow)/inflow -3.1<br />

Disposals<br />

No disposals were made during <strong>2008</strong>.<br />

126<br />

4. Other income and expenses<br />

<strong>2008</strong> 2007<br />

Release of provisions 3.6 -<br />

Additions to provisions - -<br />

Research cost -14.3 -7.4<br />

Grants 0.3 0.1<br />

Depreciation -2.2 -2.3<br />

Gains on disposal of PP&E and intangible assets -0.4 0.2<br />

Write down debtors -2.7 -2.7<br />

Other -10.9 -0.1<br />

Total -26.6 -12.2<br />

“Other” mainly includes taxes other than income taxes.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

5. Non-recurring items<br />

<strong>2008</strong> 2007<br />

Gain on disposals 12.8 58.4<br />

Restructuring (incl. impairment losses) -18.2 -15.6<br />

Environmental provisions -14.2 -2.8<br />

Other income and expenses -7.3 -4.9<br />

Total -26.9 35.1<br />

The non-recurring items for <strong>2008</strong> show an expense of 26.9 million EUR (2007: income of<br />

35.1 million EUR).<br />

The gain on disposals mainly includes the sale of land in England. The land has been sold for<br />

5.7 million GBP, while the land had no carrying amount. The non-recurring result of this sale amounts<br />

to 7.1 million EUR.<br />

The impairment losses amount to 12.3 million EUR and are mainly related to property, plant and<br />

equipment of subsidiaries in the business group Plastics Converting (12.2 million EUR).<br />

On December 10th <strong>2008</strong>, the environmental permit of <strong>Tessenderlo</strong> Chemie NV (Belgium) was extended<br />

for a period of 20 years. <strong>Tessenderlo</strong> Chemie NV committed itself to invest in a new production process<br />

and to find a durable solution to its environmental problems in Limburg (Belgium). As a consequence<br />

of these commitments additional discounted environmental provisions were recorded for an amount of<br />

14.5 million EUR.<br />

127<br />

Other income and expenses in <strong>2008</strong> relate to several incurred charges, including expenses as a<br />

consequence of acquisitions, provisions on receivables and exceptional charges which are not covered by<br />

insurance.<br />

The non-recurring items in 2007 mainly included the gain realised on the sale of <strong>Tessenderlo</strong> Davison<br />

Companies (TDC), a joint marketing venture with Davison Petroleum Products, (DDP), Ruston, United<br />

States. The non-recurring gain of this business disposal amounted to 52.0 million EUR. In addition, the<br />

sale of the subsidiary PB Gelatins France and the sale of land of <strong>Tessenderlo</strong> Kerley generated a nonrecurring<br />

gain of 4.2 million EUR.<br />

The restructuring provisions and expenses, as well as the environmental provisions, in 2007 mainly<br />

concerned the final phase of the Target 2007 restructuring plan (9.1 million EUR) in the business group<br />

Chemicals (7.5 million EUR) and the business unit Fine Chemicals (1.6 million EUR).<br />

The impairment losses in 2007 amounted to EUR 8.4 million EUR and were mainly related to property,<br />

plant and equipment in the business unit Fine Chemicals (3.9 million EUR) and the business unit Gelatin<br />

(2.6 million EUR).


financial report <strong>2008</strong><br />

6. Payroll and related benefits<br />

note <strong>2008</strong> 2007<br />

Wages and salaries -286.3 -285.6<br />

Employer’s social security contributions -76.8 -77.8<br />

Other personnel costs -43.1 -31.1<br />

Contributions to defined contribution<br />

-3.8 -3.9<br />

plans<br />

Increase in liability for defined benefit<br />

23 -4.6 -8.3<br />

plans<br />

Movement in asset for defined benefit<br />

23 -0.5 -1.1<br />

plans<br />

Total -415.1 -407.8<br />

The average number of FTEs for <strong>2008</strong> amount to 7,878 (2007: 7,794).<br />

128


<strong>Tessenderlo</strong> <strong>Group</strong><br />

7. Additional information on operating expenses<br />

by nature<br />

Depreciation, amortisation and impairment losses are included in the following line items in the<br />

income statement in <strong>2008</strong>:<br />

Depreciation<br />

and impairment<br />

losses on PP&E<br />

Amortisation and<br />

impairment losses on<br />

intangible assets<br />

Total<br />

Cost of sales -91.1 -3.8 -94.9<br />

Administrative expenses -9.8 - -9.8<br />

Sales and Marketing - -2.7 -2.7<br />

Other operating (income)/expenses -2.2 - -2.2<br />

Restructuring (incl. impairment losses) -12.3 - -12.3<br />

Total -115.4 -6.5 -121.9<br />

Total depreciation charges and impairment losses in <strong>2008</strong> amount to 124.4 million EUR (note 10 and<br />

12). Taking into account the effect of government grants in <strong>2008</strong> (note 10), the net depreciation charges<br />

amount to 121.9 million EUR.<br />

Depreciation, amortisation and impairment losses are included in the following line items in the<br />

income statement in 2007:<br />

129<br />

Depreciation<br />

and impairment<br />

losses on PP&E<br />

Amortisation and<br />

impairment losses on<br />

intangible assets<br />

Total<br />

Cost of sales -104.4 -4.1 -108.5<br />

Administrative expenses -9.1 - -9.1<br />

Other operating income/(expenses) -2.1 - -2.1<br />

Restructuring (incl. impairment losses) -6.5 - -6.5<br />

Total -122.1 -4.1 -126.2


financial report <strong>2008</strong><br />

8. Finance income and expense<br />

Finance expense:<br />

<strong>2008</strong> 2007<br />

Interest expense on financial liabilities measured at amortised<br />

-15.2 -17.7<br />

cost<br />

Foreign exchange losses -12.1 -5.0<br />

Other -2.5 -1.2<br />

Total -29.8 -23.9<br />

Finance income:<br />

<strong>2008</strong> 2007<br />

Interest income from cash and cash equivalents 2.8 4.2<br />

Dividend income, non-consolidated companies 0.4 0.2<br />

Revaluation to fair value of derivatives 5.0 1.9<br />

Total 8.2 6.3<br />

130<br />

The net interest expense of 12.4 million EUR (2007: 13.5 million EUR) decreased by 1.1 million EUR<br />

thanks to the further decrease of the average outstanding net financial debt in <strong>2008</strong> compared to 2007<br />

(see note 22).


<strong>Tessenderlo</strong> <strong>Group</strong><br />

9. Income tax expense<br />

<strong>2008</strong> 2007<br />

RECOGNISED IN THE INCOME STATEMENT<br />

Current tax expense -49.1 -50.3<br />

Adjustment current tax expense previous periods 1.1 -<br />

Deferred tax expense -13.7 3.2<br />

Total income tax expense in the income statement -61.7 -47.1<br />

Profit (+) / loss (-) before tax 202.1 175.8<br />

Less share of result of associates, net of taxes 11.5 6.0<br />

Profit (+) / loss (-) before tax and before result from associates 190.6 169.8<br />

Effective tax rate 32.4% 27.7%<br />

RECONCILIATION OF EFFECTIVE TAX RATE<br />

Profit (+) / loss (-) before tax and before results from<br />

190.6 169.8<br />

associates<br />

Theoretical tax rate (*) 33.1% 35.2%<br />

Expected income tax at the theoretical tax rate -63.1 -59.9<br />

131<br />

Difference between theoretical and effective tax expenses 1.4 12.8<br />

Adjustment on deferred taxes 0.1 -4.7<br />

Change in tax rates 0.1 -1.4<br />

Impairment (-) / reversal of an impairment (+) of a recognised<br />

deferred tax asset<br />

- -3.3<br />

Adjustment on tax expenses 1.3 17.5<br />

Non deductible expenses -2.8 -2.8<br />

Special tax regimes 5.7 4.8<br />

Use or recognition of tax losses / tax credits not previously<br />

0.4 18.1<br />

recognised<br />

Tax losses for which no deferred tax asset has been recorded -5.6 -1.2<br />

Impact of tax consolidation regimes - -<br />

Adjustment current tax expense previous periods 1.1 -<br />

Other 2.5 -1.4<br />

(*) Theoretical aggregated weighted tax rate of all group companies<br />

The impact of the change in tax rates amounts to 0.1 million EUR in <strong>2008</strong>, which is related to the change<br />

in tax rates in Luxembourg. The impact in 2007 amounted to -1.4 million EUR and was related to the<br />

change in tax rates, announced or already effective, in Germany, Italy and the United Kingdom.


financial report <strong>2008</strong><br />

10. Property, plant and equipment<br />

Land and<br />

buildings<br />

Plant,<br />

machinery<br />

and<br />

equipment<br />

Furniture<br />

and<br />

vehicles<br />

Under<br />

construction<br />

Total<br />

ACQUISITION COST<br />

At 1 January <strong>2008</strong> 416.7 1,860.4 110.7 23.0 2,410.8<br />

. acquisitions through<br />

5.5 5.9 0.2 - 11.6<br />

business combinations<br />

(note 3)<br />

. capital expenditure 7.7 42.4 10.6 33.5 94.2<br />

. sales and disposals -1.6 -14.8 -4.8 -0.6 -21.8<br />

. transfers 0.6 23.3 1.3 -26.5 -1.3<br />

. translation differences -5.8 -43.0 -1.0 -0.3 -50.1<br />

At 31 December <strong>2008</strong> 423.1 1,874.2 117.0 29.1 2,443.4<br />

132<br />

DEPRECIATION AND IMPAIRMENT LOSSES<br />

At 1 January <strong>2008</strong> -198.1 -1,431.1 -93.2 0.0 -1,722.4<br />

. acquisitions through<br />

- - - - 0.0<br />

business combinations<br />

. depreciation -13.5 -84.5 -7.7 - -105.7<br />

. sales and disposals 1.0 13.7 4.6 - 19.3<br />

. impairment losses -1.4 -10.7 -0.1 - -12.2<br />

. transfers 0.5 0.3 -0.2 - 0.6<br />

. translation differences - 36.4 0.6 - 37.0<br />

At 31 December <strong>2008</strong> -211.5 -1,475.9 -96.0 0.0 -1,783.4<br />

CARRYING AMOUNTS BEFORE GOVERNMENT GRANTS<br />

Net government grants - -8.0 - - -8.0<br />

CARRYING AMOUNTS<br />

At 1 January <strong>2008</strong> 218.6 418.7 17.5 23.0 677.8<br />

At 31 December <strong>2008</strong> 211.6 390.3 21.0 29.1 652.0


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Land and<br />

buildings<br />

Plant,<br />

machinery<br />

and<br />

equipment<br />

Furniture<br />

and<br />

vehicles<br />

Under<br />

construction<br />

Total<br />

ACQUISITION COST<br />

At 1 January 2007 415.9 1,826.8 109.4 19.4 2,371.5<br />

. acquisitions through<br />

- 6.5 - - 6.5<br />

business<br />

combinations<br />

. capital expenditure 10.0 44.1 8.9 35.6 98.6<br />

. sales and disposals -5.4 -18.4 -7.0 -0.3 -31.1<br />

. transfers 1.7 27.9 0.7 -31.2 -0.9<br />

. translation differences -5.5 -26.5 -1.3 -0.5 -33.8<br />

At 31 December 2007 416.7 1,860.4 110.7 23.0 2,410.8<br />

DEPRECIATION AND IMPAIRMENT LOSSES<br />

At 1 January 2007 -188.7 -1,362.9 -93.3 0.0 -1,644.9<br />

. acquisitions through<br />

- - - - 0.0<br />

business combinations<br />

. depreciation -14.2 -94.4 -7.1 - -115.7<br />

. sales and disposals 4.4 13.0 6.2 - 23.6<br />

. impairment losses -1.0 -5.4 - - -6.4<br />

. transfers - 0.6 - - 0.6<br />

. translation differences 1.4 18.0 1.0 - 20.4<br />

At 31 December 2007 -198.1 -1,431.1 -93.2 0.0 -1,722.4<br />

133<br />

CARRYING AMOUNTS BEFORE GOVERNMENT GRANTS<br />

Net government grants - -10.6 - - -10.6<br />

CARRYING AMOUNTS<br />

At 1 January 2007 227.2 463.9 16.1 19.4 726.6<br />

At 31 December 2007 218.6 418.7 17.5 23.0 677.8<br />

The capital expenditure amounts to 94.2 million EUR and is broken down per business segment, in the<br />

“Segment reporting” section (note 2).<br />

An amount of 11.6 million EUR is disclosed as acquisition through business combinations. The detailed<br />

information is disclosed in “Acquisitions and disposals” (note 3).<br />

Impairment losses for an amount of 12.2 million EUR were recognised during the second quarter of<br />

<strong>2008</strong> and are mainly related to impairment losses recognised on the property, plant and equipment of<br />

subsidiaries in the business group Plastics Converting. The market for the related companies’ products<br />

continued to deteriorate in <strong>2008</strong> as a consequence of the current economic difficulties, which in turn<br />

caused the <strong>Group</strong> to reevaluate its projections and views of the market’s ability to improve.<br />

The recoverable amount of these assets has been determined based on value in use calculations, and<br />

was compared to the fair value of these assets.


financial report <strong>2008</strong><br />

The impairment losses of 2007 were recorded on property, plant and equipment in the business unit<br />

Fine Chemicals and the business unit Gelatin. The recoverable amount has been determined based on<br />

value in use calculations.<br />

In 2007, the Flemish government granted <strong>Tessenderlo</strong> Chemie NV and Limburgse Vinyl Maatschappij NV<br />

12.5 million EUR for large-scale environmental investments. The remaining net government grant as<br />

per 31 December <strong>2008</strong> amounts to 8.0 million EUR (2007: 10.6 million EUR).<br />

No property, plant and equipment is pledged as security for liabilities.<br />

Assets for an amount of 0.7 million EUR are classified as non-current assets held for sale (note 19).<br />

The <strong>Group</strong> leases property, plant and equipment under a number of finance lease agreements. At the<br />

end of each of the leases, the <strong>Group</strong> has the option to purchase the equipment at a beneficial price. As<br />

per 31 December <strong>2008</strong>, the net carrying amount of leased property, plant and equipment amounted to<br />

4.8 million EUR (2007: 5.8 million EUR). For an overview of the lease payables, we refer to note 22.<br />

The finance leases mainly consist of land and buildings (4.8 million EUR).<br />

134<br />

11. Goodwill<br />

ACQUISITION COST<br />

At 1 January <strong>2008</strong> 64.6<br />

. acquisitions through business combinations 5.1<br />

. sales and disposals -<br />

. transfers 0.7<br />

. translation differences -6.5<br />

At 31 December <strong>2008</strong> 63.9<br />

IMPAIRMENT LOSSES<br />

At 1 January <strong>2008</strong> -27.4<br />

. acquisitions through business combinations -<br />

. sales and disposals -<br />

. transfers -<br />

. translation differences 1.8<br />

At 31 December <strong>2008</strong> -25.6<br />

CARRYING AMOUNTS<br />

As per 1 January <strong>2008</strong> 37.2<br />

As per 31 December <strong>2008</strong> 38.3


<strong>Tessenderlo</strong> <strong>Group</strong><br />

ACQUISITION COST<br />

At 1 January 2007 69.5<br />

. acquisitions through business combinations 0.2<br />

. sales and disposals -<br />

. transfers -<br />

. translation differences -5.1<br />

At 31 December 2007 64.6<br />

IMPAIRMENT LOSSES<br />

At 1 January 2007 -29.4<br />

. acquisitions through business combinations -<br />

. sales and disposals -<br />

. transfers -<br />

. translation differences 2.0<br />

At 31 December 2007 -27.4<br />

CARRYING AMOUNTS<br />

As per 1 January 2007 40.1<br />

As per 31 December 2007 37.2<br />

During the fourth quarter of <strong>2008</strong>, the <strong>Group</strong> completed its annual impairment test for goodwill and<br />

concluded, based on the assumptions below, that no impairment charge was deemed necessary.<br />

The <strong>Group</strong> cannot foresee whether an event that triggers impairment will occur, when it will occur or<br />

how it will affect the asset values reported. The <strong>Group</strong> believes that all of its estimates are reasonable.<br />

They are consistent with the internal reporting and reflect management’s best estimates.<br />

135<br />

Goodwill only accounts for approximately 2.1 % of the <strong>Group</strong>’s total assets as at 31 December <strong>2008</strong><br />

(2007: 2.2 %). The impairment testing on goodwill, relies on a number of critical judgements, estimates<br />

and assumptions.<br />

Goodwill has been tested for impairment on company level or at the most relevant level based on valuein-use<br />

calculations. The key judgements, estimates and assumptions used in these calculations are as<br />

follows:<br />

- The cash flow projection of the first year is based on the current year financial budget (2009).<br />

- For the next four years (2010-2013), cash flow projections used are based on a long term plan for<br />

the coming 5 years.<br />

- In order to calculate the terminal value, the data of the fifth year are extrapolated by using<br />

simplified assumptions such as constant quantities sold, combined with constant costs.<br />

- Projections are made in the functional currency of the company and are discounted at the company<br />

level Weighted Average Cost of Capital.<br />

Although the <strong>Group</strong> believes that its judgements, assumptions and estimates are appropriate, actual<br />

results may differ from these estimates under different assumptions or conditions.


financial report <strong>2008</strong><br />

12. Intangible assets<br />

USEFUL LIFE<br />

DEVELOPMENT<br />

CONCESSIONS,<br />

PATENTS,<br />

LICENSES<br />

SOFTWARE<br />

CUSTOMER<br />

LISTS<br />

OTHER<br />

OTHER<br />

TOTAL<br />

FINITE<br />

INDEFINITE<br />

136<br />

ACQUISITION VALUE<br />

At 1 January <strong>2008</strong> 3.7 27.8 12.5 10.6 19.0 1.8 75.4<br />

. acquisitions through business - - - 2.2 - - 2.2<br />

combinations (note 3)<br />

. capital expenditure - 3.9 2.1 1.0 0.2 - 7.2<br />

. sales and disposals - - - - - - 0.0<br />

. transfers - 3.3 0.3 -0.2 -3.4 - 0.0<br />

. translation differences - 0.3 -1.0 -0.4 0.7 - -0.4<br />

At 31 December <strong>2008</strong> 3.7 35.3 13.9 13.2 16.5 1.8 84.4<br />

AMORTISATION AND IMPAIRMENT LOSSES<br />

At 1 January <strong>2008</strong> -1.1 -19.4 -9.4 -3.8 -4.8 0.0 -38.5<br />

. acquisitions through business - - - - - - 0.0<br />

combinations<br />

. amortisation -0.7 -2.1 -1.5 -1.0 -1.2 - -6.5<br />

. sales and disposals - - - - - - 0.0<br />

. transfers - -0.8 -0.2 - 1.0 - 0.0<br />

. translation differences - -0.1 0.6 0.2 -0.2 - 0.5<br />

At 31 December <strong>2008</strong> -1.8 -22.4 -10.5 -4.6 -5.2 0.0 -44.5<br />

CARRYING AMOUNTS<br />

At 1 January <strong>2008</strong> 2.6 8.4 3.1 6.8 14.2 1.8 36.9<br />

At 31 December <strong>2008</strong> 1.9 12.9 3.4 8.6 11.3 1.8 39.9


<strong>Tessenderlo</strong> <strong>Group</strong><br />

USEFUL LIFE<br />

DEVELOPMENT<br />

CONCESSIONS,<br />

PATENTS,<br />

LICENSES<br />

SOFTWARE<br />

CUSTOMER LISTS<br />

OTHER<br />

OTHER<br />

TOTAL<br />

FINITE<br />

INDEFINITE<br />

ACQUISITION VALUE<br />

At 1 January 2007 3.7 22.2 12.2 6.8 9.8 2.1 56.8<br />

. acquisitions through business - 3.6 - 2.4 9.7 - 15.7<br />

combinations<br />

. capital expenditure - 2.5 0.3 1.5 1.2 - 5.5<br />

. sales and disposals - -0.4 - - - - -0.4<br />

. transfers - - 0.3 - - - 0.3<br />

. translation differences - -0.1 -0.3 -0.1 -1.7 -0.3 -2.5<br />

At 31 December 2007 3.7 27.8 12.5 10.6 19.0 1.8 75.4<br />

137<br />

AMORTISATION AND IMPAIRMENT LOSSES<br />

At 1 January 2007 -0.2 -19.0 -8.2 -3.3 -4.2 0.0 -34.9<br />

. acquisitions through business - - - - - - 0.0<br />

combinations<br />

. amortisation -0.7 -0.8 -1.4 -0.3 -0.9 - -4.1<br />

. sales and disposals - 0.2 - - - - 0.2<br />

. transfers -0.2 0.2 - - - - 0.0<br />

. translation differences - - 0.2 -0.2 0.3 - 0.3<br />

At 31 December 2007 -1.1 -19.4 -9.4 -3.8 -4.8 0.0 -38.5<br />

CARRYING AMOUNTS<br />

At 1 January 2007 3.5 3.2 4.0 3.5 5.6 2.1 21.9<br />

At 31 December 2007 2.6 8.4 3.1 6.8 14.2 1.8 36.9<br />

The capital expenditure amounts to 7.2 million EUR and is broken down per business segment, in the<br />

“Segment reporting” section (note 2).<br />

An amount of 2.2 million EUR is disclosed as acquisition through business combinations. The detailed<br />

information is disclosed in “Acquisitions and disposals” (note 3).<br />

The “other” intangible assets with finite useful lives consist mainly of two non-competition agreements,<br />

know how, a product label and land-use rights. The non-compete agreements, the product label and the<br />

know-how are being amortised on a straight-line basis over 5-15 years.


financial report <strong>2008</strong><br />

The intangible assets with indefinite useful life relate to trademarks which are considered to have an<br />

indefinite life unless plans would exist to discontinue the related activity. The intangible assets with<br />

indefinite useful life have been tested for impairment and no impairment charge was deemed necessary.<br />

No intangible assets are pledged as security for liabilities.<br />

13. Investments accounted for using the equity<br />

method<br />

Investments accounted for using the equity method consist of joint ventures and associates.<br />

The joint ventures of the <strong>Group</strong> are:<br />

Ownership<br />

Country <strong>2008</strong> 2007<br />

138<br />

Jupiter Sulphur US 50% 50%<br />

Zéoline Belgium 50% 50%<br />

Siram France 50% 50%<br />

SH Capital (<strong>Group</strong>e Fiso) France 50% 50%<br />

Ferso Bio (<strong>Group</strong>e Fiso) France 50% 50%<br />

Fiso Developpement (<strong>Group</strong>e Fiso) France 50% 50%<br />

Solagra (<strong>Group</strong>e Fiso) France 50% 50%<br />

Labrousse (<strong>Group</strong>e Fiso) France 50% 25%<br />

Ispac (<strong>Group</strong>e Fiso) France 50% 25%<br />

MPR Middle East Bahrain 50% -<br />

The associates of the <strong>Group</strong> are:<br />

Ownership<br />

Country <strong>2008</strong> 2007<br />

Alkemin US 49.50% 49.50%<br />

T-Power Belgium 33.33% -<br />

Wolf Mountain Products US 30% -<br />

Bonnet (<strong>Group</strong>e Fiso) France 25% 25%<br />

Michel (<strong>Group</strong>e Fiso) France 25% 25%


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The carrying amount of the investments accounted for using the equity method is as follows:<br />

<strong>2008</strong> 2007<br />

Alkemin 0.0 0.0<br />

<strong>Group</strong>e Fiso 14.8 12.8<br />

Jupiter Sulphur 13.5 7.0<br />

MPR Middle East 0.1 -<br />

Siram 0.8 0.9<br />

T-Power 4.6 -<br />

Wolf Mountain Products 2.8 -<br />

Zéoline 3.0 3.3<br />

Total 39.6 24.0<br />

Summary financial information on investments accounted for using the equity method at 100 percent:<br />

<strong>2008</strong> 2007<br />

Current assets 123.6 56.7<br />

Non-current assets 141.6 48.3<br />

Current liabilities 68.8 30.6<br />

Non-current liabilities 108.0 21.9<br />

Revenue 121.0 105.8<br />

Profit (+) / loss (-) from operations 38.5 21.0<br />

Profit for the period (+) / loss (-) attributable to equity holders 23.0 12.0<br />

139<br />

The above financial information includes results of the new associates T-Power and Wolf Mountain<br />

Products as from December <strong>2008</strong>. The results of MPR Middle East are insignificant and are included as<br />

from January <strong>2008</strong>.<br />

14. Investments<br />

<strong>2008</strong> 2007<br />

Investments in equity securities 4.5 5.6<br />

Cash guarantees / deposits 0.7 0.5<br />

Total 5.2 6.1<br />

Investments in equity securities <strong>2008</strong> 2007<br />

TC Nederland, Netherlands 0.8 0.8<br />

Indaver, Belgium 0.6 0.6<br />

TC Espana, Spain 0.6 0.6<br />

GLOBE International, Belgium 0.5 0.5<br />

LVM United Kingdom Ltd, United Kingdom 0.2 0.2<br />

Polycoop, Argentina - 1.1<br />

Ashdec Umwelt, Austria 0.4 -<br />

Other 1.4 1.8<br />

Total 4.5 5.6<br />

The investments in unquoted companies are measured at cost as their fair value can not be reliably<br />

determined.


financial report <strong>2008</strong><br />

15. Deferred tax assets and liabilities<br />

ASSETS LIABILITIES NET<br />

<strong>2008</strong> 2007 <strong>2008</strong> 2007 <strong>2008</strong> 2007<br />

Property, plant & equipment 5.5 3.5 -31.1 -31.0 -25.6 -27.5<br />

Goodwill 1.4 1.7 - - 1.4 1.7<br />

Intangible assets 1.4 2.3 - - 1.4 2.3<br />

Inventories 2.4 2.7 -8.3 -1.9 -5.9 0.8<br />

Receivables - 0.1 - - 0.0 0.1<br />

Derivative financial instruments - - -0.1 -0.2 -0.1 -0.2<br />

Other current assets 0.8 0.5 - - 0.8 0.5<br />

Employee benefits 3.1 4.9 -3.2 -3.9 -0.1 1.0<br />

Provisions 3.4 4.0 -16.2 -15.5 -12.8 -11.5<br />

Other items - 0.1 -0.3 - -0.3 0.1<br />

Losses carried forward 26.3 33.6 - - 26.3 33.6<br />

Impairment of deferred tax assets -11.8 -11.8 - - -11.8 -11.8<br />

Gross deferred tax assets / (liabilities) 32.5 41.6 -59.2 -52.5 -26.7 -10.9<br />

Set off of tax -14.8 -15.3 14.8 15.3<br />

140<br />

Net deferred tax assets / (liabilities) 17.7 26.3 -44.4 -37.2 -26.7 -10.9<br />

All movements of deferred tax assets and deferred tax liabilities are recorded through the income<br />

statement, except for conversion differences (-0.7 million EUR in <strong>2008</strong>) and the existing deferred tax<br />

assets and deferred tax liabilities at date of acquisitions (-1.4 million EUR in <strong>2008</strong>).<br />

On 31 December <strong>2008</strong>, a deferred tax liability of 18.6 million EUR (2007: 15.8 million EUR) relating<br />

to undistributed reserves within the subsidiaries of the <strong>Group</strong> has not been recognised because<br />

management believes that this liability will not be incurred in the foreseeable future.<br />

Tax losses carried forward on which no deferred tax asset is recognised amount to 45.7 million EUR<br />

(2007: 78.8 million EUR). These tax losses have an indefinite life. Deferred tax assets have not been<br />

recognised on these items because it is not probable that future taxable profits (within the next 5 years)<br />

will be available against which the unused tax losses can be utilised.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

16. Trade and other receivables<br />

<strong>2008</strong> 2007<br />

Non-current trade and other receivables<br />

Trade receivables 0.7 0.2<br />

Gross trade receivables 0.7 0.2<br />

Amounts written off - -<br />

Other receivables 2.2 5.1<br />

Prepayments - -<br />

Receivables from related parties - -<br />

Assets related to employee benefit schemes 14.5 10.2<br />

Total 17.4 15.5<br />

<strong>2008</strong> 2007<br />

Current trade and other receivables<br />

Trade receivables 401.7 378.5<br />

Gross trade receivables 416.2 391.6<br />

Amounts written off -14.5 -13.1<br />

Other receivables 58.1 44.3<br />

Prepayments 0.6 0.9<br />

Receivables from related parties 9.1 0.3<br />

Total 469.5 424.0<br />

141<br />

Receivables from related parties concern receivables on joint-ventures and associates (note 30).<br />

17. Inventories<br />

<strong>2008</strong> 2007<br />

Consumables 132.3 95.1<br />

Work in progress 23.2 21.4<br />

Finished goods 274.3 184.3<br />

Goods purchased for resale 43.9 39.1<br />

Total 473.7 339.9<br />

There are no inventories pledged for security.<br />

The cost of inventories recognised as an expense in <strong>2008</strong>, amounts to 1,414.7 million EUR<br />

(2007: 1,078.3 million EUR), included in cost of sales.<br />

The carrying amount of inventory, which was set at net realisable value as per year-end <strong>2008</strong> amounts to<br />

146.1 million EUR (2007: 38.0 million EUR). An amount of 22.7 million EUR was expensed in <strong>2008</strong><br />

(2007: 3.7 million EUR) of which 19.4 million EUR relates to an inventory write-off during the fourth quarter<br />

of <strong>2008</strong>. This inventory write-off was mainly the consequence of the strong decrease of sales prices in the<br />

beginning of 2009.<br />

In <strong>2008</strong> an insignificant income was recognised as a reverse of a write-off on inventories.


financial report <strong>2008</strong><br />

18. Cash and cash equivalents<br />

<strong>2008</strong> 2007<br />

Term accounts 0.5 0.2<br />

Current accounts 53.0 93.4<br />

Cash in hand - -<br />

Total 53.5 93.6<br />

19. Non-current assets held for sale<br />

<strong>2008</strong> 2007<br />

Non-current assets held for sale 0.7 -<br />

The non-current assets held for sale at 31 December <strong>2008</strong> include the land and buildings of two sites of<br />

a subsidiary in the Business <strong>Group</strong> Plastics Converting. Following a restructuring of its activities, these<br />

assets remain unused and are set for sale.<br />

142


<strong>Tessenderlo</strong> <strong>Group</strong><br />

20. Equity<br />

Reconciliation of movement in equity<br />

Issued capital<br />

Share premium<br />

Other reserves<br />

Translation<br />

reserves<br />

Negative goodwill<br />

Retained earnings<br />

Equity attributable<br />

to equity holders<br />

of the <strong>Group</strong><br />

Minority interest<br />

Total Equity<br />

Balance at 1 January 2007 136.0 36.5 238.9 -5.6 0.4 303.3 709.5 2.2 711.7<br />

Total recognised income and<br />

- - - -12.4 - 128.9 116.5 -0.2 116.3<br />

expense<br />

Shares issued 1.0 5.5 - - - - 6.5 - 6.5<br />

Dividends paid to shareholders - - - - - -33.5 -33.5 - -33.5<br />

Share based payments - - 1.2 - - - 1.2 - 1.2<br />

Other movements - - 16.1 - - -16.1 0.0 - 0.0<br />

Balance at 31 December 2007 137.0 42.0 256.2 -18.0 0.4 382.6 800.2 2.0 802.2<br />

Balance at 1 January <strong>2008</strong> 137.0 42.0 256.2 -18.0 0.4 382.6 800.2 2.0 802.2<br />

Total recognised income and<br />

- - - -8.8 - 140.5 131.7 -0.1 131.6<br />

expense<br />

Shares issued 1.0 1.3 - - - - 2.3 - 2.3<br />

Dividends paid to shareholders - - - - - -35.0 -35.0 - -35.0<br />

Share based payments - - 0.8 - - - 0.8 - 0.8<br />

Other movements - - 82.8 - - -82.8 0.0 0.1 0.1<br />

Balance at 31 December <strong>2008</strong> 138.0 43.3 339.8 -26.8 0.4 405.3 900.0 2.0 902.0<br />

143<br />

Issued capital and share premium<br />

Ordinary shares<br />

<strong>2008</strong> 2007<br />

On issue at 1 January 27,626,444 27,419,876<br />

Issued for cash at 4 September 2007 206,568<br />

Issued for cash at 1 September <strong>2008</strong> 86,844<br />

On issue at 31 December – fully paid 27,713,288 27,626,444<br />

The number of shares comprised 7,602,211 registered shares (2007: 7,664,192) and 20,111,077 ordinary<br />

shares (2007: 19,962,252). The shares are without nominal value.<br />

Translation reserves<br />

The translation reserves comprise all foreign exchange differences arising from the translation of the<br />

financial statements of foreign operations.<br />

Dividends<br />

After the balance sheet date, the Board of Directors will propose to the shareholders at the <strong>Annual</strong><br />

Shareholders’ meeting of 2 June 2009, to approve a dividend distribution of 36.9 million EUR or a net<br />

dividend per share of 1.00 EUR. The dividend has not been accounted for.


financial report <strong>2008</strong><br />

21. Earnings per share<br />

Basic earnings per share<br />

The calculation of the basic earnings per share is based on the profit attributable to ordinary<br />

shareholders and the weighted average number of ordinary shares outstanding during the year.<br />

The weighted average number of ordinary shares and the earnings per share are calculated as follows:<br />

<strong>2008</strong> 2007<br />

Number of ordinary shares at 1 January 27,626,444 27,419,876<br />

Effect of shares issued 28,789 66,964<br />

Weighted average number of ordinary shares 27,655,233 27,486,840<br />

Profit (+) / loss (-) attributable to equity holders of the <strong>Group</strong><br />

140.5 128.9<br />

(in million EUR)<br />

Basic earnings per share (in EUR) 5.08 4.69<br />

Diluted earnings per share<br />

144<br />

The calculation of diluted earnings per share is based on the profit attributable to ordinary shareholders<br />

and the diluted weighted average number of ordinary shares outstanding during the year.<br />

The weighted average number of ordinary shares (diluted) and the diluted earnings per share are<br />

calculated as follows:<br />

<strong>2008</strong> 2007<br />

Weighted average number of ordinary shares at 31st December 27,655,233 27,486,840<br />

Effect of share option on issue 6,622 35,898<br />

Diluted weighted average number of ordinary shares at 31st December 27,661,855 27,522,738<br />

Profit (+) / loss (-) attributable to equity holders<br />

140.5 128.9<br />

of the <strong>Group</strong> (in million EUR)<br />

Diluted earnings per share (in EUR) 5.08 4.68<br />

22. Financial liabilities<br />

<strong>2008</strong> 2007<br />

Non-current financial liabilities 96.7 122.6<br />

Current financial liabilities 251.4 214.8<br />

Total financial liabilities 348.1 337.4<br />

Cash and cash equivalents -53.5 -93.6<br />

Net financial liabilities 294.6 243.8


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The net debt equity ratio at the end of <strong>2008</strong> is 32.7 % (year end 2007: 30.4 %).<br />

<strong>2008</strong> 2007<br />

Non-current financial liabilities<br />

Lease payables 1.9 2.6<br />

Credit institutions 94.8 120.0<br />

Total 96.7 122.6<br />

Terms and debt repayment schedule <strong>2008</strong>:<br />

other<br />

currencies<br />

in EUR<br />

in EUR Total Rate (%)<br />

Effective<br />

rate (%)<br />

Maturity<br />

Credit institutions - 20.0 floating 3.59 June ‘10-’13<br />

Credit institutions - 40.0 3.368 (fixed) - Oct ‘10-’13<br />

Credit institutions - 30.0 3.65 (fixed) - Dec ‘10-’12<br />

Credit institutions - 4.8 floating 0-4.5 ‘10-’15<br />

Lease payables - 1.9 5,8 (fixed) - ‘10-’16<br />

Total 0.0 96.7<br />

Total: equivalent in EUR 0.0 96.7 96.7<br />

145<br />

Terms and debt repayment schedule 2007:<br />

other<br />

currencies<br />

in EUR<br />

in EUR Total Rate (%)<br />

Effective<br />

rate (%)<br />

Maturity<br />

Credit institutions - 25.0 floating 5.18 June ‘09-’13<br />

Credit institutions - 50.0 3.368 (fixed) - Oct ‘09-’13<br />

Credit institutions - 40.0 3.65 (fixed) - Dec ‘09-’12<br />

Credit institutions 0.8 4.2 floating 0-4.5 ‘09-’15<br />

Lease payables - 2.6 5.8 (fixed) - ‘08-’16<br />

Total 0.8 121.8<br />

Total: equivalent in EUR 0.8 121.8 122.6<br />

Some covenants like balance sheet or interest coverage ratios or coverage of net debt by EBITDA may<br />

apply to long term debt and medium term facilities. All ratios have been respected in <strong>2008</strong>.<br />

<strong>2008</strong> 2007<br />

Current financial liabilities<br />

Current portion long term financial liabilities 25.0 25.0<br />

Lease payable within 1 year 0.1 0.1<br />

Credit institutions and commercial paper 226.3 189.7<br />

Total 251.4 214.8


financial report <strong>2008</strong><br />

Of the current financial liabilities per 31 December <strong>2008</strong>, 71.6 million EUR (2007: 51.6 million EUR) are<br />

represented by treasury bills (commercial paper) issued by <strong>Tessenderlo</strong> Finance (25.8 million EUR), a<br />

Belgian subsidiary and by <strong>Tessenderlo</strong> Nl Holding (45.8 million EUR), a Dutch subsidiary. The interest<br />

rate on this commercial paper amounts from Euribor +0.10% to Euribor +0.17%, depending on the<br />

duration of the loan.<br />

The <strong>Group</strong> uses short-term credit lines with credit institutions for the remaining part of the financing.<br />

Analysis of non-current and current financial liabilities by currency (<strong>2008</strong>):<br />

EUR USD GBP Others Total<br />

Current financial liabilities (*) 211.8 22.0 15.0 2.6 251.4<br />

Non-current financial liabilities 96.7 - - - 96.7<br />

Total financial liabilities 308.5 22.0 15.0 2.6 348.1<br />

In percentage of total financial liabilities 88.62% 6.32% 4.31% 0.75% 100.00%<br />

Analysis of non-current and current financial liabilities by currency (2007):<br />

EUR USD GBP Others Total<br />

146<br />

Current financial liabilities (*) 180.2 22.8 3.7 8.1 214.8<br />

Non-current financial liabilities 121.8 - - 0.8 122.6<br />

Total financial liabilities 302.0 22.8 3.7 8.9 337.4<br />

In percentage of total financial liabilities 89.51% 6.76% 1.10% 2.64% 100.00%<br />

(*) Part of these loans are denominated in EUR and afterwards swapped in GBP (see also note 26). The<br />

original loan remains in EUR.<br />

Terms and repayment schedule for finance lease contracts for 2007 and <strong>2008</strong>:<br />

Lease<br />

payables<br />

<strong>2008</strong><br />

Interest<br />

<strong>2008</strong><br />

Principal<br />

<strong>2008</strong><br />

Lease<br />

payables<br />

2007<br />

Interest<br />

2007<br />

Principal<br />

2007<br />

Less than one year 0.2 0.1 0.1 0.3 0.2 0.1<br />

Between one and five years 1.9 0.2 1.7 2.5 0.3 2.2<br />

More than five years 0.2 0.0 0.2 0.5 0.1 0.4<br />

Total 2.3 0.3 2.0 3.3 0.6 2.7


<strong>Tessenderlo</strong> <strong>Group</strong><br />

23. Employee benefits<br />

The provision for early retirement and defined benefit pension plans recognised in the balance sheet is<br />

as follows:<br />

Early<br />

retirement<br />

provision<br />

Defined benefit<br />

pension plan<br />

Total<br />

Balance at 1 January <strong>2008</strong> 16.8 29.6 46.4<br />

Additions 0.6 1.6 2.2<br />

Use of provision - -0.3 -0.3<br />

Reversal of provision -4.6 -5.3 -9.9<br />

Translation differences - -0.3 -0.3<br />

Transfers 2.8 - 2.8<br />

Balance at 31 December <strong>2008</strong> 15.6 25.3 40.9<br />

The entity’s accounting policy for recognising actuarial gains and losses<br />

The recognition of actuarial gains and losses is determined separately for each defined benefit plan.<br />

All actuarial gains and losses as at 1 January 2004, the date of transition to IFRSs, were recognised. All<br />

actuarial gains and losses subsequent to 1 January 2004 exceeding a corridor of 10 % of the higher of<br />

the present value of the defined benefit obligations and the fair value of plan assets are recognised in<br />

the income statement over the expected average remaining working lives of employees participating in<br />

the plan. Otherwise, the actuarial gain or loss is not recognised.<br />

147<br />

A general description of the type of plan<br />

• Employee Benefits<br />

These provisions are recorded to cover the post employment benefits and cover the pension plans and<br />

other benefits in accordance with local practices and conditions, following an actuarial calculation taking<br />

into account the financing of insurance companies and other pension funds. The most important pension<br />

plans are located in Belgium, the Netherlands, the United States of America, the United Kingdom,<br />

Germany and Italy.<br />

• Defined contribution plans<br />

The defined contribution pension plans are plans for which the company pays pre-determined<br />

contributions to a legal entity or a separate fund, in accordance with the settings of the plans. The<br />

company’s legal or constructive obligation is limited to the amount contributed. The contributions are<br />

recognised as an expense in the income statement as incurred and are included in “Payroll and related<br />

benefits” (note 6).<br />

• Defined benefit plans<br />

These plans are financed externally by pension funds or insurance companies. Independent actuaries<br />

perform an actuarial valuation on a regular basis. All actuarial gains and losses as at 1 January 2004,<br />

the date of transition to IFRSs, were recognised.


financial report <strong>2008</strong><br />

The amounts recognised in the balance sheet are as follows:<br />

<strong>2008</strong> 2007 2006 2005 2004<br />

Present value of wholly funded obligations 78.9 83.7 93.2 77.8 50.3<br />

Present value of partially funded obligations 71.2 75.4 76.2 92.3 94.4<br />

Present value of wholly unfunded obligations 18.0 18.9 17.3 19.4 18.2<br />

Total present value of obligations 168.1 178.0 186.7 189.5 162.9<br />

Fair value of plan assets 147.3 161.7 167.6 159.1 135.8<br />

Deficit 20.8 16.3 19.1 30.4 27.1<br />

Unrecognised actuarial gains (losses) -10.0 3.1 -2.5 -13.0 -3.1<br />

Net liability 10.8 19.4 16.6 17.4 24.0<br />

Unrecognised in % of funded obligations 5.95% -1,74% 1,34% 6,86% 1,90%<br />

Unrecognised in % of plan assets 6.79% -1.92% 1.49% 8.17% 2.28%<br />

Amounts in the balance sheet:<br />

Liabilities 25.3 29.6 29.4 29.7 28.7<br />

Assets (note 16) 14.5 10.2 12.8 12.4 4.7<br />

Net liability 10.8 19.4 16.6 17.3 24.0<br />

148<br />

The amounts recognised in the income statement are as follows:<br />

<strong>2008</strong> 2007<br />

Current service cost 6.0 5.8<br />

Interest cost 9.0 9.1<br />

Expected return on plan assets -9.5 -9.5<br />

Past service cost (benefit) -0.4 4.0<br />

Total, included in ‘payroll and related benefits’ (note 6) 5.1 9.4<br />

The past service cost in 2007 was mainly related to a plan settlement in a US subsidiary, a plan<br />

curtailment in the Italian subsidiaries and a change in French law concerning employee benefits.<br />

These items are presented under non-recurring items.<br />

The net periodic pension cost is included in the following line items of the income statement:<br />

<strong>2008</strong> 2007<br />

Cost of sales 3.0 3.5<br />

Distribution expenses 0.1 0.1<br />

Sales and marketing expenses 0.7 1.0<br />

Administrative expenses 1.3 0.8<br />

Other operating income/(expenses) - -<br />

Non-recurring items, net - 4.0<br />

Total 5.1 9.4


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Changes in the present value of the defined benefit obligation are as follows:<br />

<strong>2008</strong> 2007<br />

Opening defined benefit obligation 178.0 186.7<br />

Change in scope of consolidation - 4.0<br />

Current service cost 7.3 7.2<br />

Past service cost - 2.1<br />

Interest cost 9.0 9.1<br />

Actuarial losses (gains) -11.1 -10.3<br />

Exchange differences on foreign plans -5.6 -3.0<br />

Settlement - -7.7<br />

Benefits paid -9.5 -10.1<br />

Closing defined benefit obligation 168.1 178.0<br />

Changes in the fair value of plan assets are as follows:<br />

<strong>2008</strong> 2007<br />

Opening fair value of plan assets 161.7 167.6<br />

Change in scope of consolidation - 0.7<br />

Expected return 9.5 9.5<br />

Actuarial gains and (losses) -21.9 -4.1<br />

Contributions by employee 1.3 1.3<br />

Contributions by employer 13.9 7.7<br />

Exchange differences on foreign plans -7.7 -3.2<br />

Settlement - -7.7<br />

Benefits paid -9.5 -10.1<br />

Closing fair value of plan assets 147.3 161.7<br />

149<br />

The expected rates of return on individual categories of plan assets are determined by reference to<br />

relevant indices. The overall expected rate of return is calculated by weighting the individual rates in<br />

accordance with the anticipated balance in the total investment portfolio.<br />

The actual return on plan assets in <strong>2008</strong> and 2007 was -15.1 million EUR and 5.2 million EUR<br />

respectively.<br />

The <strong>Group</strong> expects to contribute 9.2 million EUR to its defined benefit pension plans in 2009.<br />

The major categories of plan assets as a percentage of total plan assets are as follows:<br />

<strong>2008</strong> 2007<br />

Equities 20% 26 %<br />

Fixed interest investments 11% 12 %<br />

Cash and deposits 11% 10 %<br />

Property 3% 2 %<br />

Insurance contracts 55% 50 %<br />

Total 100% 100%


financial report <strong>2008</strong><br />

The principal actuarial assumptions at the balance sheet date (expressed as weighted averages) are:<br />

<strong>2008</strong> 2007<br />

Discount rate at 31 December 6.1% 5.3 %<br />

Expected return on plan assets at 31 December 5.8% 5.7 %<br />

Future salary increases 3.4% 3.2 %<br />

Termination benefits (pre-retirement plans, other termination obligations)<br />

These benefits arise as a result of the company’s decision to terminate the employment of an employee<br />

or group of employees before the normal retirement date or of an employee’s decision to accept<br />

voluntary redundancy in exchange for those benefits. These benefits are accrued for at the moment of<br />

notification.<br />

Share based payments<br />

150<br />

A warrant plan has been created in order to increase the loyalty and motivation of the <strong>Group</strong>’s senior<br />

management. The plan gives senior management the opportunity to accept warrants which gives them<br />

the right to subscribe to shares. The Board of Directors yearly determines the list of beneficiaries. There<br />

exist no conditions on the number of years of service, however the beneficiaries may not have resigned<br />

or been dismissed (and serving their notice), except for persons who retire or take pre-retirement.<br />

The exercise price of the warrant equals the lower of the average market price of the underlying shares<br />

in the 30 trading days preceding the offer date or the market price on the last day preceding the offer<br />

date.<br />

The table below gives an overview of the granted and accepted warrants at 31 December <strong>2008</strong>.<br />

Allocation date<br />

Last exercise<br />

date<br />

Exercise price<br />

Number of<br />

outstanding<br />

warrants<br />

November ‘01 July ‘09 24.07 1,740<br />

November ‘02 July ‘12 25.87 12,200<br />

November ‘03 July ‘10 26.45 9,800<br />

November ‘04 July ‘11 31.69 32,600<br />

November ‘05 July ‘12 27.11 42,200<br />

November ‘06 July ‘13 30.02 62,880<br />

January ‘08 December ‘12 43.10 97,175<br />

Total 258,595<br />

IFRS 2 requires share based payments made to employees to be recognised in the financial statements<br />

based on the fair value of the warrants measured at grant date. According to the transition provisions<br />

included in IFRS 2, the warrants granted before 7 November 2002 and not yet vested at 1 January 2005<br />

are not amortised through the income statement.<br />

The fair value of the warrants granted is determined using the Black & Scholes valuation model.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

A new share based program was issued as per 8 November 2007. On December 12th <strong>2008</strong>, the Board of<br />

Directors decided to offer a second tranche of warrants, which had to be accepted by their beneficiaries<br />

by February 10th 2009. On February 10th 2009, 130.750 warrants were granted to senior management<br />

(exercise price of 22.07 EUR for French residents, 22.09 EUR for American residents, 23.08 EUR for all<br />

others).<br />

The weighted average fair value of the warrants and assumptions used in the measurement of the<br />

warrants, granted in <strong>2008</strong>, are:<br />

<strong>2008</strong> 2007<br />

Fair value of warrants (EUR) 2.3 -<br />

Share price (EUR) 30.72 -<br />

Exercise price (EUR) 43.10 -<br />

Expected volatility 24.20% -<br />

Expected option life (years) 4.5 -<br />

Expected dividend yield 3.61% -<br />

Risk free interest rate 4.12% -<br />

The number and weighted average exercise price of share warrants is as follows:<br />

Weighted<br />

average<br />

exercise<br />

price<br />

Number of<br />

warrants<br />

Weighted<br />

average<br />

exercise<br />

price<br />

Number of<br />

warrants<br />

<strong>2008</strong> 2007<br />

151<br />

Outstanding at the beginning of the<br />

29.10 167,420 29.00 259,240<br />

period<br />

Forfeited during the period 31.69 6,000 44.63 4,080<br />

Exercised during the period - - 28.10 87,740<br />

Granted during the period 43.10 97,175 - -<br />

Outstanding at the end of the period 34.30 258,595 29.10 167,420<br />

Exercisable at the end of the period 29.28 56,340 25.98 23,740<br />

No warrants were exercised in <strong>2008</strong>.<br />

The weighted average remaining contractual life of the warrants outstanding as per 31 December <strong>2008</strong><br />

amounts to 3.6 years (2007: 4.5 years).


financial report <strong>2008</strong><br />

24. Provisions<br />

<strong>2008</strong> 2007<br />

Non-current provisions 85.7 63.1<br />

Current provisions 0.9 8.6<br />

Total 86.6 71.7<br />

ENVIRONMENT RESTRUCTURING OTHER TOTAL<br />

Balance at 1 January <strong>2008</strong> 12.9 5.7 53.1 71.7<br />

Additions 14.5 - 9.1 23.6<br />

Use of provision -1.0 -0.4 -2.3 -3.7<br />

Reversal of provision -0.7 -2.3 -0.5 -3.5<br />

Effect of discounting - - - 0.0<br />

Other movements 4.8 -2.8 -3.5 -1.5<br />

Balance at 31 December <strong>2008</strong> 30.5 0.2 55.9 86.6<br />

The increase of provisions can be mainly explained by the recording of additional environmental<br />

provisions, next to the fluctuations of provisions due to the normal business activities.<br />

152<br />

On December 10th <strong>2008</strong>, the environmental permit of <strong>Tessenderlo</strong> Chemie NV (Belgium) was extended<br />

for a period of 20 years. <strong>Tessenderlo</strong> Chemie NV committed itself to invest in a new production process<br />

and to find a durable solution to its environmental problems in Limburg (Belgium). As a consequence<br />

of these commitments additional discounted environmental provisions were recorded for an amount of<br />

14.5 million EUR.<br />

“Other” provisions include mainly a non-recurring provision of 37.0 million EUR set up following the<br />

investigations performed by the European Commission on feed phosphates. The European Commission<br />

performed an investigation in 2004 on pretended contra competitive practices in the segment of the feed<br />

phosphates. In relation with this investigation, the <strong>Group</strong> recorded a provision of 20,0 million EUR in<br />

2004 and an additional 17,0 million EUR in 2006. This investigation is still ongoing.<br />

For the majority of the non-current provisions, a cash-outflow is not expected to take place within<br />

5 years.<br />

25. Trade and other payables<br />

<strong>2008</strong> 2007<br />

Trade payables 290.1 290.1<br />

Other amounts payable 41.6 43.5<br />

Remuneration and social security 57.2 52.5<br />

Total 388.9 386.1


<strong>Tessenderlo</strong> <strong>Group</strong><br />

26 Financial instruments<br />

Exposure to foreign currency, credit risk and interest rate risk arises in the normal course of the <strong>Group</strong>’s<br />

business. Derivative financial instruments are used to reduce the exposure to fluctuations in foreign<br />

exchange rates. While these are subject to the risk of market rates changing subsequent to acquisition,<br />

such changes are generally offset by opposite effects on the hedged items.<br />

Foreign currency risk<br />

Currency risk is the risk that the value of a financial instrument will fluctuate due to changes in<br />

foreign exchange rates. The <strong>Group</strong> incurs foreign currency risks on sales, purchases, investments and<br />

borrowings that are denominated in a currency other than the company’s functional currency.<br />

The currencies giving rise to this risk are primarily GBP, USD, PLN, HUF, YEN and CHF.<br />

Subsidiaries are required to submit information on their net foreign exchange positions when invoiced<br />

(customers, suppliers) to <strong>Tessenderlo</strong> Finance, a Belgian subsidiary created in January 2006.<br />

All the positions are netted at the level of <strong>Tessenderlo</strong> Finance and the net positions (long/short), which<br />

are very small, are then sold or bought on the market.<br />

The main management tools are the spot, purchase and sales of currencies followed by currencyswaps.<br />

<strong>Group</strong> borrowings are generally carried out by the <strong>Group</strong>’s holding and finance companies, which make<br />

the proceeds of these borrowings available to the operating entities.<br />

In principle, operating entities are financed in their own local currencies, with this currency being<br />

obtained, where appropriate, by currency-swaps against the currency held by the finance company.<br />

In that way, there is no exchange risk either in the finance company or in the company finally using the<br />

funds. The cost of this currency-swap is included in the finance costs.<br />

153<br />

In emerging countries, it is not always possible to borrow in local currency because local financial<br />

markets are too narrow, or funds are not available or because the financial conditions are too onerous.<br />

Those amounts are relatively small for the <strong>Group</strong>.<br />

• Exposure to foreign currency risk<br />

The <strong>Group</strong>’s exposure to foreign currency risk was as follows based on nominal amounts (for the<br />

exchange rates used, we refer to note 1 “Summary of significant accounting policies”):<br />

<strong>2008</strong> 2007<br />

EUR USD GBP EUR USD GBP<br />

Assets 4.3 29.2 77.7 10.6 79.6 92.7<br />

Liabilities -9.8 -39.7 -8.5 -11.1 -52.1 -4.9<br />

Gross exposure -5.5 -10.5 69.2 -0.5 27.5 87.8<br />

Forward exchange contracts 3.6 12.5 -70.0 -5.7 -40.7 -89.8<br />

Net exposure -1.9 2.0 -0.8 -6.2 -13.2 -2.0<br />

Net exposure (in EUR) -1.9 1.4 -0.8 -6.2 -9.0 -1.5


financial report <strong>2008</strong><br />

The difference between the amount covered and the amount in position is due to a mismatching between<br />

the recording and the value date of the operations. Coverage of exposure is done on a continuous basis.<br />

Credit risk<br />

The <strong>Group</strong> is high risk averse. In its strategy to increase shareholder value, the <strong>Group</strong> aims at a dynamic<br />

corporate portfolio management to develop confidently new markets: corporate exposure, asset quality,<br />

portfolio diversification are considered together with the maximisation of market shares, which requires<br />

efficient processes, cost effective payment default protection and CRM good practices.<br />

The international financial and economic crisis results in a deep crisis of confidence. The <strong>Group</strong> focuses<br />

especially on its stable relationships with long term partners. Special and legitimate attention is given to<br />

new relationships, for which, if necessary, secured payment methods are used.<br />

A Corporate Credit Procedure, a quick and consistent credit decision process, appropriate payment<br />

terms, an efficient collection tool and an accurate risk mitigation tool are used to accelerate the cash<br />

flow, to minimize bad debts and to increase sales.<br />

An in-house scoring model aims at defining, with the use of sector-based benchmarks, the portfolio<br />

in term of risks through an analysis of performance indicators and the financial structure. When a<br />

risk cannot be assessed or when it is too high, the <strong>Group</strong> resorts to credit insurance or other forms of<br />

guarantees.<br />

154<br />

At 31 December <strong>2008</strong>, no significant concentrations of credit risk existed. The liquidities available at the<br />

end of the year are deposited at very short term at local ranking banks.<br />

The maximum exposure to credit risk at the reporting date was:<br />

<strong>2008</strong> 2007<br />

Trade receivables 402.4 378.7<br />

Gross trade receivables 416.9 391.8<br />

Amounts written off -14.5 -13.1<br />

Other receivables 60.3 49.4<br />

Receivables from related parties 9.1 0.3<br />

Assets related to employee benefit schemes 14.5 10.2<br />

Derivative financial instruments 5.4 1.9<br />

Cash & cash equivalents 53.5 93.6<br />

Total 545.2 534.1<br />

The maximum exposure to credit risk for trade receivables at the reporting date by business group was<br />

(see also note 16):<br />

<strong>2008</strong> 2007<br />

Chemicals 181.8 152.2<br />

Specialities 105.1 93.1<br />

Plastics Converting 112.8 132.1<br />

Unallocated 2.7 1.6<br />

Total 402.4 379.0


<strong>Tessenderlo</strong> <strong>Group</strong><br />

The aging of trade receivables at the reporting date was:<br />

Gross<br />

Amounts<br />

written off Gross<br />

Amounts<br />

written off<br />

<strong>2008</strong> <strong>2008</strong> 2007 2007<br />

Not past due 271.7 3.5 263.8 0.1<br />

Past due 0-30 days 87.1 1.1 74.0 0.6<br />

Past due 31-120 days 38.9 1.3 36.5 0.6<br />

Past due 121-365 days 12.5 1.9 8.7 2.8<br />

More than one year 6.6 6.6 9.1 9.0<br />

Total 416.8 14.4 392.1 13.1<br />

The movement in the allowance for impairment in respect of trade receivables during the year was as<br />

follows:<br />

<strong>2008</strong> 2007<br />

Balance at 1 January 13.1 11.6<br />

Impairment loss recognised 4.3 3.9<br />

Reversal of impairment loss -1.0 -1.6<br />

Other movement -2.0 -0.8<br />

Balance at 31 December 14.4 13.1<br />

155<br />

Interest risk<br />

At the reporting date, the interest rate policy of the <strong>Group</strong>’s interest-bearing financial instruments was:<br />

<strong>2008</strong> 2007<br />

Fixed rate instruments<br />

Financial assets - -<br />

Financial liabilities note 22 92.0 112.7<br />

Variable rate instruments<br />

Financial assets note 18 53.5 93.6<br />

Financial liabilities note 22 256.1 224.7<br />

On the total amount of financial liabilities at the end of <strong>2008</strong>, 72.0 million EUR and 20.0 million EUR<br />

carry a fixed interest rate respectively until 2010-2016 and until 2009.<br />

• Fair value sensitivity analysis for fixed rate instruments<br />

The <strong>Group</strong> does not account for any fixed rate financial liabilities at fair value through profit and loss,<br />

and the <strong>Group</strong> does not designate derivatives (interest rate swaps) as hedging instruments under a fair<br />

value hedge accounting model. Therefore a change in interest rates at the reporting date would not<br />

affect profit or loss.


financial report <strong>2008</strong><br />

• Cash flow sensitivity analysis for variable rate instruments<br />

The average interest rate on the average debt in <strong>2008</strong> amounted to 4.7 % (2007: 4.8 %).<br />

An increase (decrease) of 100 basis points in interest rates at the reporting date would have decreased<br />

(increased) profit and loss by 1.4 million EUR (2007: 1.3 million EUR). This analysis assumes that all<br />

other variables, in particular foreign currency rates, remain constant.<br />

Liquidity risk<br />

The <strong>Group</strong> will be able to meet its financial obligations as they fall due.<br />

The <strong>Group</strong>’s approach to manage liquidity is to ensure, as far as possible, that it will always have<br />

sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without<br />

incurring unacceptable losses or risking damage to the <strong>Group</strong>’s reputation.<br />

The <strong>Group</strong> establishes forecasts on a regular base on short and longer term in order to be able to adapt<br />

financial means to forecasted needs.<br />

In addition, the <strong>Group</strong> maintains the following credit lines:<br />

156<br />

• A credit line of 420.0 million EUR, which is not confirmed.<br />

• A credit line of 30.0 million USD. This credit line is valid till June 2009, and the interest rate would<br />

be libor + 0.55 %.<br />

In addition, the <strong>Group</strong> uses a commercial paper program of maximum 200.0 million EUR.<br />

The following are the contractual maturities of financial liabilities, including interest payments and<br />

excluding the impact of netting agreements.<br />

<strong>2008</strong><br />

Carrying<br />

amount<br />

Contractual<br />

cashflows<br />

less than<br />

one year<br />

between<br />

1 and 5<br />

years<br />

more<br />

than 5<br />

years<br />

Non-Derivative Financial liabilities<br />

Credit institutions 25.0 27.3 5.8 21.5 -<br />

Credit institutions 50.0 55.1 11.7 43.4 -<br />

Credit institutions 40.0 43.7 11.5 32.2 -<br />

Credit institutions 231.1 233.1 228.1 3.3 1.7<br />

Finance lease liabilities 2.0 2.3 0.2 1.9 0.2<br />

Derivative Financial liabilities<br />

Forward exchange contracts 5.2 - - - -<br />

Inflow - -97.4 -97.4 - -<br />

Outflow - 92.5 92.5 - -<br />

Total 353.3 356.6 252.4 102.3 1.9


<strong>Tessenderlo</strong> <strong>Group</strong><br />

2007<br />

Carrying<br />

amount<br />

Contractual<br />

cashflows<br />

less than<br />

one year<br />

between<br />

1 and 5<br />

years<br />

more<br />

than 5<br />

years<br />

Non-Derivative Financial liabilities<br />

Credit institutions 30.0 34.3 6.3 22.9 5.1<br />

Credit institutions 60.0 67.1 12.0 44.8 10.3<br />

Credit institutions 50.0 55.6 11.9 43.7 -<br />

Credit institutions 194.7 196.0 191.5 2.0 2.5<br />

Finance lease liabilities 2.7 3.3 0.3 2.5 0.5<br />

Derivative Financial liabilities<br />

Forward exchange contracts -1.5 - - - -<br />

Inflow - -170.6 -170.6 - -<br />

Outflow - 169.0 169.0 - -<br />

Total 335.9 354.7 220.4 115.9 18.4<br />

Fair value of financial assets and liabilities<br />

The fair values together with the carrying amounts shown in the balance sheet are as follows:<br />

Note<br />

Carrying<br />

amount<br />

<strong>2008</strong><br />

Fair<br />

value<br />

<strong>2008</strong><br />

Carrying<br />

amount<br />

2007<br />

Fair<br />

value<br />

2007<br />

157<br />

Derivative financial instruments 26 5.4 5.4 1.9 1.9<br />

Cash and cash equivalents 18 53.5 53.5 93.6 93.6<br />

Investments 14 5.2 5.2 6.1 6.1<br />

Trade and other receivables 16 472.4 472.4 429.3 429.3<br />

Non-current financial liabilities 22 -96.7 -91.5 -122.6 -117.5<br />

Leasing payables 22 -1.9 -1.8 -2.6 -2.5<br />

Credit institutions 22 -94.8 -89.7 -120.0 -115.0<br />

Current financial liabilities 22 -251.4 -251.0 -214.8 -214.5<br />

Current portion long term financial<br />

22 -25.0 -24.6 -25.0 -24.7<br />

liabilities<br />

Leasing payables 22 -0.1 -0.1 -0.1 -0.1<br />

Credit institutions and commercial paper 22 -226.3 -226.3 -189.7 -189.7<br />

Trade and other payables 25 -388.9 -388.9 -364.6 -364.6<br />

-200.5 -194.9 -171.1 -165.7<br />

Estimation of fair values<br />

• Derivative financial instruments<br />

The fair value of a derivative financial instrument is the amount for which an asset could be exchanged,<br />

or a liability settled, between knowledgeable, willing parties in an arm’s length transaction.<br />

The fair value of forward contracts is calculated as the discounted value of the difference between the<br />

contract rate and the current forward rate.


financial report <strong>2008</strong><br />

The fair value of these instruments generally reflects the estimated amounts that the <strong>Group</strong> would<br />

receive on settlement of favorable contracts or be required to pay to terminate unfavorable contracts<br />

at the reporting date, and thereby takes into account the current unrealised gains or losses on open<br />

contracts.<br />

The fair value of forward exchange contracts used at 31 December <strong>2008</strong> was 5.2 million EUR recognised<br />

in the income statement on the line net revaluation to fair value of derivatives, which is included in the<br />

finance income (2007: 1.5 million EUR).<br />

The following table indicates the fair values of all outstanding derivative financial instruments at yearend:<br />

Contractual<br />

Contractual<br />

amount Fair value amount<br />

<strong>2008</strong> 2007<br />

Fair value<br />

Forward exchange contracts 97.4 5.2 169.0 1.5<br />

The contractual amount indicates the volume of outstanding derivatives at the balance sheet date and<br />

therefore does not reflect the group’s exposure to risks from such transactions.<br />

158<br />

In respect to the forward exchange contracts, the table below indicates the underlying contractual<br />

amount of the outstanding contracts per currency at year-end (selling of foreign currencies).<br />

Amount<br />

in foreign<br />

currency<br />

Amount in<br />

EUR<br />

Amount<br />

in foreign<br />

currency<br />

Amount in<br />

EUR<br />

<strong>2008</strong> 2007<br />

GBP 70.0 78.2 93.9 128.1<br />

USD 17.5 12.9 42.9 29.1<br />

Other - 6.3 - 11.8<br />

Total 97.4 169.0<br />

The <strong>Group</strong> also holds a position in emission allowances of which the fair value as per 31 December <strong>2008</strong>,<br />

amounted to 0.2 million EUR (2007: 0.4 million EUR).<br />

• Interest-bearing loans and borrowings<br />

The fair value is calculated based on discounted expected future principal and interest cash flows.<br />

The interest rates used to discount estimated cash flows, where applicable, are based on the<br />

government yield curve at the reporting date plus an adequate credit spread, and were as follows:<br />

<strong>2008</strong> 2007<br />

Loans and borrowings 5.9-6.0% 5.0-5.2%


<strong>Tessenderlo</strong> <strong>Group</strong><br />

• Financial lease payables<br />

The fair value is estimated as the present value of future cash flows, discounted at market interest rates<br />

for homogeneous financial lease agreements. The estimated fair values reflect the change in interest<br />

rates.<br />

The interest rates used to discount estimated cash flows, where applicable, are based on the<br />

government yield curve at the reporting date plus an adequate credit spread, and were as follows:<br />

<strong>2008</strong> 2007<br />

Leases 8.0 % 8.0 %<br />

• Trade and other receivables/payables<br />

For current trade and other receivables/payables, the notional amount is deemed to reflect the fair<br />

value. Non-current receivables/payables are discounted to determine the fair value.<br />

27. Operating leases<br />

The non-cancellable operating leases are payable as follows:<br />

159<br />

<strong>2008</strong> 2007<br />

Less than one year 4.8 3.6<br />

Between one and five years 16.2 12.6<br />

More than five years 5.5 4.7<br />

Total 26.5 20.9<br />

During the current year, 11.2 million EUR was recognised as an expense in the income statement in<br />

respect of operating leases (2007: 9.5 million EUR).<br />

Operating leases mainly consist of land and buildings (7.8 million EUR), property, plant and equipment<br />

(15.0 million EUR) and furniture and vehicles (3.7 million EUR).<br />

28. Guarantees and commitments<br />

<strong>2008</strong> 2007<br />

Guarantees given by third parties on our behalf 39.0 20.5<br />

Guarantees given on behalf of third parties 4.3 6.9<br />

Guarantees received from third parties 4.7 4.4<br />

Total 48.0 31.8


financial report <strong>2008</strong><br />

Guarantees given by third parties on our behalf mainly relate to the fulfillment of our environmental<br />

obligations. The increase in <strong>2008</strong> can be explained by a new guarantee which was given on our behalf for<br />

an amount of 18.0 million EUR.<br />

Guarantees given on behalf of third parties mainly relate to guarantees given for the proper execution of<br />

projects.<br />

The guarantees received from third parties concern guarantees, which suppliers grant to the <strong>Group</strong> as<br />

guarantee for the proper execution of investment projects.<br />

29. Contingencies<br />

The <strong>Group</strong> could be confronted with a number of potential claims and disputes, which are a<br />

consequence of the daily operational activities. These claims and disputes are not of such nature that<br />

they could be subject today to a suitable provision.<br />

160<br />

It is the <strong>Group</strong>’s policy to recognise environmental provisions in the balance sheet, when the company<br />

has a present obligation (legal or constructive) as a result of a past event, when it is probable that an<br />

outflow of resources embodying economic benefits will be required to settle the obligation and a when<br />

reliable estimate can be made of the amount of the obligation.<br />

These provisions are reviewed periodically and adjusted, if necessary, as assessments and<br />

cleanups proceed and additional information becomes available. Environmental liabilities can<br />

change substantially due to the emergence of additional information on the nature or extent of the<br />

contamination, a change in legislation or other factors of a similar nature.<br />

As stated in note 24, the environmental provisions in accordance with the above policies aggregated to<br />

30.5 million EUR at 31 December <strong>2008</strong> (2007: 12.9 million EUR).<br />

While it is not feasible to predict the outcome of all pending environmental exposures, it is reasonably<br />

possible that there will be a need for future provisions for environmental costs which, in management’s<br />

opinion, based on information currently available, would not have a material effect on the <strong>Group</strong>’s<br />

financial position but could be material to the <strong>Group</strong>’s results in any one accounting period.<br />

In order to acquire the remaining 50 % stake in Fiso <strong>Group</strong>, the <strong>Group</strong> has signed call agreements with<br />

the owner of that share. The call option may be exercised from 1 June 2009 until 30 September 2009.<br />

The exercise price is determined by a formula, which takes into account the financial figures of Fiso<br />

<strong>Group</strong>.<br />

In order to acquire an additional stake of 20 % in Wolf Mountain Products, the <strong>Group</strong> holds, as agreed<br />

with the current owners of that share, an option which may be exercised from 1 January 2014 until 30<br />

June 2014. The exercise price is determined by a formula, which takes into account the financial figures<br />

of Wolf Mountain Products.<br />

The <strong>Group</strong> has been granted emission allowances for the period <strong>2008</strong>-2012 (575 KT CO2 emission


<strong>Tessenderlo</strong> <strong>Group</strong><br />

allowances per year). These granted emission allowances have been obtained free of charge.<br />

The total number of allowances which will be used by the <strong>Group</strong> in this period cannot yet be determined<br />

reliably.<br />

30. Related parties<br />

The <strong>Group</strong> has a related party relationship with its subsidiaries, associates, joint ventures and with its<br />

directors and its management committee.<br />

Transactions with joint ventures<br />

<strong>2008</strong> 2007<br />

Revenue 2.2 1.8<br />

Cost of sales -28.2 -13.3<br />

Other operating income 0.1 0.1<br />

Finance costs -0.1 -0.1<br />

Current assets 0.4 0.3<br />

Current liabilities 3.1 3.0<br />

Transactions with associates<br />

161<br />

<strong>2008</strong> 2007<br />

Revenue - -<br />

Cost of sales - -<br />

Other operating income - -<br />

Finance costs - -<br />

Current assets 8.7 -<br />

Current liabilities - -<br />

Dividends were received from joint-ventures and associates for an amount of 10.2 million EUR (2007: 4.9<br />

million EUR).<br />

Transactions with joint ventures and associates are due to the ordinary course of business and are at<br />

arm’s length.<br />

Transactions with the members of the management committee<br />

<strong>2008</strong> 2007<br />

Short-term employee benefits 2.5 2.4<br />

Post-employment benefits 0.4 0.3<br />

Share based payments 0.2 0.2<br />

Total 3.1 2.9


financial report <strong>2008</strong><br />

Short-term employee benefits include salaries (including social security contributions), bonuses earned<br />

during the year, car leases and other allowances where applicable.<br />

Director’s payments consist mainly of director’s fees (tantièmes).<br />

31. Information on the auditor’s assignments and<br />

related fees<br />

Our statutory auditor is KPMG Bedrijfsrevisoren / Réviseurs d’Entreprises, represented by Ludo Ruysen,<br />

engagement partner.<br />

Fees for auditing the annual financial statements of <strong>Tessenderlo</strong> Chemie NV and its subsidiaries are<br />

ultimately determined by the general meeting of shareholders. Audit and audit related fees for <strong>2008</strong><br />

in relation to services provided by KPMG Bedrijfsrevisoren amounted to 0.70 million EUR (2007 : 0.47<br />

million EUR), which was composed of audit services for the annual financial statements of 0.39 million<br />

EUR (2007: 0.32 million EUR) and audit related services of 0.31 million EUR (2007: 0.15 million EUR).<br />

Audit related services mainly relate to services incurred in connection with consolidation and BPM.<br />

162<br />

Audit and other fees for <strong>2008</strong> in relation to services provided by other offices of the KPMG network<br />

amounted to 0.64 million EUR (2007: 0.55 million EUR)which was composed of audit services for the<br />

annual financial statements of 0.45 million EUR (2007: 0.47 million EUR), tax services of 0.19 million<br />

EUR (2007 : 0.08 million EUR) and audit related services of 0.0 million EUR (2007: 0.0 million EUR).<br />

32. Subsequent events<br />

On January 7th 2009, Wymar International (Oeselgem, Belgium), a subsidiary of the Business Unit<br />

Profiles, in the Business <strong>Group</strong> Plastics Converting, has announced its intention to restructure its<br />

operations. The causes for this decision rest with the structural macroeconomic downturn on the<br />

various markets where Wymar operates, combined with the negative impact of the financial crisis on the<br />

investment behaviour of end consumers (new-build and renovation). These adverse market conditions<br />

are also being felt on the Central and Eastern European markets in particular. To safeguard the future<br />

of Wymar’s activities at its Oeselgem plant, it could be that redundancies cannot be ruled out. The<br />

current plan could translate in a loss of 46 jobs at Wymar International in Oeselgem. At this moment the<br />

financial impact of this restructuring of operations could not yet be determined reliably.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

33. Consolidated companies<br />

Listed below are the most important <strong>Tessenderlo</strong> <strong>Group</strong> companies. A complete list of the <strong>Group</strong><br />

companies is available at <strong>Tessenderlo</strong> Chemie NV, Troonstraat 130, 1050 Brussel.<br />

The total number of consolidated companies is 96.<br />

List of the most important consolidated companies on 31 December <strong>2008</strong><br />

accounted for by the full consolidation method<br />

Europe<br />

Belgium Dyka Plastics NV 3900 Overpelt 100%<br />

Belgium Immo Watro SA 1050 Brussels 100%<br />

Belgium Limburgse Vinyl Maatschappij NV 1050 Brussels 100%<br />

Belgium <strong>Tessenderlo</strong> Chemie NV 1050 Brussels 100%<br />

Belgium <strong>Tessenderlo</strong> Chemie International NV 1050 Brussels 100%<br />

Belgium <strong>Tessenderlo</strong> Finance NV 1050 Brussels 100%<br />

Belgium Wymar International NV 8720 Oeselgem 100%<br />

Czech Republic Dyka s.r.o. 27361 Velka Dobra 100%<br />

France Akiolis <strong>Group</strong> SAS 72000 Le Mans 100%<br />

France Calaire Chimie SAS 62100 Calais 100%<br />

France Chemilyl SAS 59120 Loos 100%<br />

France Collectoco SAS 67220 Neubois 100%<br />

France Ets Caillaud SAS 61400 Saint-Langis-Les-Mortagne 100%<br />

France Ets. Point SAS 01440 Viriat 100%<br />

France France Gras SA 56300 Le Sourn 100%<br />

France Plastival SAS 25340 Clerval 100%<br />

France Produits Chimiques de Loos SAS 59120 Loos 100%<br />

France Profex SAS 62210 Avion 100%<br />

France Progilor-Bouvart SAS 55100 Charny sur Meuse 99.90%<br />

France Saplast SAS 67100 Strasbourg 100%<br />

France Société Artésienne de Vinyle SAS 59120 Loos 100%<br />

France Soleval SAS 61400 Saint-Langis-Les-Mortagne 100%<br />

France Soparcail SAS 61400 Saint-Langis-Les-Mortagne 100%<br />

France Sotra-Seperef SAS 69650 Quincieux 100%<br />

France SR Collecte SAS 67220 Neubois 100%<br />

France Tefipar SA 75009 Paris 100%<br />

France Thermoplastiques Cousin-Tessier SAS 85130 Tiffauges 100%<br />

France Union de la Boucherie Lyonnaise SA 69960 Corbas 94.20%<br />

Germany Dyka Gmbh 14513 Teltow 100%<br />

Germany PB Gelatins GmbH 31582 Nienburg/Weser 100%<br />

Italy Farchemia srl 24047 Treviglio (BG) 100%<br />

Italy <strong>Tessenderlo</strong> Italia srl 24047 Treviglio (BG) 100%<br />

Italy <strong>Tessenderlo</strong> Partecipazioni SpA 24047 Treviglio (BG) 100%<br />

Luxembourg Térélux SA GD 2633 Luxembourg 100%<br />

Poland Dyka Polska Sp.zo.o. 55-221 Jecz-Laskowice 100%<br />

Poland T.C.T. Polska Sp.zo.o. 96-500 Sochaczew 100%<br />

Poland Wymar Polska Sp.zo.o 62-100 Wagrowiec 100%<br />

Switzerland <strong>Tessenderlo</strong> Schweiz AG 5330 Zurzach 100%<br />

The Netherlands Dyka BV 8331 LJ Steenwijk 100%<br />

The Netherlands <strong>Tessenderlo</strong> NL Holding BV 4854 MT Bavel 100%<br />

The Netherlands LVM Limburg BV 6167 RZ Geleen 100%<br />

The Netherlands Nyloplast Europe BV 3295KG s-Gravendeel 100%<br />

163


financial report <strong>2008</strong><br />

The Netherlands <strong>Tessenderlo</strong> Chemie Maastricht BV 6222 Maastricht 100%<br />

The Netherlands <strong>Tessenderlo</strong> Chemie Rotterdam BV 3133 KA Vlaardingen 100%<br />

United Kingdom Eurocell Building Plastics Ltd Alfreton-Derbyshire DE55 4 RF 100%<br />

United Kingdom Eurocell plc Alfreton-Derbyshire DE55 4 RF 100%<br />

United Kingdom Eurocell Profiles Ltd Alfreton-Derbyshire DE55 4 RF 100%<br />

United Kingdom John Davidson Pipes Ltd Longtown-Carlisle CA6 5LY 100%<br />

United Kingdom PB Gelatins UK Ltd CF 375 SQ Treforest-Mid Glamorgan 100%<br />

United Kingdom <strong>Tessenderlo</strong> Fine Chemicals Ltd ST13 8UZ Leek; Staffordshire 100%<br />

United Kingdom <strong>Tessenderlo</strong> Holding UK Ltd CF 375 SU Treforest 100%<br />

United Kingdom <strong>Tessenderlo</strong> UK Ltd Widnes, Cheshire, WA8 ONY 100%<br />

United Kingdom Wymar Systems Ltd DY13 9EZ Worcestershire 100%<br />

USA<br />

USA Chelsea Building Products Inc Oakmont - Pennsylvania 15139 100%<br />

USA PB Leiner USA Corp Davenport - Iowa 52809 100%<br />

USA <strong>Tessenderlo</strong> Kerley Inc Phoenix - Arizona 85008-3279 100%<br />

USA <strong>Tessenderlo</strong> U.S.A. Inc. Phoenix - Arizona 85008-3279 100%<br />

USA Tessendelo Kerley Services Inc New Mexico-88 220 Carlsbad 100%<br />

USA MPR Services Inc Phoenix - Arizona 85008-3279 100%<br />

Rest of the world<br />

164<br />

Argentina PB Leiner Argentina SA Santa Fe CC108-S3016WAC - Santo 100%<br />

Tomé<br />

Canada Dynaplast-Extruco Inc. G7X OB6 Jonquière - Québec 82.17%<br />

China<br />

Lianyungang Taile Chemical Industry, Lianyungang City - 222023 Jiangsu 100%<br />

Co. Ltd.<br />

Province<br />

China PB Gelatins (Pingyang) Ping Yang County - 325401 Zhejiang 80%<br />

Province<br />

China <strong>Tessenderlo</strong> Asia Holding Ltd. Chine R.P. - Hongkong 100%<br />

China <strong>Tessenderlo</strong> Trading Shanghai Chine R.P. - 20021 Shanghai 100%<br />

List of the most important consolidated companies on 31 December <strong>2008</strong><br />

accounted for by the equity method<br />

Europe<br />

Belgium T-Power SA 1050 Brussels 33.33%<br />

Belgium Zéoline SA 4480 Engis 50%<br />

France Bonnet 34500 Beziers 25%<br />

France Ferso Bio SAS 47521 Le Passage 50%<br />

France Ispac 64130 Mauleon 50%<br />

France Labrousse 46120 Anglars 50%<br />

France Michel 31800 Villeneuve de Rivière 25%<br />

France Siram SARL 50390 Nehou 50%<br />

France SH Capital 47520 Le Passage 50%<br />

France Solagra SAS 40370 Rion Des Landes 50%<br />

USA<br />

Mexico Alkemin S de RL de CV Mexico D.F. 11700 49.50%<br />

USA Jupiter Sulphur LLC Phoenix -Arizona 85008-3279 50%<br />

USA Wolf Mountain Products LLC Lindon - Utah 84042 30%


<strong>Tessenderlo</strong> <strong>Group</strong><br />

34. Critical accounting estimates and judgements<br />

The preparation of the financial statements in conformity with IFRS as adopted for use by the<br />

European Union requires management to make estimates and assumptions that affect the reported<br />

amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the<br />

financial statements and the reported amounts of revenue and expenses during the reporting period.<br />

Management bases its estimates on historical experience and various other assumptions that are<br />

believed to be reasonable under the circumstances, the results of which form the basis for making<br />

the reported amounts of revenue and expenses that may not be readily apparent from other sources.<br />

Actual results could differ from those estimates. Estimates are used in accounting for allowances for<br />

uncollectible receivables, inventory obsolescence and lower of cost of net realisable value adjustments,<br />

depreciation, employee benefits, taxes, restructuring provisions and contingencies. Estimates and<br />

assumptions are reviewed periodically and the effects of revisions are reflected in the financial<br />

statements in the period they are determined to be necessary.<br />

The <strong>Group</strong> has applied significant estimates and judgements in order to prepare the consolidated<br />

financial statements with respect to property, plant and equipment (note 10), goodwill (note 11), lower<br />

of cost of net realisable value adjustments with respect to inventories (note 17), provisions (note 24),<br />

income taxes (note 9 and 15), employee benefits (note 23) and contingencies (note 29).<br />

Statement on the true and fair view of the consolidated financial statements and<br />

the fair overview of the management report<br />

165<br />

G. Marchand (Chairman of the Board of Directors and CEO) and C. Vrebosch (CFO) certify, on behalf and<br />

for the account of the company, that, to his/their knowledge,<br />

a) the consolidated financial statements which have been prepared in accordance with International<br />

Financial <strong>Report</strong>ing Standards as adopted by the European Union, give a true and fair view of the<br />

assets, liabilities, financial position and profit or loss of the company, and the entities included in<br />

the consolidation as a whole,<br />

b) the consolidated management report includes a fair overview of the development and performance<br />

of the business and the position of the company, and the entities included in the consolidation,<br />

together with a description of the principal risks and uncertainties which they are exposed to.<br />

<strong>Report</strong> according to article 119 of the Belgian Companies Code<br />

This annual report is prepared and includes the provisions as required in article 119 of the Company<br />

Law.


financial report <strong>2008</strong><br />

AUDITOR’S REPORT<br />

166


<strong>Tessenderlo</strong> <strong>Group</strong><br />

167


financial report <strong>2008</strong><br />

STATUTORY FINANCIAL REPORT<br />

Balance sheet of <strong>Tessenderlo</strong> Chemie NV<br />

(Millions EUR) <strong>2008</strong> 2007<br />

ASSETS<br />

Intangible assets 4.0 4.7<br />

Tangible assets 202.1 205.9<br />

Financial assets 428.2 420.3<br />

Fixed assets 634.3 630.9<br />

Stocks and orders in progress 189.2 73.5<br />

Receivables due within on year 186.6 124.7<br />

Investments 0.0 30.0<br />

Cash and cash equivalents 5.5 1.4<br />

Prepaid expenses and accrued income 0.8 0.5<br />

Current assets 382.1 230.1<br />

Total assets 1,016.4 861.0<br />

168<br />

LIABILITIES<br />

Share capital 138.0 137.0<br />

Share premiums 43.4 42.0<br />

Reserves 19.3 17.5<br />

Retained earnings 314.4 264.8<br />

Capital grants 8.0 8.7<br />

Shareholders' equity 523.1 470.1<br />

Provisions 95.4 77.5<br />

Deferred taxes 1.4 0.5<br />

Provisions and deferred taxes 96.8 78.0<br />

Liabilities due in more than one year 60.2 75.2<br />

Liabilities due within one year 334.4 237.0<br />

Accrued expenses and deferred income 1.9 0.7<br />

Current liabilities 396.5 312.9<br />

Total liabilities 1,016.4 861.0


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Profit and loss statement of <strong>Tessenderlo</strong> Chemie NV<br />

(Millions EUR) <strong>2008</strong> 2007<br />

Sales and operating income<br />

Sales 931.9 643.8<br />

Change in work in progress, finished goods and orders in<br />

77.5 -15.3<br />

progress (increase+/decrease-)<br />

Production capitalised 2.0 2.0<br />

Other operating income 36.3 25.5<br />

Total operating income 1,047.7 656.0<br />

Cost of sales and operating charges (-)<br />

Raw materials and goods purchased for resale<br />

1. Purchases 623.3 318.3<br />

2. Changes in stocks (increase-/decrease+) -38.5 -0.5<br />

Services and other goods 203.4 179.0<br />

Wages, salaries, social charges and pensions 114.4 109.1<br />

Depreciations and amortizations on formation expenses, tangible<br />

25.3 28.8<br />

and intangible assets<br />

Amounts written-off stocks and trade receivable ( charges+ /<br />

0.1 -0.1<br />

write-back- )<br />

Provision for liabilities and charges (charges less utilisations and<br />

17.9 -4.8<br />

write-backs)<br />

Other operating charges 5.0 6.2<br />

Total operating charges 951.0 636.1<br />

Operating result 96.8 19.9<br />

Net financial result 17.8 29.5<br />

Ordinary profit (+) / losses (-) before taxes 114.5 49.4<br />

Extraordinary charges/income 0.1 0.0<br />

Profit before taxes 114.6 49.4<br />

Income taxes -25.3 0.6<br />

Deferred taxes -0.9 -0.2<br />

Profit (+) / losses (-) 88.4 49.8<br />

Untaxed reserves -1.7 -0.4<br />

Profit (+) / losses (-) for the year to be allocated 86.7 49.4<br />

169


financial report <strong>2008</strong><br />

Allocations and distributions<br />

(Millions EUR) <strong>2008</strong> 2007<br />

The <strong>Tessenderlo</strong> Chemie NV Board of Directors propose to allocate the<br />

- Profits, being 86.7 49.4<br />

- Increased by prior years' retained earnings 264.8 250.8<br />

Totalling: 351.5 300.2<br />

In the following manner:<br />

- Reserves 1.0 0.4<br />

- Dividends 37.0 35<br />

- Retained earnings 314.4 264.8<br />

Totalling: 351.5 300.2<br />

If the General Meeting of 2 June 2009 approves this proposed allocation, the gross dividend will be<br />

1.3333 EUR or a net dividend of 1.0000 EUR for the 27 713 288 ordinary shares and for the VVPR dividend<br />

a net amount of 1.1333 EUR remittance of coupon n° 72.<br />

170


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Excerpt from the <strong>Tessenderlo</strong> Chemie NV separate (non-consolidated) financial<br />

statements prepared in accordance with Belgian GAAP<br />

The following information is extracted from the separate Belgian GAAP financial statements of<br />

<strong>Tessenderlo</strong> Chemie NV. These separate financial statements, together with the management report of<br />

the Board of Directors to the general assembly of shareholders as well as the auditors’ report, will be<br />

filed with the National Bank of Belgium within the legally foreseen time limits. These documents are<br />

also available on request from: <strong>Tessenderlo</strong> Chemie NV, Troonstraat 130, 1050 Brussel.<br />

It should be noted that only the consolidated financial statements present a true and fair view of the<br />

financial position and performance of <strong>Tessenderlo</strong> <strong>Group</strong>.<br />

Since <strong>Tessenderlo</strong> Chemie NV is essentially a holding company, which recognises its investments at cost<br />

in its non-consolidated financial statements, these separate financial statements present no more than<br />

a limited view of the financial position of <strong>Tessenderlo</strong> Chemie NV. For this reason, the Board of Directors<br />

deemed it appropriate to publish only an abbreviated version of the non-consolidated balance sheet and<br />

income statement prepared in accordance with Belgian GAAP as at, and for the year ended 31 December<br />

<strong>2008</strong>.<br />

The statutory auditor’s report is unqualified and certifies that the non-consolidated financial statements<br />

of <strong>Tessenderlo</strong> Chemie NV prepared in accordance with Belgian GAAP for the year ended 31 December<br />

<strong>2008</strong> give a true and fair view of the financial position and results of <strong>Tessenderlo</strong> Chemie NV in<br />

accordance with all legal and regulatory dispositions.<br />

171


annual report <strong>2008</strong><br />

General information<br />

Production Units<br />

Chemicals<br />

Inorganics Production Units Main Products<br />

PB Gelatins (Vilvoorde)<br />

feed phosphates<br />

Belgium<br />

<strong>Tessenderlo</strong> Chemie Ham<br />

feed phosphates, hydrochloric<br />

acid, potassium sulphate,<br />

sulphuric acid<br />

Zeoline (Engis - Liège)<br />

zeolites<br />

172<br />

France<br />

Italy<br />

Produits Chimiques de Loos<br />

<strong>Tessenderlo</strong> Italia (Cologna<br />

Veneta) (Italphos)<br />

hydrochloric acid, potassium<br />

sulphate<br />

feed phosphates<br />

Netherlands <strong>Tessenderlo</strong> Chemie Rotterdam feed phosphates<br />

North America<br />

PVC / Chlor-alkali<br />

Belgium<br />

France<br />

<strong>Tessenderlo</strong> Kerley (Phoenix)<br />

9 production sites<br />

extensive distribution network<br />

LVM <strong>Tessenderlo</strong><br />

<strong>Tessenderlo</strong> Chemie <strong>Tessenderlo</strong><br />

Produits Chimiques de Loos<br />

SAV - Mazingarbe<br />

liquid sulphur fertilisers:<br />

ammonium, calcium, magnesium<br />

and potassium thiosulphate<br />

crop protection products, slow<br />

release nitrogen solutions<br />

vinyl chloride monomer (VCM)<br />

caustic soda, caustic potash,<br />

chlorine, ferric chloride, hydrogen<br />

sulphide, potassium carbonte<br />

lye, sodium sulphide, sodium<br />

hypochlorite (bleach)<br />

caustic potash, caustic potash<br />

flakes, mineral chlorides<br />

(aluminium, ferric and zinc),<br />

sodium hypochlorite (bleach)<br />

PVC<br />

Netherlands LVM Limburg Beek PVC<br />

North America <strong>Tessenderlo</strong> Kerley (Phoenix) sulphurous products


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Plastics Converting<br />

Profiles Production Units Main Products<br />

Belgium<br />

Wymar International (Oeselgem)<br />

PVC profiles for windows and<br />

doors, as well as interior and<br />

exterior finishing systems<br />

Canada<br />

Dynaplast Extruco (Montreal)<br />

PVC window and door profiles and<br />

profiles for various sectors<br />

France<br />

Plastival (Clerval)<br />

window and door profiles, profiles<br />

for fences, facade cladding<br />

Great Britain<br />

Eurocell Profiles<br />

Eurocell Building Plastics<br />

+ 90 distribution centers<br />

PVC profiles for windows,<br />

doors and components for<br />

conservatories and foamed<br />

profiles used as roofing<br />

components and facade cladding<br />

United States<br />

Chelsea Building Products<br />

(Oakmont)<br />

Rigid and foamed PVC profiles<br />

for building products, moulding,<br />

shutters, cladding and flooring.<br />

Rigid and foamed PVC compounds<br />

Plastic Pipe Systems<br />

Belgium<br />

France<br />

Dyka Plastics (Overpelt)<br />

+ 7 distribution centers in Belux<br />

Sotra-Seperef<br />

(St. Austreberthe and Quincieux)<br />

plastic pipe systems in PVC, PE<br />

and PP<br />

Design and production of plastic<br />

pipe systems for the construction<br />

and public works sector, the<br />

agricultural sector and the<br />

industry in general<br />

173<br />

Netherlands<br />

Dyka BV (Steenwijk)<br />

+ 20 distribution centers in The<br />

Netherlands<br />

PVC pipe systems<br />

Nyloplast<br />

fittings<br />

Poland<br />

Dyka Polska (Jelcz-Laskowice)<br />

+ 13 distribution centers<br />

PVC, PE and PP pipe systems<br />

UK<br />

John Davidson Pipes<br />

+ 27 distribution centers<br />

distribution of plastic pipe systems<br />

Compounds<br />

France<br />

CTS - Cousin-Tessier (Tiffauges)<br />

CTS - Saplast (Strasbourg)<br />

ready for use PVC and TPE<br />

mixtures mainly for injection<br />

mouldings and extrusions and<br />

thermoplastic elastomers for the<br />

car industry and for construction<br />

PVC compounds for cable and<br />

construction<br />

Plastival (Clerval)<br />

Marvyflo® compound for<br />

dashboards for cars<br />

Poland CTS - TCT Polska (Sochaczew) PVC and TPE compounds


annual report <strong>2008</strong><br />

Specialities<br />

Fine Chemicals Production Units Main Products<br />

Organic Chlorine Derivatives<br />

Belgium<br />

China<br />

Great Britain<br />

<strong>Tessenderlo</strong> Chemie <strong>Tessenderlo</strong><br />

Taile Chemical Industry<br />

(Lyanyungang)<br />

<strong>Tessenderlo</strong> Trading Shanghai<br />

<strong>Tessenderlo</strong> Fine Chemicals (Leek)<br />

benzyl chloride, benzylidene<br />

chloride benzotrichloride and<br />

derivatives<br />

benzyl chloride, benzaldehyde<br />

Trading office for all<br />

<strong>Tessenderlo</strong> <strong>Group</strong> activities<br />

acetic acid esters and triacetin<br />

aromas benzyl acetate,<br />

hexylcinnamaldehyde<br />

Italy <strong>Tessenderlo</strong> Italia (Pieve Vergonte) chlorotoluenes<br />

Netherlands <strong>Tessenderlo</strong> Chemie Maastricht benzyl alcohol<br />

Pharmaceutical Intermediates<br />

174<br />

Belgium <strong>Tessenderlo</strong> Chemie (<strong>Tessenderlo</strong>) glycine and derivatives<br />

France<br />

Calaire Chimie (Calais)<br />

pharmaceutical intermediates<br />

active pharmaceutical<br />

ingredients<br />

Italy<br />

Chemilyl (Loos)<br />

Farchemia (Treviglio)<br />

oxalyl chloride and derivatives<br />

pharmaceutical intermediates,<br />

active pharmaceutical<br />

ingredients<br />

Gelatins<br />

Argentina<br />

PB Leiner Argentina (Santa Fé)<br />

+ 2 collection centers<br />

gelatins<br />

Belgium PB Gelatins (Vilvoorde) gelatins & ossein<br />

China PB Gelatins (Pingyang) gelatins<br />

Germany PB Gelatins Germany (Nienburg) gelatins<br />

Great Britain PB Gelatins UK (Treforest) gelatins<br />

USA PB Leiner USA (Davenport) gelatins<br />

Natural Derivatives<br />

France<br />

Akiolis (Le Mans)<br />

4 rendering plants<br />

9 plants for valorisation<br />

including:<br />

*15 units for valorisation of<br />

animal materials<br />

*2 units for treatment of used<br />

vegetable oils<br />

43 collection centers


Addresses<br />

TESSENDERLO GROUP<br />

General Management,<br />

Corporate Secretary,<br />

Human Resources, IT and Organisation,<br />

Finance and Accounting Management<br />

Corporate Communication<br />

rue du Trône, 130<br />

BE-1050 Bruxelles (Belgium)<br />

Troonstraat 130<br />

BE-1050 Brussel (Belgium)<br />

Tel.: + 32 2 639 18 11<br />

Fax: + 32 2 639 19 99<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO CHEMIE NV<br />

Headoffice<br />

Stationstraat - Entrance 2<br />

Industrieterrein Schoonhees – Zone 1<br />

BE-3980 <strong>Tessenderlo</strong><br />

Tel.: + 32 13 61 22 11<br />

Fax: + 32 13 66 81 40<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO CHEMIE INTERNATIONAL NV<br />

SHARED SERVICE CENTER<br />

Ubicenter<br />

Philipssite 5 – 3rd floor<br />

BE-3001 Leuven (Belgium)<br />

Tel.: +32 16 70 72 00<br />

Fax: +32 16 70 72 80<br />

Chemicals<br />

HEADOFFICE CHEMICALS<br />

H. Hartlaan 21 – Entrance 5<br />

Industrieterrein Schoonhees – Zone 1<br />

BE-3980 <strong>Tessenderlo</strong> (Belgium)<br />

Tel.: +32 13 61 22 11<br />

Fax: +32 13 66 86 04<br />

Website: www.tessenderlogroup.com<br />

INORGANICS<br />

PRODUITS CHIMIQUES<br />

DE LOOS SAS<br />

BP 39 - FR-59374 Loos (France)<br />

rue Clémenceau<br />

FR-59120 Loos (France)<br />

Tel.: +33 320 22 58 58<br />

Fax: +33 320 93 59 80<br />

Website: www.tessenderlogroup.com<br />

<strong>Tessenderlo</strong> <strong>Group</strong><br />

TESSENDERLO CHEMIE NV<br />

Industrieterrein Ravenshout 1010 – Zone 1<br />

Bergstraat, 32 - Entrance 1<br />

BE-3945 Ham (Belgium)<br />

Tel.: +32 13 61 22 11<br />

Fax: +32 13 61 12 32<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO CHEMIE<br />

ROTTERDAM B.V.<br />

Zevenmanshaven, 139<br />

NL-3133 CA Vlaardingen (The Netherlands)<br />

Tel.: +31 10 445 27 77<br />

Fax: +31 10 445 27 38<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO ITALIA srl<br />

Feed Phosphate Plant – Division Italphos<br />

Via Quari Destra 41<br />

IT-37044 Cologna Veneta (Verona) (Italy)<br />

Tel.: +39 0442 41 38 11<br />

Fax: +39 0442 41 38 28<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO KERLEY Inc.<br />

2255 N° 44th Street, Suite 300<br />

US-Phoenix - Arizona 85008 – 3279 (USA)<br />

Tel.: +1 602 889 83 00<br />

Fax: +1 602 889 84 30<br />

Website: www.tkinet.com<br />

ZEOLINE SA<br />

rue J. Wauters, 144<br />

BE-4480 Engis (Belgium)<br />

Tel.: +32 42 73 92 63<br />

Fax: +32 42 75 79 60<br />

Sales offices<br />

HGS Handelsgesellschaft für<br />

Spezialfuttermittel mbH<br />

Mörkenstrasse 5<br />

DE-22767 Hamburg (Germany)<br />

Tel.: +49 408 797987-0<br />

Fax: +49 408 797987-60<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO CHEMIE ESPAÑA TCE SA<br />

POSTAL ADDRESS<br />

Apartado de Correos 134<br />

ES-28400 Collado Villalba (Madrid) (Spain)<br />

Tel.: +34 91 357 32 04<br />

Fax: +34 91 351 32 04<br />

Website: www.tessenderlogroup.com<br />

175


annual report <strong>2008</strong><br />

176<br />

TESSENDERLO CHEMIE<br />

ROTTERDAM B.V.<br />

Zevenmanshaven, 139<br />

NL-3133 CA Vlaardingen (The Netherlands)<br />

Tel.: +31 10 445 27 77<br />

Fax: +31 10 445 27 38<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO ITALIA srl<br />

Feed Phosphate Plant – Division Italphos<br />

Via Quari Destra 41<br />

IT-37044 Cologna Veneta (Verona) (Italy)<br />

Tel.: +39 0442 41 38 11<br />

Fax: +39 0442 41 38 28<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO KERLEY LATINOAMERICANA SA<br />

Andres de Fuenzalida 133 depto A<br />

CL-9358 Santiago (Chile)<br />

Tel.: +56 2 334 65 71<br />

Fax: +56 2 334 88 12<br />

Website: www.tkinet.com<br />

TESSENDERLO KERLEY MEXICO SA de CV<br />

Blvd. Rodolpho Elias Calles 515-13 OTE<br />

Obregon, Sonora<br />

MX-Mexico 85000 (Mexico)<br />

Tel.: +11 52 64 44 17 59 53<br />

Fax: +11 52 64 44 17 96 00<br />

Website: www.tkinet.com<br />

TESSENDERLO KERLEY MIDDLE EAST<br />

Business Center/6th floor<br />

Box 2795<br />

LA-Jounieh (Lebanon)<br />

Tel.: +961 99 34 635<br />

Fax: +961 96 43 125<br />

Website: www.tkinet.com<br />

TESSENDERLO KERLEY PERU SAC<br />

Parque Industrial<br />

Jacinto Ibanez 131<br />

PE-Arequipa (Peru)<br />

Tel.: +51 54 24 18 24<br />

Fax: +51 54 23 28 55<br />

Website: www.tkinet.com<br />

TESSENDERLO POLSKA Sp.z o.o.<br />

ul. Szarych Szeregów 7<br />

PL-60-462 Poznan (Poland)<br />

Tel.: +48 61 840 00 40<br />

Fax: +48 61 840 02 96<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO AGROCHEM TARIM VE KIMYA<br />

SAN. VE TIC. Ltd<br />

Kustepe Mahallesi<br />

Leylak Sokak, Murat Is Merkezi<br />

B. Blok, K:11 D:37<br />

TR-34387 /Istanbul (Turkey)<br />

Tel.: +90 212 217 56 26<br />

Fax: +90 212 217 56 31<br />

Website: www.tkinet.com<br />

PVC / CHLOR-ALKALI<br />

PRODUITS CHIMIQUES<br />

DE LOOS SAS<br />

BP 39 - FR-59374 Loos (France)<br />

rue Clémenceau<br />

FR-59120 Loos (France)<br />

Tel.: +33 320 22 58 58<br />

Fax: +33 320 93 59 80<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO CHEMIE NV<br />

Stationsstraat – Entrance 2<br />

Industrieterrein Schoonhees - Zone 1<br />

BE-3980 <strong>Tessenderlo</strong> (Belgium)<br />

Tel.: +32 13 61 22 11<br />

Fax: +32 13 66 81 40<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO ITALIA S.r.L.<br />

30/32 Via Mario Massari<br />

IT-28886 Pieve Vergonte (VB) (Italy)<br />

Tel.: +39 0324 86 03 59<br />

Fax: +39 0324 86 03 73<br />

Sales offices<br />

TESSENDERLO SCHWEIZ AG<br />

Zürcherstrasse 42<br />

CH-5330 Bad Zurzach (Switzerland)<br />

Tel.: +41 56 249 09 69<br />

Fax: +41 56 249 09 67<br />

Website: www.tessenderlo.ch<br />

PVC / CHLOR-ALKALI<br />

LVM Limburgse Vinyl<br />

Maatschappij NV<br />

H. Hartlaan, 21 – Entrance 5<br />

Industrieterrein Schoonhees 2030<br />

BE-3980 <strong>Tessenderlo</strong> (Belgium)<br />

Tel.: +32 13 61 22 11<br />

Fax: +32 13 66 84 06<br />

Website: www.lvm.be


<strong>Tessenderlo</strong> <strong>Group</strong><br />

LVM Limburg B.V.<br />

Koolwaterstofstraat 1<br />

NL-6161 RA Geleen (The Netherlands)<br />

Tel.: +31 464 76 81 48<br />

Fax: +31 464 76 46 41<br />

R & D Polymers<br />

H. Hartlaan, 21 – Entrance 5<br />

Industrieterrein Schoonhees 2030<br />

BE-3980 <strong>Tessenderlo</strong> (Belgium)<br />

Tel.: +32 13 61 22 11<br />

Fax: +32 13 67 20 18<br />

SAV SAS Plant Mazingarbe<br />

Chemin des Soldats<br />

BP 49<br />

FR-62160 Bully-les-Mines (France)<br />

Tel.: +33 321 72 85 06<br />

Fax: +33 321 72 82 60<br />

Website: www.tessenderlogroup.com<br />

Plastics Converting<br />

HEADOFFICE PLASTICS CONVERTING<br />

rue du Trône, 130<br />

BE-1050 Bruxelles (Belgium)<br />

Troonstraat 130<br />

BE-1050 Brussel (Belgium)<br />

Tel.: + 32 2 639 18 11<br />

Fax: + 32 2 639 19 99<br />

Website: www.tessenderlogroup.com<br />

PROFILES<br />

CHELSEA BUILDING PRODUCTS Inc.<br />

565, Cedar Way<br />

US-Oakmont, Pennsylvania 15139 (USA)<br />

Tel.: + 1 412 826 80 77<br />

Fax: +1 412 826 80 96<br />

Website: www.chelseabuildingproducts.com<br />

DYNAPLAST EXTRUCO Inc.<br />

10500, rue Colbert<br />

Anjou<br />

Montréal H1J 2H8 (Canada)<br />

Tel.: +1 514 355 68 68<br />

Fax: +1 514 355 03 52<br />

Website: www.dynaplastextruco.com<br />

EUROCELL PROFILES Ltd<br />

Clover Nook road<br />

Alfreton-Derbyshire<br />

GB-DE 55 4RF (Great Britain)<br />

Tel.: +44 1773 842 100<br />

Fax: +44 1773 842 109<br />

Website: www.eurocell.co.uk<br />

PLASTIVAL SAS<br />

2, Route de Santoche<br />

FR-25340 Clerval (France)<br />

Tel.: +33 381 99 18 18<br />

Fax: +33 381 97 84 97<br />

Website: www.plastival.fr<br />

WYMAR INTERNATIONAL NV<br />

Brugstraat 27<br />

BE-8720 Oeselgem (Belgium)<br />

Tel.: +32 9 388 95 71<br />

Fax: +32 9 388 64 95<br />

Website: www.wymar.com<br />

Sales offices<br />

EUROCELL BUILDING PLASTICS Ltd<br />

Clover Nook road<br />

Alfreton-Derbyshire<br />

GB-DE 55 4RF (Great Britain)<br />

Tel.: +44 1773 842 100<br />

Fax: +44 1773 842 109<br />

Website: www.eurocell.co.uk<br />

PROFEX SAS<br />

rue de Vimy - ZI les Quatorze<br />

FR-62210 Avion (France)<br />

Tel.: +33 321 08 57 20<br />

Fax: +33 321 08 57 30<br />

Website: www.profex.fr<br />

WYMAR HUNGARIA Kft<br />

Csepeli Út. 15<br />

HU-2310 Szigetszentmiklos (Hungary)<br />

Tel.: +36 24 444 800<br />

Fax: +36 24 443 553<br />

Website: www.wymar.hu<br />

WYMAR POLSKA Sp. z o.o.<br />

Ul. Gnieznienska 47<br />

PL-62-100 Wagrowiec (Poland)<br />

Tel.: + 48 67 26 26 246<br />

Fax: + 48 67 26 27 510<br />

Website: www.wymar.com<br />

177


annual report <strong>2008</strong><br />

178<br />

PLASTIC PIPE SYSTEMS<br />

DE HOEVE<br />

KUNSTSTOFRECYCLING B.V.<br />

De Nieuwe Haven, 16<br />

NL-7772 BC Hardenberg (The Netherlands)<br />

Tel.: +31 523 28 83 89<br />

Fax: +31 523 26 03 89<br />

DYKA B.V.<br />

Produktieweg, 7<br />

NL-8331 LJ Steenwijk (The Netherlands)<br />

Tel.: +31 521 53 49 11<br />

Fax: +31 521 53 43 35<br />

Website: www.dyka.com<br />

DYKA PLASTICS NV<br />

Nolimpark 4004<br />

Stuifzandstraat 47<br />

BE-3900 Overpelt (Belgium)<br />

Tel.: +32 11 80 04 20<br />

Fax: +32 11 64 42 46<br />

Website: www.dyka.com<br />

DYKA POLSKA Sp. z o.o.<br />

ul. Belgijska 5<br />

PL-55-221 Jelcz-Laskowice (Poland)<br />

Tel.: +48 71 301 00 00<br />

Fax: +48 71 301 00 01<br />

Website: www.dyka.com<br />

NYLOPLAST EUROPE B.V.<br />

Mijlweg 45<br />

NL- 3295 KG ‘s Gravendeel (The Netherlands)<br />

Tel: +31 78 673 20 44<br />

Fax: + 31 78 673 44 89<br />

SOTRA-SEPEREF SAS<br />

25, Route de Brévillers<br />

FR-62140 Ste Austreberthe (France)<br />

Tel.: +33 321 86 59 00<br />

Fax: +33 321 86 59 01<br />

Website: www.sotra-seperef.com<br />

SOTRA-SEPEREF SAS (2)<br />

Z.I. de Quincieux 2, BP 1<br />

FR-69650 Quincieux (France)<br />

Tel.: +33 472 26 29 72<br />

Fax: +33 478 91 19 98<br />

Website: www.sotra-seperef.com<br />

Sales offices<br />

DYKA B.V. – EXPORT<br />

Deccaweg 25<br />

NL-1042 AE Amsterdam (The Netherlands)<br />

Tel.: +31 20 50 60 081<br />

Fax: + 31 20 61 35 646<br />

Website: www.dyka.com<br />

DYKA GmbH<br />

Birkenweg, 5<br />

OT Wilhelmshorst<br />

DE-14552 Milchendorf (Germany)<br />

Tel.: +49 33 205 24 25 11<br />

Fax: +49 33 205 24 25 20<br />

Website: www.dyka.com<br />

DYKA s.r.l.<br />

46, Grigore Cobalcescu Street<br />

ap.9<br />

RO- Bucharest, sector 1 (Romania)<br />

Tel: + 40 364 262 803<br />

Fax: + 40 364 262 803<br />

Website: www.dyka.com<br />

DYKA SK s.r.o.<br />

Nejedlého 49/9<br />

SK-841 02 Bratislava (Slovak Republic)<br />

Tel.: +421 918 973 286<br />

Fax: +420 336 406 701<br />

Website: www.dyka.com<br />

DYKA s.r.o.<br />

Unhostská 505<br />

CZ-27361 Velká Dobrá (Czech Republic)<br />

Tel.: +420 312 666 011<br />

Fax: +420 312 685 026<br />

Website: www.dyka.com<br />

JOHN DAVIDSON PIPES Ltd<br />

Townfoot Industrial Estate<br />

Longtown, Carlisle<br />

GB-Cumbria CA6 5LY (Great Britain)<br />

Tel.: +44 1228 79 15 03<br />

Fax: +44 1228 79 20 51<br />

Website: www.jdpipes.co.uk<br />

COMPOUNDS<br />

CTS - COUSIN-TESSIER SAS<br />

Zone Industrielle BP 3<br />

FR-85130 Tiffauges (France)<br />

Tel.: +33 251 65 71 43<br />

Fax: +33 251 65 71 61<br />

Website: www.cts-compounds.com


<strong>Tessenderlo</strong> <strong>Group</strong><br />

CTS - SAPLAST SAS<br />

22-24, rue de la Rochelle<br />

Port du Rhin<br />

FR-67100 Strasbourg (France)<br />

Tel.: +33 388 65 82 00<br />

Fax: +33 388 40 00 80<br />

Website: www.cts-compounds.com<br />

CTS - TCT POLSKA Sp. z o.o.<br />

Ul. 15 Sierpnia 106<br />

PL-96-500 Sochaczew (Poland)<br />

Tel.: +48 46 863 13 60<br />

Fax: +48 46 863 13 80<br />

Website: www.cts-compounds.com<br />

Website: www.tct.pl<br />

PLASTIVAL SAS<br />

2, Route de Santoche<br />

FR-25340 Clerval (France)<br />

Tel.: +33 381 99 18 18<br />

Fax: +33 381 97 84 97<br />

Website: www.plastival.fr<br />

Sales offices<br />

MARVYFLO<br />

H. Hartlaan, 21 – Entrance 5<br />

Industrieterrein Schoonhees 2030<br />

BE-3980 <strong>Tessenderlo</strong> (Belgium)<br />

Tel.: +32 13 61 22 11<br />

Fax: +32 13 66 84 06<br />

Website: www.tessenderlogroup.com<br />

Specialities<br />

HEADOFFICE SPECIALITIES<br />

rue du Trône, 130<br />

BE-1050 Bruxelles (Belgium)<br />

Troonstraat 130<br />

BE-1050 Brussel (Belgium)<br />

Tel.: + 32 2 639 18 11<br />

Fax: + 32 2 639 19 99<br />

Website: www.tessenderlogroup.com<br />

FINE CHEMICALS<br />

CALAIRE CHIMIE SAS<br />

Z.I. du Pont du Leu<br />

1, Quai d’Amérique, B.P. 215<br />

FR-62104 Calais Cedex (France)<br />

Tel.: +33 321 46 21 21<br />

Fax: +33 321 46 21 20<br />

CHEMILYL SAS<br />

BP 39 – FR-59374 Loos (France)<br />

rue Clémenceau<br />

FR-59120 Loos (France)<br />

Tel.: +33 320 22 58 58<br />

Fax: +33 320 93 59 80<br />

FARCHEMIA S.r.L.<br />

Via Bergamo, 121<br />

IT-24047 Treviglio (BG) (Italy)<br />

Tel.: +39 0363 31 401<br />

Fax: +39 0363 45 985<br />

Website: www.farchemia.it<br />

TAILE CHEMICAL INDUSTRY<br />

188, Xinhai Road<br />

Lianyungang City,<br />

CN-Jiangsu Province 222023 (China)<br />

Tel.: +86 518 85 25 20 50<br />

Fax: +86 518 85 25 56 86<br />

Website: www.taile.com<br />

TESSENDERLO CHEMIE NV<br />

H. Hartlaan 21 – Entrance 3-4<br />

Industrieterrein Schoonhees 2030<br />

BE-3980 <strong>Tessenderlo</strong> (Belgium)<br />

Tel.: +32 13 61 22 11<br />

Fax: +32 13 66 29 53<br />

Website: www.tessenderlogroup.com<br />

TESSENDERLO CHEMIE MAASTRICHT B.V.<br />

Ankerkade, 111<br />

NL-6222 NL Maastricht (The Netherlands)<br />

Tel.: +31 433 52 59 59<br />

Fax: +31 433 52 59 55<br />

TESSENDERLO FINE CHEMICALS Ltd<br />

Macclesfield Road<br />

GB-Leek, Staffs ST13 8LD (Great Britain)<br />

Tel.: +44 1 538 39 91 00<br />

Fax: +44 1 538 39 90 25<br />

Website: www.tessenderlofinechemicals.co.uk<br />

TESSENDERLO ITALIA S.r.L.<br />

Fine Chemicals Plant<br />

30/32 Via Mario Massari<br />

IT-28886 Pieve Vergonte (VB) (Italy)<br />

Tel.: +39 0324 86 03 59<br />

Fax: +39 0324 86 03 73<br />

179


annual report <strong>2008</strong><br />

180<br />

Sales offices<br />

TESSENDERLO CHEMIE NV – FINE CHEMICALS<br />

Rue du trône 130<br />

1050 Bruxelles (Belgium)<br />

Troonstraat 130<br />

BE-1050 Brussel (Belgium)<br />

Tel.: + 32 2 639 18 11<br />

Fax: + 32 2 639 19 99<br />

GELATIN<br />

TESSENDERLO CHEMIE NV, AFDELING<br />

VILVOORDE<br />

PB GELATINS<br />

Bedrijvenzone “Centrale”<br />

Marius Duchéstraat, 260<br />

BE-1800 Vilvoorde (Belgium)<br />

Tel.: +32 2 255 62 21<br />

Fax: +32 2 253 96 18<br />

Website: www.pbgelatins.com<br />

PB GELATINS GmbH<br />

Große Drakenburger Straße 43<br />

DE-31582 Nienburg/Weser (Germany)<br />

Tel.: +49 50 21 60 100<br />

Fax: +49 50 21 60 10 60<br />

Website: www.pbgelatins.com<br />

PB GELATINS (Pingyang) Co, LTD<br />

Fuqian Road, Wubanqiao,<br />

Aojiang Town, Pingyang County, Wenzhou City<br />

CN-Zhejiang Province 325401 (China)<br />

Tel.: +86 577 63 66 80 05<br />

Fax: +86 577 63 66 81 83<br />

Website: www.pbgelatins.com<br />

PB GELATINS UK Ltd<br />

Treforest Industrial Estate<br />

Building A6, Severn road<br />

GB-Pontypridd CF37 5SQ (Great Britain)<br />

Tel.: +44 1443 849 300<br />

Fax: +44 1443 844 209<br />

Website: www.pbgelatins.com<br />

PB LEINER ARGENTINA<br />

Parque Industrial Sauce Viejo<br />

S3017W16 - Sauce Viejo<br />

Post Office: CC108-S3016WAC<br />

AR-Santa Fe (Argentina)<br />

Tel.: +54 342 450 1100<br />

Fax: +54 342 450 1112<br />

Website:<br />

www.pbgelatins.com - www.gelatin.com<br />

PB LEINER USA<br />

7001 Brady Street<br />

US-Davenport, Iowa 52806 (USA)<br />

Tel.: +1 563 386 8040<br />

Fax: +1 563 391 1138<br />

Website:<br />

www.pbgelatins.com - www.gelatin.com<br />

NATURAL DERIVATIVES<br />

AKIOLIS GROUP<br />

72, av. Olivier Messiaen<br />

FR-72000 Le Mans (France)<br />

Tel.: +33 2 44 81 50 10<br />

Fax: +33 2 44 81 50 12<br />

General Sales Office China<br />

TESSENDERLO TRADING SHANGHAI<br />

Room 2201,<br />

Shanghai Times Square Office Tower<br />

Huai Hai Zhong Road, 93<br />

CN-200021 Shanghai (China)<br />

Tel.: +86 21 63 91 80 66 ext 15<br />

Fax: +86 21 63 91 80 77<br />

Website: www.tessenderlogroup.com


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Index<br />

page<br />

Accounting Policies 105<br />

Addresses 175<br />

Animal feed phosphates 30<br />

Applications 22<br />

Audit (committee) 85<br />

Auditor’s report 166<br />

Balance sheet NV 168<br />

Balance (consolidated) 102<br />

Board of Directors 81<br />

BEL Mid 92<br />

Business <strong>Group</strong>s:<br />

Chemicals 28<br />

Plastics Converting 40<br />

Specialities 54<br />

Calendar (financial) 7<br />

Call warrants 88<br />

Capital 143<br />

Cash flow<br />

cover<br />

Cash flow statement 103<br />

Chart of the group 20<br />

Committees 84<br />

Compounds (pvc/tpe) 50<br />

Consolidated balance sheet 102<br />

Consolidated companies 163<br />

Consolidated income statement 100<br />

Consolidated revenue<br />

cover<br />

Contacts 7<br />

Corporate Governance 81<br />

Dividend 94<br />

Energy 76<br />

Environment 74<br />

Equity (shareholders) 143<br />

Events (recent) 26<br />

Fertilisers 30<br />

Figures over 10 years<br />

cover<br />

Financial communication 94<br />

Financial assets 138<br />

Financial notes 104<br />

Financial ratios 2<br />

Gearing 145<br />

Gelatin 60<br />

General Meeting 7<br />

Goodwill 134<br />

Graphs 2<br />

Guarantees 159<br />

Headcount 71<br />

Human resources 70<br />

IFRS 105<br />

Important figures<br />

cover<br />

Index (stock exchange) 92<br />

page<br />

Intangible assets 136<br />

International presence 18<br />

Investor relations 94<br />

Key figures<br />

cover<br />

Leadership 15<br />

Liabilities (long-term) 144<br />

Management Committee 86<br />

Markets 22<br />

Natural derivatives 64<br />

Next 150 92<br />

Number of shares NV 93<br />

Off-balance sheet commitment 159<br />

Organisation chart companies 20<br />

Pension plan 147<br />

Personnel (costs for) 128<br />

Pharmaceuticals 56<br />

Plastics 40<br />

Plastic Pipe Systems 46<br />

Press releases (dates) 7<br />

Principles of consolidation 106<br />

Production units 172<br />

Products 22<br />

Profile 14<br />

Profiles 42<br />

Profit distribution 144/170<br />

Provisions 152<br />

PVC 35<br />

Results (consolidated) 100<br />

Results NV 169<br />

Revenue breakdown 5<br />

Revenue (consolidated)<br />

cover<br />

Risk Management 76<br />

Safety 74<br />

Sales offices 175<br />

Segment <strong>Report</strong>ing 121<br />

Share <strong>Tessenderlo</strong> Chemie NV 92<br />

Shareholders 92<br />

Stock Exchange data 93<br />

Stock options 88<br />

Strategy of the group 16<br />

Subsidiary companies (consolidated) 163<br />

Tangible assets 132<br />

Taxes 131<br />

Vinyl 2010 75<br />

Water treatment 37<br />

www 184<br />

181


annual report <strong>2008</strong><br />

Financial Glossary<br />

Basic earnings per share (Basic EPS)<br />

EBITDA<br />

Profit (+) / loss (-) for the period attributable<br />

to equity holders of the group divided by the<br />

weighted average number of ordinary shares.<br />

Earnings before interests, taxes, depreciation,<br />

amortisation and provisions<br />

(Profit (+) / loss (-) from operations plus<br />

depreciation, amortisation and provisions).<br />

182<br />

Capital employed (CE)<br />

The carrying amount of property, plant and<br />

equipment (PP&E), intangible assets and<br />

goodwill together with working capital.<br />

Dividend per share (gross)<br />

Total amount paid as dividend divided by the<br />

number of shares issued at closing date.<br />

Diluted earnings per share (Diluted EPS)<br />

Profit (+) / loss (-) for the period attributable<br />

to equity holders of the group divided by the<br />

fully diluted weighted average number of<br />

ordinary shares.<br />

Diluted weighted average number of ordinary<br />

shares<br />

Weighted average number of ordinary shares,<br />

adjusted by the effect of share options on<br />

issue.<br />

EBIT<br />

Earnings before interests and taxes<br />

(Profit (+) / loss (-) from operations).<br />

Gearing<br />

Net financial liabilities divided by equity.<br />

Interest coverage<br />

Profit (+) / loss (-) for the period plus income<br />

tax expense and interest expense, divided by<br />

the interest expense.<br />

Market capitalisation<br />

Number of shares issued (at the end of the<br />

period) multiplied by the market price per<br />

share (at the end of the period).<br />

Net cash flow<br />

Profit (+) / loss (-) for the period and all<br />

non cash flow items included in the income<br />

statement (provisions, amortisations,<br />

deprecation and impairment losses).<br />

Net financial liabilities<br />

Non-current and current financial liabilities<br />

minus cash and cash equivalents.


<strong>Tessenderlo</strong> <strong>Group</strong><br />

Non-recurring items<br />

Items related to restructuring, impairment<br />

losses, claims and other income or expenses,<br />

which do not occur regularly as part of the<br />

normal activities of the company.<br />

Pay out ratio<br />

Gross dividend divided by profit for the period<br />

attributable to equity holders of the group.<br />

REBIT<br />

Recurring earnings before interests and taxes<br />

(Profit from operations before non-recurring<br />

items).<br />

REBITDA<br />

Recurring earnings before interests, taxes,<br />

depreciation, amortisation and provisions<br />

(Profit from operations plus depreciation,<br />

amortisation and provisions).<br />

Theoretical aggregated weighted tax rate<br />

Calculated by applying the statutory tax rate<br />

of each country on the profit before tax of<br />

each entity and by dividing the resulting tax<br />

charge by the total profit before tax of the<br />

group.<br />

Weighted average number of ordinary shares<br />

Number of shares outstanding at the<br />

beginning of the period, adjusted by the<br />

number of shares cancelled, repurchased or<br />

issued during the period multiplied by a timeweighting<br />

factor.<br />

Working capital<br />

Inventories, trade and other receivables<br />

minus trade and other payables.<br />

183<br />

Return on capital employed (ROCE)<br />

REBIT divided by capital employed.<br />

Return on equity (ROE)<br />

Profit (+) / loss (-) for the period divided by<br />

average equity attributable to equity holders<br />

of the group.


annual report <strong>2008</strong><br />

Editor<br />

M. Vandenbergen – Corporate Communication<br />

<strong>Tessenderlo</strong> <strong>Group</strong><br />

Troonstraat 130<br />

B-1050 Brussels (BE)<br />

Tel.: +32 2 639 18 11<br />

Concept & Pre-press<br />

Comfi & Publishing, www.comfi.be<br />

184<br />

Het jaarverslag is tevens beschikbaar in het Nederlands.<br />

Le rapport annuel est également disponible en français.<br />

The <strong>Annual</strong> <strong>Report</strong> (in <strong>English</strong>, Dutch, French) may be viewed on our website:<br />

www.tessenderlogroup.com; see News & Media – Publications.<br />

A user-friendly interactive (html) version of the <strong>English</strong> <strong>Annual</strong> <strong>Report</strong> is also available on<br />

the website.<br />

TESSENDERLO CHEMIE NV<br />

Administrative Headquarters<br />

Troonstraat 130<br />

B-1050 Brussels (Belgium)<br />

Tel. +32 2 639 18 11<br />

Fax +32 2 639 19 99<br />

BTW BE 0 412 101 728<br />

RPR Hasselt<br />

Website: www.tessenderlogroup.com


www.tessenderlogroup.com


Making it together<br />

Making it FIT<br />

Making it LASTING<br />

Making it INSPIRING<br />

Making it CONVINCING<br />

Making it WORK<br />

www.tessenderlogroup.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!